amiodarone has been researched along with Atrioventricular Nodal Re-Entrant Tachycardia in 551 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this randomized, double-blind trial, we compared parenteral amiodarone, lidocaine, and saline placebo, along with standard care, in adults who had nontraumatic out-of-hospital cardiac arrest, shock-refractory ventricular fibrillation or pulseless ventricular tachycardia after at least one shock, and vascular access." | 9.22 | Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest. ( Aufderheide, TP; Brienza, AM; Brown, SP; Callaway, CW; Christenson, J; Colella, MR; Daya, M; Desvigne-Nickens, P; Dorian, P; Dunford, JV; Egan, D; Gray, PC; Gray, R; Idris, AH; Kudenchuk, PJ; Leroux, B; Morrison, LJ; Nichol, G; Ornato, JP; Rea, T; Seals, N; Stiell, IG; Straight, R; Vaillancourt, C; Vilke, GM; Weisfeldt, ML; Wittwer, L, 2016) |
| "To compare the clinical efficacy of intravenous diltiazem, digoxin, and amiodarone for acute ventricular rate (VR) control in patients with acute symptomatic atrial fibrillation (AF) necessitating hospitalization." | 9.14 | Intravenous diltiazem is superior to intravenous amiodarone or digoxin for achieving ventricular rate control in patients with acute uncomplicated atrial fibrillation. ( Lam, KF; Lau, CP; Lee, WL; Siu, CW; Tse, HF, 2009) |
| "To explore the therapeutic effects of amiodarone and metoprolol, either alone or in combination, on chronic heart failure (CHF) complicated by ventricular arrhythmia." | 9.14 | [Therapeutic effects of amiodarone and metoprolol on chronic heart failure complicated by ventricular arrhythmia]. ( He, BB; Huang, GH; Lü, HS, 2009) |
| "EPS was performed 1 month after starting amiodarone, and Holter-monitoring was recorded before and 1 month after amiodarone in 188 patients with sustained VT/VF because of structural heart diseases." | 9.13 | Electrophysiologic study-guided amiodarone for sustained ventricular tachyarrhythmias associated with structural heart diseases. ( Aiba, T; Aihara, N; Kamakura, S; Kurita, T; Noda, T; Okamura, H; Satomi, K; Shimizu, W; Suyama, K; Taguchi, A; Yamagata, K, 2008) |
| " Amiodarone either has no effect or improves the haemodynamics in patients with left ventricular dysfunction, but its effect on BNP is unknown." | 9.10 | Amiodarone decreases plasma brain natriuretic peptide level in patients with heart failure and ventricular tachyarrhythmia. ( Hagiwara, N; Hosaka, F; Kajimoto, K; Kasanuki, H; Matsuda, N; Shiga, T; Shoda, M; Tanizaki, K; Wakaumi, M, 2003) |
| "We sought to compare the long-term survival rates of patients with sustained ventricular tachyarrhythmia after myocardial infarction (MI) who were treated according to the results of electrophysiological (EP) study either with amiodarone or an implantable cardioverter-defibrillator (ICD)." | 9.10 | Electrophysiologically guided amiodarone therapy versus the implantable cardioverter-defibrillator for sustained ventricular tachyarrhythmias after myocardial infarction: results of long-term follow-up. ( Fromer, M; Kappenberger, L; Rapp, F; Schläpfer, J, 2002) |
| "Amiodarone (AMD) and nifekalant (NIF) are used in the treatment of ventricular fibrillation or tachycardia; however, only few studies have been conducted on their efficacies." | 8.95 | Meta-analysis of the efficacies of amiodarone and nifekalant in shock-resistant ventricular fibrillation and pulseless ventricular tachycardia. ( Chuma, M; Imai, T; Ishizawa, K; Izawa-Ishizawa, Y; Koga, T; Kondo, Y; Koyama, T; Kurata, Y; Nakura, H; Niimura, T; Sato, S; Sendo, T; Takechi, K; Tanaka, S; Zamami, Y, 2017) |
| "We report a case of amiodarone-induced thyrotoxicosis, and a broad review of the literature." | 8.82 | [Amiodarone-induced thyrotoxicosis: case report and review of the literature]. ( Bianconcini, M; Giannini, AL, 2003) |
| "Amiodarone appears to be an effective antiarrhythmic agent for reducing mortality in the postmyocardial infarction patient with ventricular ectopic activity." | 8.79 | Use of amiodarone in the postmyocardial infarction patient. ( Carlson, TA; Massumi, A; Ozdil, E, 1995) |
| "To assess the incidence of amiodarone-mediated aggravation of ventricular tachyarrhythmias or the development of new arrhythmias, such as torsade de pointes, in patients with cardiac disease." | 8.79 | Amiodarone-associated proarrhythmic effects. A review with special reference to torsade de pointes tachycardia. ( Hohnloser, SH; Klingenheben, T; Singh, BN, 1994) |
| "A case is presented in which amiodarone was administered to suppress paroxysmal atrial fibrillation in a patient with an idiopathic cardiomyopathy." | 8.79 | Nonsustained polymorphous ventricular tachycardia during amiodarone therapy for atrial fibrillation complicating cardiomyopathy. Management with intravenous magnesium sulfate. ( Curwin, JH; Sachs, RG; Winters, SL, 1997) |
| "To report a new case and review the literature of amiodarone-related epididymitis to improve knowledge of the clinical characteristics of this reaction." | 8.78 | Amiodarone-induced epididymitis: report of a new case and literature review of 12 cases. ( Biron, P; Kus, T; Sadek, I, 1993) |
| " We included adult patients with shockable rhythms, such as ventricular fibrillation and pulseless ventricular tachycardia, who were administered either lidocaine or amiodarone." | 8.12 | Comparison of the effects of lidocaine and amiodarone for out-of-hospital cardiac arrest patients with shockable rhythms: a retrospective observational study from a multicenter registry. ( Amagasa, S; Fukushima, F; Kashiura, M; Kishihara, Y; Moriya, T; Yasuda, H, 2022) |
| "To describe the successful management of ventricular fibrillation (VF) and ventricular tachycardia (VT) using cardiopulmonary resuscitation, including defibrillation, followed by continuous rate infusion of IV amiodarone, in a cat with cardiac arrest secondary to tachyarrhythmia." | 7.96 | Successful management of ventricular fibrillation and ventricular tachycardia using defibrillation and intravenous amiodarone therapy in a cat. ( Berlin, N; Kelmer, E; Maiorkis, I; Ohad, DG, 2020) |
| "We describe a case of amiodarone-induced thyrotoxicosis (AIT) with cardiopulmonary arrest (CPA) in a 49-year-old woman." | 7.88 | Amiodarone-induced Thyrotoxicosis with Cardiopulmonary Arrest. ( Hasegawa, N; Inoue, K; Kakuta, Y; Kondo, T; Kowase, S; Miki, K; Nishikawa, T; Omura, M; Saito, J; Sugisawa, C; Tsurutani, Y, 2018) |
| "To determine the association between amiodarone and lidocaine and outcomes in children with cardiac arrest with pulseless ventricular tachycardia (pVT) and ventricular fibrillation (VF)." | 7.80 | Outcomes associated with amiodarone and lidocaine in the treatment of in-hospital pediatric cardiac arrest with pulseless ventricular tachycardia or ventricular fibrillation. ( Berg, MD; Berg, RA; Donoghue, AJ; Hammond, R; Hoyme, DB; Samson, RA; Valdes, SO, 2014) |
| " The sheep were prophylactically treated with amiodarone plus lidocaine before ligation of the four to six coronary artery branches supplying the apex of the heart (arrhythmia prevention [AP] group, n = 45) and with epinephrine (shock prevention [SP] group, n = 49), respectively." | 7.79 | Prophylactic amiodarone and lidocaine improve survival in an ovine model of large size myocardial infarction. ( Griffith, BP; Li, T; Sanchez, PG; Watkins, AC; Wei, X; Wu, ZJ, 2013) |
| "To examine whether low-dose ranolazine and/or dronedarone can protect against vulnerability to atrial fibrillation (AF) and ventricular tachyarrhythmias." | 7.79 | Low doses of ranolazine and dronedarone in combination exert potent protection against atrial fibrillation and vulnerability to ventricular arrhythmias during acute myocardial ischemia. ( Belardinelli, L; Kanas, AF; Nearing, BD; Pagotto, VP; Sobrado, MF; Verrier, RL; Zeng, D, 2013) |
| "To report a case of amiodarone-induced thyrotoxicosis (AIT) concomitant with thyroid cancer in multinodular goiter (MNG)." | 7.78 | Amiodarone-induced thyrotoxicosis with thyroid papillary cancer in multinodular goiter: case report. ( Akamizu, T; Inaba, H; Kobayashi, S; Komatsu, M; Suzuki, S; Takeda, T, 2012) |
| "To evaluate the efficacy of amiodarone in dogs with refractory supraventricular and ventricular arrhythmias and to document the side effects in treated dogs." | 7.78 | Retrospective evaluation of the use of amiodarone in dogs with arrhythmias (from 2003 to 2010). ( Dukes-McEwan, J; Fonfara, S; López-Alvarez, J; Pedro, B; Stephenson, H, 2012) |
| "The effects of dronedarone, a non-iodinated derivative of amiodarone, on ventricular tachycardia and ventricular fibrillation post-myocardial infarction are not well established." | 7.74 | Comparative antiarrhythmic efficacy of amiodarone and dronedarone during acute myocardial infarction in rats. ( Agelaki, MG; Baltogiannis, GG; Fotopoulos, A; Kolettis, TM; Korantzopoulos, P; Pantos, C; Tsalikakis, DG, 2007) |
| "This study investigated whether chronic and acute amiodarone treatment has differential effects on ventricular arrhythmogenesis during acute myocardial infarction in rats." | 7.74 | Comparative effects of acute vs. chronic oral amiodarone treatment during acute myocardial infarction in rats. ( Agelaki, MG; Baltogiannis, GG; Fotopoulos, A; Kolettis, TM; Mourouzis, I; Pantos, C; Vlahos, AP, 2007) |
| "A 47-year-old male had bilateral upper extremity thrombophlebitis after use of intravenous amiodarone for sustained ventricular tachycardia complicating myocardial infarction." | 7.73 | Bilateral upper extremity thrombophlebitis related to intravenous amiodarone: a case report. ( Aljitawi, O; Shabaneh, B; Whitaker, J, 2005) |
| "Two patients presented with atrial fibrillation which was refractory to amiodarone but successfully treated with bepridil." | 7.73 | [Cardioversion of amiodarone-insensitive atrial fibrillation by bepridil in heart failure: two case reports]. ( Hadano, Y; Iwami, T; Kimura, M; Matsuzaki, M; Miyazaki, Y; Ogawa, H; Shimizu, A; Takaki, A; Wakeyama, T, 2006) |
| "Amiodarone was required in 10 cases of recurrent symptomatic paroxysmal atrial fibrillation (AF) and in 5 cases of ventricular tachycardia (VT) (M = 12, F = 3, mean age: 63 +/- 14)." | 7.72 | Radioiodine ablation of the thyroid to prevent recurrence of amiodarone-induced thyrotoxicosis in patients with resistant tachyarrhythmias. ( Arlot, S; Delonca, J; Hermida, JS; Jarry, G; Moullart, V; Rey, JL; Schvartz, C; Tcheng, E, 2004) |
| "Thyrotoxicosis is a well-documented and studied complication of treatment with amiodarone, but little has been written about the risks and treatment of recurrent thyrotoxicosis upon re-exposure to amiodarone." | 7.72 | Can amiodarone be restarted after amiodarone-induced thyrotoxicosis? ( Braverman, LE; Cooper, DS; Kloos, RT; Ladenson, PW; Ryan, LE, 2004) |
| "Amioradone-induced hyperthyroidism is a common complication of amiodarone therapy." | 7.72 | [Prevention of recurrent amiodarone-induced hyperthyroidism by iodine-131]. ( Arlot, S; Hermida, JS; Jarry, G; Moullart, V; Rey, JL; Schvartz, C; Tcheng, E, 2004) |
| "The effects of short-term amiodarone and dronedarone treatments on action potential characteristics and arrhythmia (ventricular tachycardia ) induced by reperfusion after global low-flow ischemia were studied in rat hearts." | 7.71 | Beneficial effects of amiodarone and dronedarone (SR 33589b), when applied during low-flow ischemia, on arrhythmia and functional parameters asssessed during reperfusion in isolated rat hearts. ( Barbé, C; Kreher, P; Rochetaing, A, 2001) |
| "In 232 Japanese patients receiving long-term amiodarone therapy for life-threatening ventricular tachyarrhythmias, hyperthyroidism and hypothyroidism developed in 29 patients (12." | 7.71 | Amiodarone-Induced thyroid dysfunction and ventricular tachyarrhythmias during long-term therapy in Japan. ( Hagiwara, N; Kasanuki, H; Matsuda, N; Sato, K; Shiga, T; Shoda, M; Wakaumi, M, 2001) |
| "For a patient with idiopathic dilated cardiomyopathy, an implantable defibrillator, and amiodarone induced thyrotoxicosis associated with ventricular fibrillation storm." | 7.71 | Electrical storm due to amiodarone induced thyrotoxicosis in a young adult with dilated cardiomyopathy: thyroidectomy as the treatment of choice. ( Manios, EG; Marketou, ME; Simantirakis, EN; Vardas, PE, 2001) |
| "The efficacy and safety of amiodarone in the management of atrial fibrillation (AF) or flutter in 108 Japanese patients with heart failure was retrospectively examined." | 7.71 | Effect of low-dose amiodarone on atrial fibrillation or flutter in Japanese patients with heart failure. ( Hagiwara, N; Hosaka, F; Imai, T; Kasanuki, H; Matsuda, N; Shiga, T; Shoda, M; Sugiura, R; Suzuki, T; Wakaumi, M; Yamada, Y, 2002) |
| "The medical records, including radiographic imaging, pathology and operative reports, of 2 postpubertal boys who had sterile epididymitis after prolonged therapy with amiodarone were reviewed." | 7.70 | Amiodarone induced epididymitis in children. ( Diamond, DA; Hutcheson, J; Peters, CA, 1998) |
| "We compared the ability of a new amiodarone-like agent, SR 33589, with that of amiodarone, D,L-sotalol, and lignocaine to reduce the incidence of ventricular fibrillation (VF) and associated arrhythmias caused by acute coronary artery occlusion in anesthetized pigs." | 7.69 | Effects of a new amiodarone-like agent, SR 33589, in comparison to amiodarone, D,L-sotalol, and lignocaine, on ischemia-induced ventricular arrhythmias in anesthetized pigs. ( Chatelain, P; Finance, O; Manning, A, 1995) |
| "Amiodarone-induced hyperthyroidism in a relatively rare complication of long-term treatment with this molecule." | 7.69 | [Value of thyroidectomy in amiodarone-induced hyperthyroidism. Apropos of 3 cases]. ( Dupuis, JM; Painvin, I; Rohmer, V; Ronceray, J; Tadéi, A; Victor, J, 1996) |
| "The authors report the case of a patient treated with amiodarone for syncopal ventricular tachycardia complicating idiopathic dilated cardiomyopathy in whom symptomatic hyperthyroidism led to a discussion of the different therapeutic options available in this type of case." | 7.69 | [Treatment of amiodarone-induced hyperthyroidism by carbimazole with maintenance of amiodarone]. ( Bonal, J; Bouchiat, C; Cellarier, G; Dussarat, GV; Talard, P, 1996) |
| "We describe a patient who was treated with amiodarone for ventricular arrhythmia based on arrhythmogenic right ventricular dysplasia and who subsequently developed severe amiodarone-induced thyrotoxicosis." | 7.69 | A case of amiodarone-induced thyrotoxicosis successfully treated with prednisolone. ( Hayashi, K; Kondoh, J; Numaguchi, Y; Sassa, H; Sone, T; Suzuki, T; Tsuboi, H, 1997) |
| "Seventy-seven consecutive patients (mean age 62 years) with episodes of sustained ventricular tachycardia (VT) or ventricular fibrillation (VF) after acute myocardial infarction (AMI) were evaluated to assess the long-term efficacy of first-line amiodarone treatment and to identify clinical and laboratory factors associated with a high risk of death or arrhythmia recurrence." | 7.68 | Risk stratification and prognosis of patients treated with amiodarone for malignant ventricular tachyarrhythmias after myocardial infarction. ( Facchin, D; Feruglio, GA; Proclemer, A; Vanuzzo, D, 1993) |
| "One hundred twenty-two patients treated chronically with amiodarone for sustained ventricular tachycardia or ventricular fibrillation after failing conventional antiarrhythmic therapy were analyzed to determine which factors were predictive of sudden cardiac death during follow-up." | 7.68 | Stratification of sudden death risk in patients receiving long-term amiodarone treatment for sustained ventricular tachycardia or ventricular fibrillation. ( Foster, JR; Olson, PJ; Simpson, RJ; Woelfel, A, 1993) |
| "Intravenous amiodarone was administered in 1-mg/kg body weight aliquots followed by continuous infusion to patients with potentially life-threatening tachyarrhythmias that had not been abolished by standard therapies." | 7.68 | Intravenous amiodarone for life-threatening tachyarrhythmias in children and young adults. ( Denfield, SW; Fenrich, AL; Friedman, RA; Knilans, TK; Marlow, D; Perry, JC, 1993) |
| "Amiodarone treated patients had a lower incidence of AF (22." | 6.71 | Amiodarone prevents symptomatic atrial fibrillation and reduces the risk of cerebrovascular accidents and ventricular tachycardia after open heart surgery: results of the Atrial Fibrillation Suppression Trial (AFIST). ( Kluger, J; White, CM, 2003) |
| "Amiodarone was administered at a dosage of 800 mg/day for 2 weeks followed by 400 mg/day thereafter." | 6.68 | Effect of amiodarone therapy on mortality in patients with left ventricular dysfunction and asymptomatic complex ventricular arrhythmias: Argentine Pilot Study of Sudden Death and Amiodarone (EPAMSA). ( Gambarte, A; Garguichevich, JJ; Gentile, A; Hauad, S; Ramos, JL; Scapin, O; Sirena, J; Tibaldi, M; Toplikar, J, 1995) |
| "A similar morning peak of sudden cardiac death was found in both the amiodarone (n = 42) and the placebo (n = 54) groups, and the overall circadian pattern did not differ between them (p = 0." | 6.68 | Effects of amiodarone on the circadian pattern of sudden cardiac death (Department of Veterans Affairs Congestive Heart Failure-Survival Trial of Antiarrhythmic Therapy). ( Behrens, S; Fisher, SG; Fletcher, RD; Franz, MR; Ney, G; Singh, SN, 1997) |
| "Amiodarone has emerged as the leading antiarrhythmic therapy for termination and prevention of ventricular arrhythmia in different clinical settings because of its proven efficacy and safety." | 6.46 | Amiodarone for the treatment and prevention of ventricular fibrillation and ventricular tachycardia. ( Dorian, P; Van Herendael, H, 2010) |
| "Further studies, including the Sudden Cardiac Death Heart Trial (SCD HeFT), should help determine the role of amiodarone in heart failure patients." | 6.40 | Amiodarone in congestive heart failure. ( Singh, S, 1998) |
| "No sustained ventricular tachycardia, ventricular fibrillation, sudden cardiac death, or cardiovascular mortality were observed." | 5.72 | Propafenone use in coronary artery disease patients undergoing atrial fibrillation ablation. ( Aksu, T; Aras, D; Cay, S; Kara, M; Ozcan, F; Ozeke, O; Topaloglu, S, 2022) |
| "Long QT syndrome is characterized by electrocardiographic appearance of long QT intervals and propensity to polymorphic ventricular tachycardia." | 5.38 | A neonate with long QT syndrome, refractory ventricular arrhythmias, and lidocaine toxicity. ( Montenegro, LM; Naim, M; Nathan, AT; Vetter, VL, 2012) |
| "On day 21, he was complicated with acute respiratory distress syndrome." | 5.33 | Fatal case of amiodarone-induced acute respiratory distress syndrome in a patient with severe left ventricular dysfunction due to extensive anterior acute myocardial infarction. ( Ando, H; Eto, Y; Fukumoto, Y; Ikeuchi, M; Kishi, T; Kuwata, K; Nakamura, R; Okamatsu, S; Ozawa, M; Sekiya, M; Sobashima, A; Yamada, A; Yamawaki, T, 2006) |
| "Among these arrhythmias, ventricular tachycardia may be resistant to treatment." | 5.30 | Sustained ventricular tachycardia in cardiac hemochromatosis treated with amiodarone. ( Kumbasar, SD; Paksoy, N; Semiz, E; Tosun, Z; Yalçinkaya, S, 1997) |
| "Amiodarone was effective in preventing VT recurrence." | 5.30 | Hyperkalemia probably reverses the antiarrhythmic effects of amiodarone: a case report. ( Akiyama, J; Morishima, A; Tomizawa, T; Umezawa, S, 1999) |
| "Amiodarone has been shown to improve survival in patients with impaired left ventricular function and ventricular trachyarrhythmias." | 5.29 | [Symptomatic bradycardia with amiodarone in patients with pre-existing conduction disorders]. ( Hofmann, R; Leisch, F, 1995) |
| "The aim of the study was to systematically review evidence on the effectiveness and safety of oral mexiletine administered in monotherapy or in combination with other antiarrhythmic drugs for recurrent ventricular arrhythmia (ventricular tachycardia/ventricular fibrillation, VT/VF) in adult patients with structural heart disease (SHD) and implantable cardioverter defibrillators (ICDs)." | 5.22 | Mexiletine for recurrent ventricular tachycardia in adult patients with structural heart disease and implantable cardioverter defibrillator: an EHRA systematic review. ( Anic, A; Boveda, S; Conte, G; de Asmundis, C; Farkowski, MM; Karlinski, M; Lewandowski, M; Marijon, E; Mugnai, G; Providencia, R; Pytkowski, M, 2022) |
| "In this randomized, double-blind trial, we compared parenteral amiodarone, lidocaine, and saline placebo, along with standard care, in adults who had nontraumatic out-of-hospital cardiac arrest, shock-refractory ventricular fibrillation or pulseless ventricular tachycardia after at least one shock, and vascular access." | 5.22 | Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest. ( Aufderheide, TP; Brienza, AM; Brown, SP; Callaway, CW; Christenson, J; Colella, MR; Daya, M; Desvigne-Nickens, P; Dorian, P; Dunford, JV; Egan, D; Gray, PC; Gray, R; Idris, AH; Kudenchuk, PJ; Leroux, B; Morrison, LJ; Nichol, G; Ornato, JP; Rea, T; Seals, N; Stiell, IG; Straight, R; Vaillancourt, C; Vilke, GM; Weisfeldt, ML; Wittwer, L, 2016) |
| "To compare the clinical efficacy of intravenous diltiazem, digoxin, and amiodarone for acute ventricular rate (VR) control in patients with acute symptomatic atrial fibrillation (AF) necessitating hospitalization." | 5.14 | Intravenous diltiazem is superior to intravenous amiodarone or digoxin for achieving ventricular rate control in patients with acute uncomplicated atrial fibrillation. ( Lam, KF; Lau, CP; Lee, WL; Siu, CW; Tse, HF, 2009) |
| "To explore the therapeutic effects of amiodarone and metoprolol, either alone or in combination, on chronic heart failure (CHF) complicated by ventricular arrhythmia." | 5.14 | [Therapeutic effects of amiodarone and metoprolol on chronic heart failure complicated by ventricular arrhythmia]. ( He, BB; Huang, GH; Lü, HS, 2009) |
| "EPS was performed 1 month after starting amiodarone, and Holter-monitoring was recorded before and 1 month after amiodarone in 188 patients with sustained VT/VF because of structural heart diseases." | 5.13 | Electrophysiologic study-guided amiodarone for sustained ventricular tachyarrhythmias associated with structural heart diseases. ( Aiba, T; Aihara, N; Kamakura, S; Kurita, T; Noda, T; Okamura, H; Satomi, K; Shimizu, W; Suyama, K; Taguchi, A; Yamagata, K, 2008) |
| " Furthermore, combination of BVP and oral administration of amiodarone significantly prevented recurrence of ventricular tachycardia and paroxysmal atrial fibrillation, and maintained sinus rhythm for a long period." | 5.11 | Effect of biventricular pacing therapy in patients with dilated cardiomyopathy with severe congestive heart failure. ( Baba, H; Goto, K; Kawagoe, J; Noma, M; Origuchi, H; Sakamoto, M; Sese, A; Takemoto, M; Yamamoto, H; Yoshimura, H, 2004) |
| " Amiodarone either has no effect or improves the haemodynamics in patients with left ventricular dysfunction, but its effect on BNP is unknown." | 5.10 | Amiodarone decreases plasma brain natriuretic peptide level in patients with heart failure and ventricular tachyarrhythmia. ( Hagiwara, N; Hosaka, F; Kajimoto, K; Kasanuki, H; Matsuda, N; Shiga, T; Shoda, M; Tanizaki, K; Wakaumi, M, 2003) |
| "We sought to compare the long-term survival rates of patients with sustained ventricular tachyarrhythmia after myocardial infarction (MI) who were treated according to the results of electrophysiological (EP) study either with amiodarone or an implantable cardioverter-defibrillator (ICD)." | 5.10 | Electrophysiologically guided amiodarone therapy versus the implantable cardioverter-defibrillator for sustained ventricular tachyarrhythmias after myocardial infarction: results of long-term follow-up. ( Fromer, M; Kappenberger, L; Rapp, F; Schläpfer, J, 2002) |
| " In 1987, the Cardiac Arrest Study Hamburg (CASH), a prospective, randomized trial, was initiated to compare metoprolol, amiodarone, propafenone, and ICD implantation in patients surviving sudden cardiac death due to documented ventricular tachycardia and/or ventricular fibrillation." | 5.07 | Preliminary results of the Cardiac Arrest Study Hamburg (CASH). CASH Investigators. ( Cappato, R; Kuck, KH; Rüppel, R; Schneider, MA; Siebels, J, 1993) |
| "The Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (CASCADE) study evaluated antiarrhythmic drug treatment of survivors of out-of-hospital ventricular fibrillation (VF) not associated with a Q-wave myocardial infarction who were at especially high risk of recurrence of VF." | 5.07 | Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE Study). The CASCADE Investigators. ( , 1993) |
| "Amiodarone (AMD) and nifekalant (NIF) are used in the treatment of ventricular fibrillation or tachycardia; however, only few studies have been conducted on their efficacies." | 4.95 | Meta-analysis of the efficacies of amiodarone and nifekalant in shock-resistant ventricular fibrillation and pulseless ventricular tachycardia. ( Chuma, M; Imai, T; Ishizawa, K; Izawa-Ishizawa, Y; Koga, T; Kondo, Y; Koyama, T; Kurata, Y; Nakura, H; Niimura, T; Sato, S; Sendo, T; Takechi, K; Tanaka, S; Zamami, Y, 2017) |
| "Amiodarone is an antiarrhythmic agent among the I most powerful and the most frequently used for the control of recurrent ventricular tachycardia and the secondary prevention of recurrent atrial fibrillation." | 4.90 | [Amiodarone and the thyroid]. ( Beckers, A; Benoit, A; Betea, D; Brescia, L; Delvenne, P; Hamoir, E, 2014) |
| "We report a case of amiodarone-induced thyrotoxicosis, and a broad review of the literature." | 4.82 | [Amiodarone-induced thyrotoxicosis: case report and review of the literature]. ( Bianconcini, M; Giannini, AL, 2003) |
| " For patients who have a history of sustained ventricular tachycardia(VT) or ventricular fibrillation(VF) amiodarone or an implantable cardioverter defibrillator(ICD) should be considered, and these therapy may benefit some high risk patients who have nonsustained VT." | 4.81 | [Heart failure]. ( Komuro, I; Yonezawa, M, 2002) |
| "Amiodarone is a highly efficacious antiarrhythmic agent for many cardiac arrhythmias, ranging from atrial fibrillation to malignant ventricular rhythm disturbances." | 4.81 | Amiodarone: an emergency medicine perspective. ( Taylor, SE, 2002) |
| " In patients with a history of resuscitated ventricular fibrillation (VF) or unstable ventricular tachycardia (VT), the ICD was superior to therapy with amiodarone in 3 large trials involving 2,024 patients." | 4.80 | Implantable devices versus antiarrhythmic drug therapy in recurrent ventricular tachycardia and ventricular fibrillation. ( Hohnloser, SH, 1999) |
| "Amiodarone is an antiarrhythmic agent commonly used in the treatment of supraventricular and ventricular tachyarrhythmias." | 4.80 | Amiodarone: clinical trials. ( Luck, JC; Naccarelli, GV; Patel, HM; Wolbrette, DL, 2000) |
| "Despite the antiarrhythmic efficacy of amiodarone, a definitive correlation between amiodarone treatment and increased non-arrhythmic mortality in patients with heart failure and depressed ventricular function has been reported." | 4.80 | Perspectives: does amiodarone increase non-sudden deaths? If so, why? ( Auricchio, A; Klein, HU; Nisam, S, 2000) |
| "Amiodarone appears to be an effective antiarrhythmic agent for reducing mortality in the postmyocardial infarction patient with ventricular ectopic activity." | 4.79 | Use of amiodarone in the postmyocardial infarction patient. ( Carlson, TA; Massumi, A; Ozdil, E, 1995) |
| "To assess the incidence of amiodarone-mediated aggravation of ventricular tachyarrhythmias or the development of new arrhythmias, such as torsade de pointes, in patients with cardiac disease." | 4.79 | Amiodarone-associated proarrhythmic effects. A review with special reference to torsade de pointes tachycardia. ( Hohnloser, SH; Klingenheben, T; Singh, BN, 1994) |
| " Randomized clinical trials of prophylactic amiodarone in patients with congestive heart failure and nonsustained ventricular tachycardia have produced conflicting results." | 4.79 | Evaluation and treatment of nonsustained ventricular tachycardia. ( Wilber, DJ, 1996) |
| " The trials were conducted independently from each other and both have a randomized, placebo controlled design to assess the efficacy of the class III agent amiodarone in patients with acute myocardial infarction." | 4.79 | [Anti-arrhythmia therapy after myocardial infarct: preliminary results of EMIAT and CAMIAT studies]. ( Kuck, KH, 1996) |
| "A case is presented in which amiodarone was administered to suppress paroxysmal atrial fibrillation in a patient with an idiopathic cardiomyopathy." | 4.79 | Nonsustained polymorphous ventricular tachycardia during amiodarone therapy for atrial fibrillation complicating cardiomyopathy. Management with intravenous magnesium sulfate. ( Curwin, JH; Sachs, RG; Winters, SL, 1997) |
| "Cases of hypothyroidism and hyperthyroidism associated with amiodarone therapy are described, and the mechanisms, clinical appearance, and management of amiodarone-induced thyroid dysfunction are discussed." | 4.78 | Amiodarone-induced thyroid dysfunction. ( Jaffe, CA; Khanderia, U; Theisen, V, 1993) |
| "To report a new case and review the literature of amiodarone-related epididymitis to improve knowledge of the clinical characteristics of this reaction." | 4.78 | Amiodarone-induced epididymitis: report of a new case and literature review of 12 cases. ( Biron, P; Kus, T; Sadek, I, 1993) |
| " We included adult patients with shockable rhythms, such as ventricular fibrillation and pulseless ventricular tachycardia, who were administered either lidocaine or amiodarone." | 4.12 | Comparison of the effects of lidocaine and amiodarone for out-of-hospital cardiac arrest patients with shockable rhythms: a retrospective observational study from a multicenter registry. ( Amagasa, S; Fukushima, F; Kashiura, M; Kishihara, Y; Moriya, T; Yasuda, H, 2022) |
| "We enrolled all consecutive patients with unsuccessful/not feasible catheter ablation and ineffective/contraindicated amiodarone or beta-blockers, which started the mexiletine treatment for refractory ventricular tachycardia (VT) or ventricular fibrillation (VF) between January 2010 and January 2020." | 4.12 | Mexiletine for ventricular arrhythmias in patients with chronic coronary syndrome: a cohort study. ( Bilato, C; Cavedon, S; Mecenero, A; Mugnai, G; Paolini, C; Perrone, C, 2022) |
| "We retrospectively evaluated survival in 160 consecutive adults with refractory ventricular fibrillation/ventricular tachycardia out-of-hospital cardiac arrest treated with the University of Minnesota (UMN) ECPR protocol (transport with ongoing cardiopulmonary resuscitation [CPR] to the cardiac catheterization laboratory for ECPR) compared with 654 adults who had received standard CPR in the amiodarone arm of the ALPS trial (Amiodarone, Lidocaine, or Placebo Study)." | 3.96 | Improved Survival With Extracorporeal Cardiopulmonary Resuscitation Despite Progressive Metabolic Derangement Associated With Prolonged Resuscitation. ( Aufderheide, TP; Bartos, JA; Carlson, C; Conterato, M; Duval, S; Frascone, RJ; Grunau, B; John, R; Kalra, R; Raveendran, G; Ripeckyj, A; Trembley, A; Yannopoulos, D, 2020) |
| "To describe the successful management of ventricular fibrillation (VF) and ventricular tachycardia (VT) using cardiopulmonary resuscitation, including defibrillation, followed by continuous rate infusion of IV amiodarone, in a cat with cardiac arrest secondary to tachyarrhythmia." | 3.96 | Successful management of ventricular fibrillation and ventricular tachycardia using defibrillation and intravenous amiodarone therapy in a cat. ( Berlin, N; Kelmer, E; Maiorkis, I; Ohad, DG, 2020) |
| "To determine the association between amiodarone or lidocaine and outcomes in adult in-hospital cardiac arrest (IHCA) with shock-refractory ventricular fibrillation (VF) or pulseless ventricular tachycardia (pVT)." | 3.96 | Outcomes associated with amiodarone and lidocaine for the treatment of adult in-hospital cardiac arrest with shock-refractory pulseless ventricular tachyarrhythmia. ( Chang, WT; Chen, WJ; Huang, CH; Liu, YB; Tsai, MS; Wang, CH; Wu, YW; Yu, PH, 2020) |
| "We describe a case of amiodarone-induced thyrotoxicosis (AIT) with cardiopulmonary arrest (CPA) in a 49-year-old woman." | 3.88 | Amiodarone-induced Thyrotoxicosis with Cardiopulmonary Arrest. ( Hasegawa, N; Inoue, K; Kakuta, Y; Kondo, T; Kowase, S; Miki, K; Nishikawa, T; Omura, M; Saito, J; Sugisawa, C; Tsurutani, Y, 2018) |
| "To determine the association between amiodarone and lidocaine and outcomes in children with cardiac arrest with pulseless ventricular tachycardia (pVT) and ventricular fibrillation (VF)." | 3.80 | Outcomes associated with amiodarone and lidocaine in the treatment of in-hospital pediatric cardiac arrest with pulseless ventricular tachycardia or ventricular fibrillation. ( Berg, MD; Berg, RA; Donoghue, AJ; Hammond, R; Hoyme, DB; Samson, RA; Valdes, SO, 2014) |
| " The sheep were prophylactically treated with amiodarone plus lidocaine before ligation of the four to six coronary artery branches supplying the apex of the heart (arrhythmia prevention [AP] group, n = 45) and with epinephrine (shock prevention [SP] group, n = 49), respectively." | 3.79 | Prophylactic amiodarone and lidocaine improve survival in an ovine model of large size myocardial infarction. ( Griffith, BP; Li, T; Sanchez, PG; Watkins, AC; Wei, X; Wu, ZJ, 2013) |
| "To examine whether low-dose ranolazine and/or dronedarone can protect against vulnerability to atrial fibrillation (AF) and ventricular tachyarrhythmias." | 3.79 | Low doses of ranolazine and dronedarone in combination exert potent protection against atrial fibrillation and vulnerability to ventricular arrhythmias during acute myocardial ischemia. ( Belardinelli, L; Kanas, AF; Nearing, BD; Pagotto, VP; Sobrado, MF; Verrier, RL; Zeng, D, 2013) |
| "To report a case of amiodarone-induced thyrotoxicosis (AIT) concomitant with thyroid cancer in multinodular goiter (MNG)." | 3.78 | Amiodarone-induced thyrotoxicosis with thyroid papillary cancer in multinodular goiter: case report. ( Akamizu, T; Inaba, H; Kobayashi, S; Komatsu, M; Suzuki, S; Takeda, T, 2012) |
| "To evaluate the efficacy of amiodarone in dogs with refractory supraventricular and ventricular arrhythmias and to document the side effects in treated dogs." | 3.78 | Retrospective evaluation of the use of amiodarone in dogs with arrhythmias (from 2003 to 2010). ( Dukes-McEwan, J; Fonfara, S; López-Alvarez, J; Pedro, B; Stephenson, H, 2012) |
| "We conducted a retrospective analysis of ST-segment elevation myocardial infarction patients with sustained ventricular tachycardia/ventricular fibrillation in Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO) IIB and GUSTO III and compared all-cause death in patients receiving amiodarone, lidocaine, or no antiarrhythmic." | 3.77 | Antiarrhythmic drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarction. ( Alexander, JH; Ardissino, D; Califf, RM; Granger, CB; Mehta, RH; Ohman, EM; Piccini, JP; Pieper, KS; Schulte, PJ; Van de Werf, F; White, HD, 2011) |
| "The effects of dronedarone, a non-iodinated derivative of amiodarone, on ventricular tachycardia and ventricular fibrillation post-myocardial infarction are not well established." | 3.74 | Comparative antiarrhythmic efficacy of amiodarone and dronedarone during acute myocardial infarction in rats. ( Agelaki, MG; Baltogiannis, GG; Fotopoulos, A; Kolettis, TM; Korantzopoulos, P; Pantos, C; Tsalikakis, DG, 2007) |
| "This study investigated whether chronic and acute amiodarone treatment has differential effects on ventricular arrhythmogenesis during acute myocardial infarction in rats." | 3.74 | Comparative effects of acute vs. chronic oral amiodarone treatment during acute myocardial infarction in rats. ( Agelaki, MG; Baltogiannis, GG; Fotopoulos, A; Kolettis, TM; Mourouzis, I; Pantos, C; Vlahos, AP, 2007) |
| "A 47-year-old male had bilateral upper extremity thrombophlebitis after use of intravenous amiodarone for sustained ventricular tachycardia complicating myocardial infarction." | 3.73 | Bilateral upper extremity thrombophlebitis related to intravenous amiodarone: a case report. ( Aljitawi, O; Shabaneh, B; Whitaker, J, 2005) |
| " Suddenly on the 6th day of the so far uncomplicated AMI ventricular fibrillation developed and was successfully treated with DC shock, and amiodarone (150 mg i." | 3.73 | [Polymorphic ventricular tachycardia in acute myocardial infarction without ST elevation in a patient with thrombocytopenia]. ( Bromblik, A; Bryniarski, L; Czamara, M; Dragan, J; Kukla, P; Szczuka, K; Słowiak-Lewińska, T, 2006) |
| "Two patients presented with atrial fibrillation which was refractory to amiodarone but successfully treated with bepridil." | 3.73 | [Cardioversion of amiodarone-insensitive atrial fibrillation by bepridil in heart failure: two case reports]. ( Hadano, Y; Iwami, T; Kimura, M; Matsuzaki, M; Miyazaki, Y; Ogawa, H; Shimizu, A; Takaki, A; Wakeyama, T, 2006) |
| "Eleven patients developed amiodarone- induced thyrotoxicosis (AIT), ten developed amiodarone-induced hypothyroidism (AIH) and one patient first developed AIT, followed by AIH." | 3.72 | Differential diagnosis and clinical course of amiodarone-induced thyroid dysfunction. ( Acu, B; Alyan, O; Arda, K; Demirkan, D; Ozdemir, O; Soylu, M, 2003) |
| "Amiodarone was required in 10 cases of recurrent symptomatic paroxysmal atrial fibrillation (AF) and in 5 cases of ventricular tachycardia (VT) (M = 12, F = 3, mean age: 63 +/- 14)." | 3.72 | Radioiodine ablation of the thyroid to prevent recurrence of amiodarone-induced thyrotoxicosis in patients with resistant tachyarrhythmias. ( Arlot, S; Delonca, J; Hermida, JS; Jarry, G; Moullart, V; Rey, JL; Schvartz, C; Tcheng, E, 2004) |
| "Thyrotoxicosis is a well-documented and studied complication of treatment with amiodarone, but little has been written about the risks and treatment of recurrent thyrotoxicosis upon re-exposure to amiodarone." | 3.72 | Can amiodarone be restarted after amiodarone-induced thyrotoxicosis? ( Braverman, LE; Cooper, DS; Kloos, RT; Ladenson, PW; Ryan, LE, 2004) |
| "Amioradone-induced hyperthyroidism is a common complication of amiodarone therapy." | 3.72 | [Prevention of recurrent amiodarone-induced hyperthyroidism by iodine-131]. ( Arlot, S; Hermida, JS; Jarry, G; Moullart, V; Rey, JL; Schvartz, C; Tcheng, E, 2004) |
| "We describe a case of amiodarone induced hyponatremia consistent with the syndrome of inappropriate antidiuretic hormone (SIADH) that developed during amiodarone loading, similar to three prior reports." | 3.72 | Syndrome of inappropriate antidiuretic hormone secretion induced by amiodarone therapy. ( Aslam, MK; Gnaim, C; Kowal, RC; Kutnick, J; McGuire, DK, 2004) |
| "Although chronic amiodarone has been proven to be effective to suppress ventricular tachycardia (VT) and ventricular fibrillation (VF), how we predict the recurrence of VT/VF after chronic amiodarone remains unknown." | 3.72 | Excessive increase in QT interval and dispersion of repolarization predict recurrent ventricular tachyarrhythmia after amiodarone. ( Aiba, T; Aihara, N; Inagaki, M; Kamakura, S; Kurita, T; Satomi, K; Shimizu, W; Sunagawa, K; Suyama, K; Taguchi, A, 2004) |
| "The effects of short-term amiodarone and dronedarone treatments on action potential characteristics and arrhythmia (ventricular tachycardia ) induced by reperfusion after global low-flow ischemia were studied in rat hearts." | 3.71 | Beneficial effects of amiodarone and dronedarone (SR 33589b), when applied during low-flow ischemia, on arrhythmia and functional parameters asssessed during reperfusion in isolated rat hearts. ( Barbé, C; Kreher, P; Rochetaing, A, 2001) |
| "In 232 Japanese patients receiving long-term amiodarone therapy for life-threatening ventricular tachyarrhythmias, hyperthyroidism and hypothyroidism developed in 29 patients (12." | 3.71 | Amiodarone-Induced thyroid dysfunction and ventricular tachyarrhythmias during long-term therapy in Japan. ( Hagiwara, N; Kasanuki, H; Matsuda, N; Sato, K; Shiga, T; Shoda, M; Wakaumi, M, 2001) |
| "This report deals with two cases of amiodarone induced pulmonary toxicity in dilated cardiomyopathy leading to respiratory insufficiency." | 3.71 | [Amiodarone induced pulmonary toxicity]. ( Alter, P; Grimm, W; Maisch, B, 2002) |
| "For a patient with idiopathic dilated cardiomyopathy, an implantable defibrillator, and amiodarone induced thyrotoxicosis associated with ventricular fibrillation storm." | 3.71 | Electrical storm due to amiodarone induced thyrotoxicosis in a young adult with dilated cardiomyopathy: thyroidectomy as the treatment of choice. ( Manios, EG; Marketou, ME; Simantirakis, EN; Vardas, PE, 2001) |
| "The efficacy and safety of amiodarone in the management of atrial fibrillation (AF) or flutter in 108 Japanese patients with heart failure was retrospectively examined." | 3.71 | Effect of low-dose amiodarone on atrial fibrillation or flutter in Japanese patients with heart failure. ( Hagiwara, N; Hosaka, F; Imai, T; Kasanuki, H; Matsuda, N; Shiga, T; Shoda, M; Sugiura, R; Suzuki, T; Wakaumi, M; Yamada, Y, 2002) |
| "The medical records, including radiographic imaging, pathology and operative reports, of 2 postpubertal boys who had sterile epididymitis after prolonged therapy with amiodarone were reviewed." | 3.70 | Amiodarone induced epididymitis in children. ( Diamond, DA; Hutcheson, J; Peters, CA, 1998) |
| "The effect of oral amiodarone (AMD) therapy on left ventricular (LV) function was evaluated retrospectively in Japanese patients with ventricular tachyarrhythmias and congestive heart failure." | 3.70 | Effect of relatively low dose amiodarone therapy on left ventricular function in patients with ventricular tachyarrhythmias. ( Yamada, S; Yamaguchi, I, 1998) |
| "We report amiodarone-induced pulmonary toxicity in an 18-year-old boy who had undergone corrective surgery for tetralogy of Fallot 4 years earlier, and was treated with amiodarone because of recurrent malignant postoperative ventricular tachyarrhythmias." | 3.70 | Amiodarone-induced pulmonary toxicity in an adolescent. ( Balijepally, S; Kothari, SS; Taneja, K, 1999) |
| "The aim of this study was to evaluate the survival of patients with hypertrophic cardiomyopathy (HCM) after resuscitated ventricular fibrillation or syncopal sustained ventricular tachycardia (VT/VF) when treated with low dose amiodarone or implantable cardioverter defibrillators (ICDs)." | 3.70 | Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy. ( Elliott, PM; McKenna, WJ; Poloniecki, J; Rowland, E; Sharma, S; Varnava, A, 1999) |
| "We compared the ability of a new amiodarone-like agent, SR 33589, with that of amiodarone, D,L-sotalol, and lignocaine to reduce the incidence of ventricular fibrillation (VF) and associated arrhythmias caused by acute coronary artery occlusion in anesthetized pigs." | 3.69 | Effects of a new amiodarone-like agent, SR 33589, in comparison to amiodarone, D,L-sotalol, and lignocaine, on ischemia-induced ventricular arrhythmias in anesthetized pigs. ( Chatelain, P; Finance, O; Manning, A, 1995) |
| "Amiodarone-induced hyperthyroidism in a relatively rare complication of long-term treatment with this molecule." | 3.69 | [Value of thyroidectomy in amiodarone-induced hyperthyroidism. Apropos of 3 cases]. ( Dupuis, JM; Painvin, I; Rohmer, V; Ronceray, J; Tadéi, A; Victor, J, 1996) |
| "The authors report the case of a patient treated with amiodarone for syncopal ventricular tachycardia complicating idiopathic dilated cardiomyopathy in whom symptomatic hyperthyroidism led to a discussion of the different therapeutic options available in this type of case." | 3.69 | [Treatment of amiodarone-induced hyperthyroidism by carbimazole with maintenance of amiodarone]. ( Bonal, J; Bouchiat, C; Cellarier, G; Dussarat, GV; Talard, P, 1996) |
| "We describe a patient who was treated with amiodarone for ventricular arrhythmia based on arrhythmogenic right ventricular dysplasia and who subsequently developed severe amiodarone-induced thyrotoxicosis." | 3.69 | A case of amiodarone-induced thyrotoxicosis successfully treated with prednisolone. ( Hayashi, K; Kondoh, J; Numaguchi, Y; Sassa, H; Sone, T; Suzuki, T; Tsuboi, H, 1997) |
| "Seventy-seven consecutive patients (mean age 62 years) with episodes of sustained ventricular tachycardia (VT) or ventricular fibrillation (VF) after acute myocardial infarction (AMI) were evaluated to assess the long-term efficacy of first-line amiodarone treatment and to identify clinical and laboratory factors associated with a high risk of death or arrhythmia recurrence." | 3.68 | Risk stratification and prognosis of patients treated with amiodarone for malignant ventricular tachyarrhythmias after myocardial infarction. ( Facchin, D; Feruglio, GA; Proclemer, A; Vanuzzo, D, 1993) |
| " "Conventional" antiarrhythmic agents, which primarily block cardiac sodium channels, are relatively ineffective in preventing arrhythmia recurrence; amiodarone and sotalol appear to be effective in reducing recurrence and mortality rates, although the extent of benefit is not well understood." | 3.68 | The implantable defibrillator and antiarrhythmic drugs--competitive and complementary treatment for severe ventricular arrhythmia. ( Dorian, P; Newman, D, 1993) |
| "A 78-year-old man with a history of congestive heart failure and coronary artery disease began taking amiodarone to suppress sustained ventricular tachycardia." | 3.68 | Amiodarone-clonazepam interaction. ( Ellsworth, AJ; Leversee, JH; Witt, DM, 1993) |
| "One hundred twenty-two patients treated chronically with amiodarone for sustained ventricular tachycardia or ventricular fibrillation after failing conventional antiarrhythmic therapy were analyzed to determine which factors were predictive of sudden cardiac death during follow-up." | 3.68 | Stratification of sudden death risk in patients receiving long-term amiodarone treatment for sustained ventricular tachycardia or ventricular fibrillation. ( Foster, JR; Olson, PJ; Simpson, RJ; Woelfel, A, 1993) |
| "Intravenous amiodarone was administered in 1-mg/kg body weight aliquots followed by continuous infusion to patients with potentially life-threatening tachyarrhythmias that had not been abolished by standard therapies." | 3.68 | Intravenous amiodarone for life-threatening tachyarrhythmias in children and young adults. ( Denfield, SW; Fenrich, AL; Friedman, RA; Knilans, TK; Marlow, D; Perry, JC, 1993) |
| "Catheter ablation improves ventricular tachycardia (VT) event-free (time to event) survival in patients with antiarrhythmic drug (AAD)-refractory VT and previous myocardial infarction (MI)." | 3.30 | Ventricular Tachycardia and ICD Therapy Burden With Catheter Ablation Versus Escalated Antiarrhythmic Drug Therapy. ( Essebag, V; Gardner, M; Gray, C; Healey, JS; Hruczkowski, T; Nault, I; Parkash, R; Samuel, M; Sapp, JL; Sterns, LD, 2023) |
| "All patients enrolled in the Ventricular Tachycardia Ablation vs." | 3.11 | Ventricular tachycardia characteristics and outcomes with catheter ablation vs. antiarrhythmic therapy: insights from the VANISH trial. ( Deyell, MW; Doucette, S; Essebag, V; Gardner, M; Gray, C; Gula, L; Healey, JS; Nault, I; Parkash, R; Sapp, JL; Sterns, LD, 2022) |
| "Mexiletine has limited efficacy in the treatment of recurrent VT despite high-dose amiodarone therapy, in patients with ischemic heart disease." | 2.87 | Mexiletine or catheter ablation after amiodarone failure in the VANISH trial. ( Deyell, MW; Doucette, S; Essebag, V; Gardner, M; Gray, C; Healey, JS; Hruczkowski, T; Leong-Sit, P; Nault, I; Nery, PB; Parkash, R; Rivard, L; Sapp, JL; Steinberg, C; Sterns, LD, 2018) |
| "Procainamide therapy was associated with less major cardiac adverse events and a higher proportion of tachycardia termination within 40 min." | 2.84 | Randomized comparison of intravenous procainamide vs. intravenous amiodarone for the acute treatment of tolerated wide QRS tachycardia: the PROCAMIO study. ( Almendral, J; Arribas, F; Coll-Vinent, B; Del Arco, C; Martín, A; Ortiz, M; Peinado, R, 2017) |
| "Recurrent ventricular tachycardia among survivors of myocardial infarction with an implantable cardioverter-defibrillator (ICD) is frequent despite antiarrhythmic drug therapy." | 2.82 | Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs. ( Blier, L; Essebag, V; Gula, L; Healey, JS; Leong-Sit, P; Nery, PB; Parkash, R; Raymond, JM; Redfearn, D; Rivard, L; Roux, JF; Sapp, JL; Sarrazin, JF; Sterns, LD; Stevenson, WG; Tang, AS; Thibault, B; Tung, SK; Veenhuyzen, GD; Wells, GA, 2016) |
| "IV-amiodarone was administered to 60 patients with ventricular tachyarrhythmia between 2007 and 2012." | 2.80 | Clinical and Electrocardiographic Characteristics of Electrical Storms Due to Monomorphic Ventricular Tachycardia Refractory to Intravenous Amiodarone. ( Akutsu, K; Atarashi, H; Hayashi, H; Hayashi, M; Iwasaki, YK; Katoh, T; Kobayashi, Y; Maruyama, M; Miyauchi, Y; Murata, H; Shimizu, W; Takahashi, K; Tanaka, K; Tsuboi, I; Ueno, A; Uetake, S; Yamamoto, T; Yodogawa, K, 2015) |
| " Group A contained patients demonstrating amiodarone lung toxicity diagnosed by chest X-ray, KL-6 or D(LCO) (n=6), whereas group B included patients treated without any adverse effects (n=20)." | 2.74 | Relationship between amiodarone-induced subclinical lung toxicity and Th1/Th2 balance. ( Harada, M; Hiramatsu, S; Kuruma, T; Maruyama, T; Odashiro, K; Yasuda, S; Yasuda, Y, 2009) |
| "An intravenous bolus injection and subsequent continuous infusion of NIF at a relatively low dosage were effective in treating severe ventricular tachyarrhythmias complicating ACS, reducing the potential risk of proarrhythmia." | 2.74 | Effects of intravenous nifekalant as a lifesaving drug for severe ventricular tachyarrhythmias complicating acute coronary syndrome. ( Abe, A; Ikeda, T; Ishiguro, H; Mera, H; Miwa, Y; Miyakoshi, M; Shimizu, H; Tsukada, T; Yoshino, H; Yusu, S, 2009) |
| " Despite careful precautions, serious proarrhythmias, the major limiting side effect of dofetilide, still occurred during long-term follow-up." | 2.73 | Observations on the safety and effectiveness of dofetilide in patients with paroxysmal atrial fibrillation and normal left ventricular function. ( Bauman, JL; Kehoe, RF; Leal, S; Mykytsey, A; Razminia, M; Saleem, M; Wang, T; Zheutlin, T, 2007) |
| "Amiodarone treated patients had a lower incidence of AF (22." | 2.71 | Amiodarone prevents symptomatic atrial fibrillation and reduces the risk of cerebrovascular accidents and ventricular tachycardia after open heart surgery: results of the Atrial Fibrillation Suppression Trial (AFIST). ( Kluger, J; White, CM, 2003) |
| "Amiodarone is widely used in ventricular tachyarrhythmias and atrial fibrillation, known to prolong QT-intervals." | 2.71 | Iohexol contrast medium induces QT prolongation in amiodarone patients. ( Figulla, HR; Goernig, M; Hartog, CS; Kirmeier, T; Krack, A; Leder, U, 2004) |
| "Nonsustained ventricular tachycardia is frequently seen in patients with heart failure and may be associated with worsened survival by univariate analysis." | 2.69 | Prevalence and significance of nonsustained ventricular tachycardia in patients with premature ventricular contractions and heart failure treated with vasodilator therapy. Department of Veterans Affairs CHF STAT Investigators. ( Carson, PE; Fisher, SG; Fletcher, RD; Singh, SN, 1998) |
| "Amiodarone has been used widely in these patients but its value in preventing sudden death is still uncertain." | 2.69 | Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment. ( Castelli, G; Cecchi, F; Ciaccheri, M; Dolara, A; Marconi, P; Montereggi, A; Nannini, M; Olivotto, J; Troiani, V, 1999) |
| "Most studies of cardiac arrest report outcome following out-of-hospital resuscitation." | 2.69 | In-hospital versus out-of-hospital presentation of life-threatening ventricular arrhythmias predicts survival: results from the AVID Registry. Antiarrhythmics Versus Implantable Defibrillators. ( Cannom, DS; Epstein, AE; Greene, HL; Herre, JM; Lancaster, S; Ocampo, C; Powell, J; Rosenberg, Y; Yao, Q, 1999) |
| "Well-tolerated ventricular tachycardia in patients with structural heart disease does not carry a significantly better prognosis than ventricular tachyarrhythmia with more severe hemodynamic consequences." | 2.69 | Determinants of outcome in patients with sustained ventricular tachyarrhythmias: the antiarrhythmics versus implantable defibrillators (AVID) study registry. ( Cook, JR; Epstein, AE; Greene, HL; Jadonath, R; Lancaster, S; Marinchak, RA; Pacifico, A; Pinski, SL; Yao, Q, 2000) |
| " Thus, in these patients, the speed and dosing accuracy of an intravenous formulation would be beneficial." | 2.68 | Dose-ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias. The Intravenous Amiodarone Multicenter Investigators Group. ( Cannom, DS; Chilson, DA; Friehling, T; Kopelman, HA; Kowey, PR; Levine, JH; Platia, EV; Scheinman, MM; Wilber, DJ, 1995) |
| "Amiodarone was administered at a dosage of 800 mg/day for 2 weeks followed by 400 mg/day thereafter." | 2.68 | Effect of amiodarone therapy on mortality in patients with left ventricular dysfunction and asymptomatic complex ventricular arrhythmias: Argentine Pilot Study of Sudden Death and Amiodarone (EPAMSA). ( Gambarte, A; Garguichevich, JJ; Gentile, A; Hauad, S; Ramos, JL; Scapin, O; Sirena, J; Tibaldi, M; Toplikar, J, 1995) |
| "Two of three patients with noninducible ventricular tachycardia during amiodarone showed profound ventricular tachycardia slowing during Ia therapy." | 2.68 | Prediction of electrophysiologic study results in patients treated with amiodarone. ( Ferrick, KJ; Fisher, JD; Kim, SG; Roth, JA; Singh, S, 1995) |
| " However, there was no clear dose-response relation observed in this trial with respect to success rates (primary end point), time to first recurrence of tachyarrhythmia (post hoc analysis) or mortality (secondary end point) over 24 h." | 2.68 | Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias. Intravenous Amiodarone Multicenter Trial Group. ( Chilson, DA; Gomes, A; Levine, JH; Massumi, A; Platia, EV; Scheinman, MM; Winkle, RA; Woosley, RL, 1996) |
| "Amiodarone was judged effective in 7 patients by both tests (group I) and in 15 by either electrophysiologic study or Holter monitoring (group II)." | 2.68 | [Prediction of long-term efficacy of amiodarone for refractory ventricular tachycardia: clinical significance of electrophysiologic study and Holter monitoring]. ( Hosoda, S; Kasanuki, H; Ohnishi, S; Tsuchiya, M, 1996) |
| "A similar morning peak of sudden cardiac death was found in both the amiodarone (n = 42) and the placebo (n = 54) groups, and the overall circadian pattern did not differ between them (p = 0." | 2.68 | Effects of amiodarone on the circadian pattern of sudden cardiac death (Department of Veterans Affairs Congestive Heart Failure-Survival Trial of Antiarrhythmic Therapy). ( Behrens, S; Fisher, SG; Fletcher, RD; Franz, MR; Ney, G; Singh, SN, 1997) |
| "Treatment with amiodarone results in significant QT prolongation without altering QT dispersion." | 2.68 | Influence of amiodarone on QT dispersion in patients with life-threatening ventricular arrhythmias and clinical outcome. ( Helguera, ME; Kidwell, GA; Meierhenrich, R; Tebbe, U, 1997) |
| "Patients with ventricular tachycardia also had either syncope or other serious cardiac symptoms, along with a left ventricular ejection fraction of 0." | 2.68 | A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. ( , 1997) |
| "The frequency-dependent electrophysiologic effects of sematilide (n = 11) and amiodarone (n = 22) were determined at (1) drug-free baseline, (2) during steady-state (> 48 hours) dosing with sematilide (455 +/- 5 mg/d [mean +/- SEM]) or after 10." | 2.67 | The effects of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of amiodarone and sematilide in humans. ( Follmer, C; Godfrey, R; Pruitt, C; Sager, PT; Uppal, P, 1994) |
| "Amiodarone therapy has been implicated as a risk factor for cardiothoracic surgical procedures." | 2.67 | Are patients receiving amiodarone at increased risk for cardiac operations? ( Butany, J; Downar, E; Maruyama, H; Mickleborough, LL; Mohamed, S; Rappaport, DC; Sun, Z, 1994) |
| "The sotalol dose was titrated to 240 mg twice daily over 7 days." | 2.67 | Electrophysiologic effects of sotalol and amiodarone in patients with sustained monomorphic ventricular tachycardia. ( Bakr, O; Daoud, E; Hummel, JD; Kou, W; Man, KC; Morady, F; Niebauer, M; Strickberger, SA; Williamson, BD, 1994) |
| " Adverse effects occurred in 18 patients (58%), however none necessitated termination of amiodarone therapy." | 2.67 | Clinical efficacy and safety of intravenous Amiodarone in infants and children. ( Figa, FH; Freedom, RM; Gow, RM; Hamilton, RM, 1994) |
| "In 1987, the Cardiac Arrest Study Hamburg (CASH), a prospective, multicenter, randomized controlled study, was started in survivors of sudden cardiac death resulting from documented ventricular tachyarrhythmias." | 2.67 | Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg). ( Kuck, KH; Siebels, J, 1994) |
| "Uncontrolled studies in which patients have been treated with an oral loading dose of 2 to 4 g/day of amiodarone have suggested that, compared with a conventional loading dose, this dosing regimen results in more rapid control of spontaneous ventricular tachycardia and ventricular tachycardia induced by programmed stimulation." | 2.67 | Prospective, randomized comparison of conventional and high dose loading regimens of amiodarone in the treatment of ventricular tachycardia. ( Calkins, H; Hasse, C; Hummel, JD; Kalbfleisch, SJ; Langberg, JJ; Man, KC; Morady, F; Strickberger, SA; Vorperian, V; Williamson, B, 1993) |
| "Amiodarone has a more favourable therapeutic profile than flecainide and propafenone in these patients, having less tendency to worsen heart failure." | 2.67 | A multicentre, randomized trial on the benefit/risk profile of amiodarone, flecainide and propafenone in patients with cardiac disease and complex ventricular arrhythmias. Antiarrhythmic Drug Evaluation Group (A.D.E.G.). ( , 1992) |
| "Amiodarone therapy was well tolerated in all but one patient." | 2.67 | [Risk stratification and long-term therapy with amiodarone in patients with idiopathic dilated cardiomyopathy]. ( Faber, T; Furtwängler, A; Hohnloser, S; Just, H; Meinertz, T; Zehender, M, 1992) |
| "Amiodarone was relatively safe and moderately effective for the treatment of sustained stable VT." | 2.58 | Amiodarone for sustained stable ventricular tachycardia in the prehospital setting. ( Andrew, E; Bernard, S; Foerster, CR; Smith, K, 2018) |
| "Amiodarone has multiple and complex electrophysiological effects that render it a very effective antiarrhythmic drug for the treatment of both, supraventricular and ventricular arrhythmias." | 2.55 | [Clinical aspects of treatment with amiodarone]. ( Haverkamp, W; Israel, C; Parwani, A, 2017) |
| "Prevention of ventricular tachycardia (VT) recurrence with the use of antiarrhythmic drugs or catheter ablation may be warranted." | 2.55 | Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate. ( AbdelWahab, A; Sapp, J, 2017) |
| "Benign and malignant cardiac tumors have been associated with ventricular tachycardia." | 2.50 | Ventricular tachycardia associated with radiation-induced cardiac sarcoma. ( Ballany, W; Beaty, EH; Madias, C; Trohman, RG, 2014) |
| "Incessant ventricular tachycardia and "electrical storms" are emergencies, requiring urgent action in a close cooperation between critical care physicians and cardiologists." | 2.48 | [Incessant or recurrent ventricular tachycardia. Indications for emergency ablation]. ( Figulla, HR; Kühnert, H; Prochnau, D; Surber, R, 2012) |
| "Amiodarone is an antiarrhythmic medication used to treat and prevent certain types of serious, life-threatening ventricular arrhythmias." | 2.47 | Amiodarone supplants lidocaine in ACLS and CPR protocols. ( Camporesi, EM; Mangar, D; Mizzi, A; Tran, T, 2011) |
| "Amiodarone treatment affects thyroid status in about the half of patients." | 2.46 | [Amiodarone-induced thyroid gland dysfunctions]. ( Caglayan, E; Dietlein, M; Er, F; Erdmann, E; Gassanov, N, 2010) |
| "Amiodarone has emerged as the leading antiarrhythmic therapy for termination and prevention of ventricular arrhythmia in different clinical settings because of its proven efficacy and safety." | 2.46 | Amiodarone for the treatment and prevention of ventricular fibrillation and ventricular tachycardia. ( Dorian, P; Van Herendael, H, 2010) |
| "Sustained hemodynamically tolerated ventricular tachycardia (HTVT) comprises up to 30% of all cases of monomorphic ventricular tachycardia in patients with CAD." | 2.43 | Can amiodarone prevent sudden cardiac death in patients with hemodynamically tolerated sustained ventricular tachycardia and coronary artery disease? ( Arya, A; Haghjoo, M; Sadr-Ameli, MA, 2005) |
| "During ventricular tachycardia (VT) elicited by cross-field stimulation, spiral-type excitations rotating around functional block lines (FBLs) were visualized." | 2.43 | Optical imaging of spiral waves: pharmacological modification of spiral-type excitations in a 2-dimensional layer of ventricular myocardium. ( Honjo, H; Ishiguro, Y; Kamiya, K; Kodama, I; Nakagawa, H; Okuno, Y; Sakuma, I; Yamazaki, M, 2005) |
| "The most important arrhythmia is ventricular tachycardia which degenerates to ventricular fibrillation." | 2.43 | [Strategy for cardiac arrhythmias in acute coronary syndrome]. ( Sugi, K, 2006) |
| "Amiodarone is a highly efficacious antiarrhythmic agent for many cardiac arrhythmias, ranging from atrial fibrillation to malignant ventricular tachyarrhythmias, and seems to be superior to other antiarrhythmic agents." | 2.42 | Arrhythmias in the intensive care patient. ( Brandts, B; Trappe, HJ; Weismueller, P, 2003) |
| "Sotalol was approved for treatment of atrial fibrillation and atrial flutter (AF)." | 2.42 | Oral class III antiarrhythmics: what is new? ( Khan, MH, 2004) |
| "Recurrent sustained ventricular tachycardia and ventricular fibrillation in the acute phase after cardiac surgery is the most lethal arrhythmia and may warrant acute intervention and aggressive treatment." | 2.41 | [Management of lethal ventricular arrhythmias after cardiac surgery]. ( Ohnishi, S, 2002) |
| "A wide spectrum of ventricular and supraventricular tachyarrhythmias occurs in the setting of congestive cardiac failure." | 2.41 | Significance and control of cardiac arrhythmias in patients with congestive cardiac failure. ( Singh, BN, 2002) |
| "amiodarone) because of atrial fibrillation or non-sustained VT that may activate the device." | 2.41 | Antiarrhythmic therapy in heart failure. ( Breithardt, G; Eckardt, L; Haverkamp, W, 2002) |
| "Amiodarone is an antiarrhythmic agent commonly used in the treatment of supraventricular and ventricular tachyarrhythmias." | 2.41 | Amiodarone: what have we learned from clinical trials? ( Dell'Orfano, JT; Luck, JC; Naccarelli, GV; Patel, HM; Wolbrette, DL, 2000) |
| "In patients with asymptomatic ventricular tachyarrhythmias in heart failure, class I antiarrhythmic drugs should be avoided due to proarrhythmic and negative inotropic effects that may be responsible for increased mortality in some trials." | 2.41 | [Long-term outcome of pharmacological and nonpharmacological treatment for ventricular arrhythmias]. ( Kasanuki, H; Ohnishi, S, 2000) |
| "Procainamide is effective for stable ventricular tachycardia, and amiodarone is effective in the treatment of shock-refractory ventricular fibrillation." | 2.41 | Intravenous antiarrhythmic agents. ( Dorian, P; Pinter, A, 2001) |
| " The most serious adverse reaction is pulmonary toxicity." | 2.40 | [Amiodarone-induced pulmonary toxicity]. ( Berg, M; Heisel, A; Schieffer, H; Stopp, M; Ukena, D, 1997) |
| "Patients with sustained ventricular tachyarrhythmias in the absence of a reversible cause require long-term therapy." | 2.40 | Clinical trials of antiarrhythmic drugs in patients with sustained ventricular tachyarrhythmias. ( Mitchell, LB, 1997) |
| " The studies that were reviewed were selected on the basis of time published (from 1983 to 1995) and the completeness of information provided regarding patient clinical characteristics, drug dosing and methods of evaluation, efficacy analyses, long-term follow-up and complications." | 2.40 | Intravenous amiodarone. ( Filart, RA; Kowey, PR; Marinchak, RA; Rials, SJ, 1997) |
| "For patients who have not had sustained ventricular tachycardia or ventricular fibrillation antiarrhythmic therapy should generally be avoided, but may benefit some high risk patients." | 2.40 | Pharmacologic and nonpharmacologic treatment of ventricular arrhythmias in heart failure. ( Stevenson, WG; Sweeney, MO, 1997) |
| "Drugs can cause cardiac arrhythmias in a number of clinical situations, and many of the implicated agents are used to treat non-cardiac conditions." | 2.40 | Drug-induced cardiac arrhythmias: incidence, prevention and management. ( Doig, JC, 1997) |
| "Patients with symptomatic ventricular tachycardia, ventricular fibrillation, or aborted sudden cardiac death remain at high risk for arrhythmia recurrence." | 2.40 | Drugs versus devices in controlling ventricular tachycardia, ventricular fibrillation, and recurrent cardiac arrest. ( Borggrefe, M; Breithardt, G; Eckardt, L; Haverkamp, W, 1997) |
| "Further studies, including the Sudden Cardiac Death Heart Trial (SCD HeFT), should help determine the role of amiodarone in heart failure patients." | 2.40 | Amiodarone in congestive heart failure. ( Singh, S, 1998) |
| "In addition to primary prevention of ventricular tachycardia and supraventricular tachycardia, antiarrhythmic drug therapy may potentiate tachycardia rate slowing and make ventricular tachycardia more tolerated hemodynamically and possibly more amendable to pacing therapy." | 2.40 | Concomitant device and drug therapy: current trends, potential benefits, and adverse interactions. ( Ashar, M; Deely, MP; Marchlinski, FE; Nayak, H; Saligan, J; Zado, ES, 1999) |
| "Patients with congestive heart failure frequently have ventricular arrhythmias on ambulatory electrocardiographic recordings and sudden cardiac death is seen in almost 50% of such patients." | 2.40 | Class III drugs and congestive heart failure: focus on the congestive heart failure-survival trial of antiarrhythmic therapy. ( Fletcher, RD; Singh, SN, 1999) |
| "The incidence of nonsustained ventricular tachycardia (NSVT) after myocardial infarction (MI), has decreased significantly in the thrombolytic era and may not have a high enough power to predict sudden cardiac death or all-cause mortality post-MI." | 2.40 | The role of antiarrhythmic therapy in the management of nonsustained ventricular tachycardia. ( Gomes, JA, 1999) |
| "Noninducible ventricular tachycardia during electrophysiological testing and abolition of ventricular tachycardia during electrocardiographic monitoring on amiodarone appear equally predictive of long-term amiodarone success, but this conclusion seems dependent on the stimulation protocol used." | 2.39 | Invasive and noninvasive methods to predict the long-term efficacy of amiodarone: a compilation of clinical observations using meta-analysis. ( Bauman, JL; Nazari, J; Roberts, SA; Viana, MA, 1994) |
| "Pharmacological therapy of cardiac arrhythmias continues to evolve, with an increasing shift from class I to class III compounds and beta-blockers." | 2.39 | Class III antiarrhythmic drugs. ( Ahmed, R; Singh, BN, 1994) |
| "sustained ventricular tachycardia, ventricular fibrillation, aborted sudden cardiac death) are changing." | 2.39 | [Pharmacologic therapy of ventricular tachyarrhythmias: value of class III anti-arrhythmia drugs]. ( Block, M; Böcker, D; Borggrefe, M; Breithardt, G; Haverkamp, W, 1996) |
| "Between 1983 and 1991, 86 cases of ventricular tachycardia (VT) resistant to antiarrhythmic therapy were treated by endocardious catheter fulguration: there were 21 cases of right ventricular dysplasia (RVD), 35 chronic myocardial infarctions (MI), 11 dilated cardiomyopathies (DCM), 10 bundle branch VT, 5 idiopathic septal VT, 3 operated Fallot procedures, 1 Ebstein's anomaly." | 2.38 | [Treatment of ventricular tachycardia by endocardial fulguration. Apropos of 86 cases]. ( Fellat, R; Fontaine, G; Frank, R; Gallais, Y; Lazraq, S; Tonet, J, 1993) |
| "Life-threatening ventricular tachyarrhythmias are the main reason for sudden cardiac death in coronary heart disease." | 2.38 | Pharmacological therapy in coronary heart disease: prevention of life-threatening ventricular tachyarrhythmias and sudden cardiac death. ( Eggeling, T; Hombach, V; Kochs, M, 1993) |
| "Amiodarone has been demonstrated to be an important and effective antiarrhythmic agent, as has sotalol." | 2.38 | Empiric use of amiodarone and sotalol. ( Nora, M; Zipes, DP, 1993) |
| "Amiodarone has been shown to both increase and decrease the DFT." | 2.38 | Concomitant amiodarone and the implantable cardioverter-defibrillator: is there a place? ( McCollam, PL; Nappi, JM, 1993) |
| "Furthermore, the occurrence of ventricular tachycardia (VT) storm or incessant VTs and the number of patients scheduled for intracardiac ablation did not differ among both groups, whereas the rate of rehospitalization was lower in the cohort with only beta-blockers." | 1.91 | Single beta-blocker or combined amiodarone therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator patients: Insights from the German DEVICE registry. ( Brachmann, J; Eckardt, L; Frey, N; Gonska, BD; Hochadel, M; Ince, H; Jung, W; Kääb, S; Kleemann, T; Lugenbiel, P; Perings, CA; Schmidt, C; Senges, J; Stellbrink, C; Wiedmann, F, 2023) |
| "In the patient, the paroxysmal atrial fibrillation was responsible for S-L-S-S sequence." | 1.91 | The short-long-short-short sequence and polymorphic ventricular tachycardias storm. ( Li, J; Liu, Q; Yang, L, 2023) |
| "Awake patients in ventricular fibrillation is a phenomenon limited to patients who are mechanically supported." | 1.91 | Stable Ventricular Fibrillation: A Paradigm Rather Than Septal Shift? ( Bracy, CL; Gupta, R; Hockstein, MA; Hockstein, MJ; Kobres, PY; Lam, PH; Rao, SD; Sheikh, FH, 2023) |
| "No sustained ventricular tachycardia, ventricular fibrillation, sudden cardiac death, or cardiovascular mortality were observed." | 1.72 | Propafenone use in coronary artery disease patients undergoing atrial fibrillation ablation. ( Aksu, T; Aras, D; Cay, S; Kara, M; Ozcan, F; Ozeke, O; Topaloglu, S, 2022) |
| "Ventricular tachycardia was detected by electrocardiography." | 1.72 | Primary hypothyroidism with an episode of ventricular tachycardia in a patient with COVID-19: A case report. ( Cheng, YC; Lee, IT; Liao, PH; Liu, PY, 2022) |
| "Patients with early recurrence and LVEFs ≤32% had a 1-year rate of mortality or HTx of 55%." | 1.72 | Clinical Outcomes in Patients With Dilated Cardiomyopathy and Ventricular Tachycardia. ( Arya, A; Baldinger, SH; Berruezo, A; Carbucicchio, C; Catto, V; de Riva, M; Deneke, T; Ebert, M; Gaspar, T; Hindricks, G; Kumar, S; Piorkowski, C; Shivkumar, K; Soejima, K; Stevenson, WG; Tedrow, UB; van Rein, N; Vaseghi, M; Wijnmaalen, AP; Zeppenfeld, K, 2022) |
| " Previous literature has described fixed-dose propofol boluses and continuous infusions to convert ventricular arrhythmias; however, to our knowledge, there are no reports of a weight-based dosing strategy for VT." | 1.62 | Ventricular tachycardia converts to sinus rhythm after administration of propofol. ( Galletta, G; Li, I; Mokszycki, R; Saltzman, D; Shannon, K, 2021) |
| "Cardiac lipomas are rare benign heart tumors." | 1.56 | Ventricular tachycardia: beginning and ending fate of a benign invasive cardiac lipoma. ( Ahmed, MM; Aladmawi, M; Alamro, B; ALsanei, A; AlSomali, A; Echahidi, NM; Fawzy, N; Kharabsheha, S; Vriz, O, 2020) |
| "However, incessant ventricular tachycardia occurred frequently which necessitated several countershocks." | 1.56 | [Amiodarone-induced Ventricular Tachycardia after Coronary Artery Bypass Grafting;Report of a Case]. ( Kobiki, J; Taki, T; Tamura, N; Yanagi, S, 2020) |
| "An elderly woman had ventricular tachycardia, and her defibrillator failed to discharge." | 1.51 | Wide-QRS Tachycardia in an 89-Year-Old Woman With an ICD. ( Glancy, DL; Kawji, MM, 2019) |
| "Polymorphic ventricular tachycardia (VT) without QT prolongation is well described in patients without structural heart disease (mainly idiopathic ventricular fibrillation and Brugada syndrome) and in patients with acute ST-elevation myocardial infarction." | 1.51 | Quinidine-Responsive Polymorphic Ventricular Tachycardia in Patients With Coronary Heart Disease. ( Amit, G; Asher, E; Belhassen, B; Chorin, E; Halkin, A; Havakuk, O; Hochstadt, A; Laish-Farkash, A; Lee, JK; Rosso, R; Tovia-Brodie, O; Viskin, D; Viskin, S, 2019) |
| "Amiodarone is an effective and widely used antiarrhythmic drug with many possible adverse effects including hypercholesterolaemia and hepatotoxicity." | 1.48 | Desmosterol accumulation in users of amiodarone. ( Gylling, H; Kupari, M; Lampi, AM; Lehtonen, J; Piironen, V; Simonen, P; Stenman, UH, 2018) |
| "Idiopathic ventricular tachycardia: Frequent monomorphic premature ventricular contractions or non-sustained ventricular tachycardia without underlying structural heart disease is not a rare condition and may cause significant symptoms." | 1.48 | [Update Ventricular Tachycardia]. ( Fürnkranz, A; Makimoto, H, 2018) |
| "Amiodarone is a highly effective treatment for supraventricular and ventricular tachyarrhythmia; however, it could be associated with several serious adverse effects, including liver injury." | 1.48 | Amiodarone-induced reversible and irreversible hepatotoxicity: two case reports. ( Hayashi, K; Kawashiri, MA; Kurose, N; Nishida, N; Oyama, T; Sakata, K; Sasaki, M; Sawada, T; Tada, H; Tanaka, Y; Tsuda, T; Yamagishi, M; Yoshida, T, 2018) |
| "Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare but potentially lethal inherited arrhythmia syndrome induced by adrenergic stress." | 1.48 | A delayed diagnosis of catecholaminergic polymorphic ventricular tachycardia with a mutant of RYR2 at c.7580T>G for 6 years in a 9-year-old child. ( Duan, H; Hua, Y; Li, Y; Lu, Y; Qiao, L; Wang, C; Yan, S; Zhou, K, 2018) |
| "Ventricular tachycardia is a life threatening cardiac arrhythmia." | 1.46 | Fatal monomorphic ventricular tachycardia in a semi-urban setting in Cameroon: a case report. ( Dikoume, L; Luchuo, EB; Nkoke, C, 2017) |
| "VT recurrence was higher for >1RFA vs 1RFA (29% vs 24%, P <." | 1.46 | Outcomes after repeat ablation of ventricular tachycardia in structural heart disease: An analysis from the International VT Ablation Center Collaborative Group. ( Bunch, TJ; Burkhardt, JD; Callans, DJ; Della Bella, P; Di Biase, L; Dickfeld, T; Frankel, DS; Lakkireddy, D; Marchlinski, FE; Mathuria, N; Nakahara, S; Natale, A; Santangeli, P; Sauer, WH; Shivkumar, K; Stevenson, WG; Tedrow, U; Tholakanahalli, VN; Tung, R; Tzou, WS; Vakil, K; Vaseghi, M; Vergara, P; Vunnam, R; Weiss, JP, 2017) |
| "A 58-year-old woman presenting with a ventricular tachycardia of 190 beats/min was administered amiodarone through an accidently placed arterial access in the left cubital fossa." | 1.43 | Acute Thrombotic Occlusion of the Left Brachial Artery After Intra-Arterial Administration of Amiodarone. ( Knie, W; Landmesser, U; Mochmann, HC; Rauch, U; Skurk, C; Witkowski, M, 2016) |
| "Dronedarone is a benzofuran derivative resembling amiodarone that was intended to reduce the iodine-associated tissue deposition and organ toxicity seen with the latter." | 1.43 | The use of dronedarone for recurrent ventricular tachycardia: a case report and review of the literature. ( Brent Mitchell, L; Kuriachan, V; Rizkallah, J, 2016) |
| "Amiodarone was started to control ventricular excitability, which persisted over 72h with gradual decrease in frequency of VT and VE." | 1.43 | Aconite poisoning with arrhythmia and shock. ( Bajari, R; Bohra, G; Gupta, A; Lakhotia, M; Sagar, A; Tak, S, 2016) |
| "Amiodarone was also used in 90% of the ICD group." | 1.40 | Implantable cardioverter-defibrillators for treatment of sustained ventricular arrhythmias in patients with Chagas' heart disease: comparison with a control group treated with amiodarone alone. ( Baggio, JM; Ferreira, LG; Gali, WL; Gomes, GG; Junqueira, LF; Marin-Neto, JA; Sarabanda, AV, 2014) |
| "Recent guidelines for treating ventricular fibrillation (VF) and ventricular tachycardia (VT) stress class III antiarrhythmic drugs, but some malignant arrhythmias refractory to these agents still occur in clinical practice." | 1.40 | Renewed impact of lidocaine on refractory ventricular arrhythmias in the amiodarone era. ( Ikeda, U; Miura, T; Motoki, H; Okada, A; Takeuchi, T; Tomita, T; Yoshie, K, 2014) |
| "Terfenadine is a second generation histamine receptor antagonist which is widely used as a non‑sedating antihistamine to relieve allergic responses." | 1.40 | Comparative study of the protective effects of terfenadine and amiodarone on barium chloride/aconitine-induced ventricular arrhythmias in rats: a potential role of terfenadine. ( Li, S; Liu, B; Su, Y; Xiong, M; Xu, Y, 2014) |
| "The results suggest that pretreatment with saffron, especially at the dosage of 100 mg/kg/day, attenuates the susceptibility and incidence of fatal ventricular arrhythmia during the reperfusion period in the rat." | 1.39 | Protective effects of saffron (Crocus sativus) against lethal ventricular arrhythmias induced by heart reperfusion in rat: a potential anti-arrhythmic agent. ( Bashiri, A; Ghasemipour-Afshar, E; Joukar, S; Naghsh, N; Sheibani, M, 2013) |
| "Amiodarone has a variable oral bioavailability." | 1.39 | [Amiodarone administered orally or intravenously - the same or different drug?]. ( Kosior, DA; Krzykwa, A; Postuła, M, 2013) |
| "Polymorphic ventricular tachycardia or ventricular fibrillation tachyarrhythmias usually result in syncope or sudden cardiac death in cases of Brugada syndrome, while monomorphic tachycardia, as in our case, is rare." | 1.39 | [Monomorphic ventricular tachycardia during the ajmaline test]. ( Akpınar, O; Kanadaşı, M; Kurt, K, 2013) |
| "Standardised test protocol for an NCS is safe in patients with an ICD regardless of the leads type." | 1.38 | Safety of nerve conduction studies in patients with implantable cardioverter-defibrillators. ( Antczak, J; Banach, M; Derejko, M; Derejko, P; Niewiadomska, M; Przybylski, A; Rakowicz, M; Szumowski, Ł; Walczak, F, 2012) |
| "Long QT syndrome is characterized by electrocardiographic appearance of long QT intervals and propensity to polymorphic ventricular tachycardia." | 1.38 | A neonate with long QT syndrome, refractory ventricular arrhythmias, and lidocaine toxicity. ( Montenegro, LM; Naim, M; Nathan, AT; Vetter, VL, 2012) |
| "The fibroma was successfully resected, and further follow-up evaluation was uneventful." | 1.38 | Large right ventricular fibroma in a 6-month-old infant. ( Horovitz, A; Roubertie, F; Thambo, JB; van Geldorp, IE, 2012) |
| "The ECG documented ventricular tachycardia (VT) when the patient has palpitations." | 1.38 | The presence of giant epsilon waves in a patient with arrhythmogenic right ventricular cardiomyopathy. ( Bao, H; Cheng, X; Hong, K; Li, J, 2012) |
| "Bidirectional ventricular tachycardia (BVT) is an uncommon type of polymorphic ventricular tachycardia (PVT) with alternating polarity of the QRS complex most commonly described digitalis toxicity." | 1.38 | Bidirectional ventricular tachycardia due to coronary allograft vasculopathy a unique presentation. ( Bhavnani, SP; Clyne, CA, 2012) |
| "Dronedarone is a multichannel blocker with similar electrophysiological properties to amiodarone." | 1.37 | Suppression of ventricular tachycardia with dronedarone: a case report. ( Freudenberger, R; Levin, V; Marchlinski, FE; Shaaraoui, M, 2011) |
| "Despite advances in ablation of ventricular tachycardia (VT), recognized toxicity of amiodarone, and potential harm of implantable cardioverter defibrillator (ICD) shocks, there appears to be reluctance to pursue catheter ablation." | 1.37 | Ventricular tachycardia ablation remains treatment of last resort in structural heart disease: argument for earlier intervention. ( Callans, DJ; Frankel, DS; Marchlinski, FE; Mountantonakis, SE; Robinson, MR; Zado, ES, 2011) |
| "The management of ventricular tachycardia depends on clinical symptoms and is influenced by the presence of structural heart disease." | 1.37 | Electrocardiography Series. What is the cause of the regular wide QRS complex tachycardia? ( Kireyev, D; Lim, SL; Poh, KK; Teo, SG, 2011) |
| "Giant cell myocarditis is a rare and highly lethal disease that is characterized by a rapidly progressive course of biventricular dysfunction." | 1.37 | Incessant ventricular tachycardia and cardiogenic shock: a common presentation of an uncommon diagnosis. ( Drafts, BC; Dubose, TD; Sutton, BJ; Thohan, V, 2011) |
| "Arrhythmogenic right ventricular cardiomyopathy is a desmosomal disease." | 1.37 | Guidelines for the diagnosis and management of arrhythmogenic right ventricular cardiomyopathy. ( Smith, W, 2011) |
| "Ranolazine is a drug that exerts antianginal and antiischemic effects and also acts as an antiarrhythmic in isolation and in combination with other class III medications." | 1.37 | Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocks. ( Anderson, JL; Bair, TL; Bunch, TJ; Crandall, BG; Day, JD; Lappe, DL; Mader, KM; Mahapatra, S; May, HT; Molden, J; Muhlestein, JB; Murdock, D; Osborn, JS; Weiss, JP, 2011) |
| "Knowledge on ventricular tachycardia (VT) in isolated ventricular noncompaction (IVNC) is limited." | 1.36 | Septal ventricular tachycardia with alternating LBBB-RBBB morphology in isolated ventricular noncompaction. ( Bulková, V; Fiala, M; Januska, J; Pleva, M, 2010) |
| "As the population ages, recurrent ventricular tachycardia (VT) is increasingly encountered in elderly patients with ischemic heart disease." | 1.36 | Mortality and safety of catheter ablation for antiarrhythmic drug-refractory ventricular tachycardia in elderly patients with coronary artery disease. ( Inada, K; Koplan, BA; Roberts-Thomson, KC; Seiler, J; Steven, D; Stevenson, WG; Tedrow, UB, 2010) |
| "Procainamide was not more effective than amiodarone for the termination of sustained VT, but the ability to detect a significant difference was limited by the study design and potential confounding." | 1.36 | Amiodarone or procainamide for the termination of sustained stable ventricular tachycardia: an historical multicenter comparison. ( deSouza, IS; Ellinor, PT; Marill, KA; Nishijima, DK; Ruskin, JN; Senecal, EL; Setnik, GS; Stair, TO, 2010) |
| "A case of sustained monomorphic ventricular tachycardia underdetected by a single chamber implantable cardioverter defibrillator because of RR interval irregularity is presented." | 1.35 | Irregular ventricular tachycardia underdetected by implantable cardioverter defibrillator device. ( Chatzis, D; Kourouklis, S; Kouvelas, K; Kyriakides, Z; Manolis, AG, 2008) |
| "The amiodarone drip was discontinued." | 1.35 | Management of isolated yew berry toxicity with sodium bicarbonate: a case report in treatment efficacy. ( Donovan, JW; Kane, B; Kane, K; Pierog, J, 2009) |
| "Sotalol was associated with a greater risk of any clinically relevant ventricular arrhythmia as defined by sustained ventricular tachycardia or ICD therapy (hazard ratio [HR]: 2." | 1.35 | Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: a report from the North American ARVC Registry. ( Cannom, DS; Estes, NA; Glidden, DV; Marcus, F; Marcus, GM; Polonsky, B; Scheinman, MM; Smith, LM; Zareba, W, 2009) |
| "Electrocardiography (ECG) showed ventricular tachycardia." | 1.35 | A case of myotonic dystrophy presenting with ventricular tachycardia and atrial fibrillation. ( Eroğlu, S; Müderrisoğlu, H; Ozbiçer, S; Ozin, B, 2009) |
| "The combination of ventricular tachycardia (VT) and severe left ventricular dysfunction presents a serious challenge in management of acute fulminant myocarditis (AFM)." | 1.35 | Ventricular tachycardia in acute fulminant myocarditis: medical management and follow-up. ( Acharya, S; Flood, V; Rao, SP; Sathanandam, S; Sharma, JR, 2008) |
| "Malignant ventricular tachyarrhythmias have a circadian distribution." | 1.34 | Circadian pattern of spontaneous ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators. ( Aksu, H; Akyol, A; Alper, AT; Cakmak, N; Cinar, B; Eksik, A; Erdinler, I; Gürkan, K; Norgaz, T; Yildirim, A, 2007) |
| "Recurrent life-threatening episodes of ventricular tachycardia persisted despite maximal antiarrhythmic theraphy with amiodarone, metoprolol and mexiletine." | 1.33 | Suppression by propranolol and amiodarone of an electrical storm refractory to metoprolol and amiodarone. ( Anastasiou-Nana, MI; Kanakakis, J; Rokas, S; Tsagalou, EP, 2005) |
| "A case of ventricular tachycardia in a 37-year-old man after ingestion of heroin and cocaine, treated with naloxone is described." | 1.33 | Ventricular tachycardia following naloxone administration in an illicit drug misuse. ( Hunter, R, 2005) |
| "Ventricular tachycardia is one of the most feared complications after surgical repair of Tetralogy of Fallot and it is associated with sudden death." | 1.33 | [Radiofrequency ablation of ventricular tachycardia in a patient after surgery for Tetralogy of Fallot: case report]. ( Baeza, M; Fajuri, A; Frangini, P; González, R; Vergara, I, 2005) |
| "Sustained monomorphic ventricular tachycardia was defined as a tachycardia with uninterrupted duration or rapid recurrence despite automatic internal cardiac defibrillator therapy for at least 5 minutes before amiodarone treatment, monomorphic morphology, rate greater than 120 beats/min, QRS duration greater than 120 ms, and subsequently determined to be ventricular tachycardia by ECG criteria (eg, atrioventricular dissociation), implanted device interrogation, or formal electrophysiology study." | 1.33 | Amiodarone is poorly effective for the acute termination of ventricular tachycardia. ( deSouza, IS; Marill, KA; Nishijima, DK; Ruskin, JN; Setnik, GS; Stair, TO, 2006) |
| " Inadequate dosing and later administration of amiodarone in the code were two confounding factors in this study." | 1.33 | Comparing intravenous amiodarone or lidocaine, or both, outcomes for inpatients with pulseless ventricular arrhythmias. ( Henderson, SO; Idrees, U; Kane-Gill, SL; Kirisci, L; Ou, NN; Oyen, LJ; Rea, RS; Rudis, MI; Seybert, AL; Stauss, JL, 2006) |
| "On day 21, he was complicated with acute respiratory distress syndrome." | 1.33 | Fatal case of amiodarone-induced acute respiratory distress syndrome in a patient with severe left ventricular dysfunction due to extensive anterior acute myocardial infarction. ( Ando, H; Eto, Y; Fukumoto, Y; Ikeuchi, M; Kishi, T; Kuwata, K; Nakamura, R; Okamatsu, S; Ozawa, M; Sekiya, M; Sobashima, A; Yamada, A; Yamawaki, T, 2006) |
| "Two patients presented with ventricular tachycardia and one had an atrioventricular re-entrant tachycardia." | 1.33 | Tachycardia-induced elevations in cardiac troponin in the absence of coronary artery disease. ( Cruz, L; Hong, R; Yeo, KK, 2006) |
| "The selective ablation of the recurrent ventricular tachycardia (VT) in a 75-year old patient after extensive inferior myocardial infarction (24 years ago), with low ejection fraction was performed." | 1.33 | [Eleven-years long follow-up in a patient after myocardial infarction, with low ejection fraction and recurrent ventricular tachycardia. The role of implantable cardioverter defibrillator and selective ablation]. ( Chojnowska, L; Derejko, P; Grzybowski, J; Iwanek, M; Kepski, R; Przybylski, A; Szumowski, Ł; Szwed, H; Urbanek, P; Walczak, F, 2006) |
| "We report a case of a patient with paroxysmal atrial fibrillation (PAF) and with a permanent AAIR (bipolar atrial-inhibited adaptive rate) pacemaker who suffered life-threatening episodes of arrhythmias during operation." | 1.33 | Anesthetic management of an AAI pacemaker patient with paroxysmal atrial fibrillation during colorectal surgery. ( Borel, CO; Lin, JA; Wang, WB; Wong, CS; Wu, CT; Yang, CP; Yeh, CC, 2006) |
| "In an electrophysiological study the ventricular tachycardia could be induced and successfully ablated." | 1.33 | Ventricular tachycardia induced by abuse of ephedrine in a young healthy woman. ( Kozak, M; Rakovec, P; Sebestjen, M, 2006) |
| "Polymorphic ventricular tachycardia (VT) comprises a variety of different subforms." | 1.33 | Amiodarone and polymorphic ventricular tachycardia: to slow down or to accelerate the underlying rhythm? ( Goethals, M; Pollet, P, 2006) |
| "Nonischemic heart disease, especially idiopathic dilated cardiomyopathy, is relatively common among Japanese patients receiving amiodarone for concomitant ventricular arrhythmia, but the hemodynamic effects of amiodarone in these Japanese patients are unclear." | 1.32 | Hemodynamics during chronic amiodarone administration in Japanese patients with idiopathic dilated cardiomyopathy and ventricular arrhythmia: a retrospective study. ( Ishizuka, N; Kasanuki, H; Matsuda, N; Shiga, T; Suzuki, T; Wakaumi, M, 2003) |
| "To determine whether retinal electrophysiologic changes can be detected and correlated with funduscopic findings in patients with the long-term use of amiodarone." | 1.32 | Retinal evaluation of patients on chronic amiodarone therapy. ( Blumenkranz, MS; Chun, SH; Marmor, MF; Shaikh, N; Shaikh, S; Spin, JM, 2003) |
| "Cardiac mortality and sudden cardiac death rates also were higher in group 3 patients." | 1.32 | Clinical usefulness of electrophysiologic testing in patients with ventricular tachycardia and chronic chagasic cardiomyopathy treated with amiodarone or sotalol. ( de Paola, AA; Fenelon, G; Friedman, PA; Leite, LR; Silva, GG; Simoes, A, 2003) |
| "The number of premature ventricular complexes (PVCs)/min for each of the 20 minutes preceding the onset of ventricular tachyarrhythmia, the shortest coupling intervals between PVC and normal sinus beat, and the presence of short-long-short (SLS) interval sequences were examined." | 1.32 | Study of precursors of ventricular tachycardia from data stored in the memory of a dual chamber implantable cardioverter defibrillator. ( Iscolo, N; Kacet, S; Lavergne, T; Leenhardt, A; Mabo, P; Sadoul, N; Saoudi, N, 2003) |
| "Idiopathic ventricular tachycardia is rare, especially in infants." | 1.32 | Verapamil sensitive idiopathic ventricular tachycardia in an infant. ( Chi, CS; Fu, YC; Jan, SL; Wang, JD, 2003) |
| "Pharmacological treatment of the supraventricular tachycardia solved the problem." | 1.32 | Inappropriate single chamber ICD discharges due to supraventricular tachycardia with high degree atrioventricular block. ( De Palma, C; Kreutzer, E; Scaglione, J; Socas, AG, 2004) |
| "A 75-year-old man suffered sustained ventricular tachycardia with syncopal attack." | 1.32 | A patient with sustained ventricular tachycardia: identification of a responder to amiodarone using signal-averaged electrocardiogram. ( Ito, S; Kawaguchi, T; Kawano, T; Kobayashi, A; Koshiba, K; Nakaya, Y; Nisikado, A; Nomura, M; Sawa, Y; Tabata, T; Wakatsuki, T; Yamaguchi, K, 2004) |
| "In one patient with amiodarone-induced pneumonitis, the KL-6 level increased from 695 to 2,100 U/ml concurrently with worsening interstitial changes shown by high resolution computed tomography." | 1.31 | [Diagnostic usefulness of KL-6 measurements in patients with pulmonary complications after administration of amiodarone]. ( Endoh, Y; Hanai, R; Kasanuki, H; Nagashima, H; Narimatsu, A; Ohnishi, S; Takizawa, T; Uno, M; Uto, K, 2000) |
| "Patients for whom recurrent ventricular tachycardia and fibrillation are suppressed with intravenous amiodarone and who are discharged receiving oral amiodarone have an 80% 1-year survival rate." | 1.31 | Long-term follow-up of patients requiring intravenous amiodarone to suppress hemodynamically destabilizing ventricular arrhythmias. ( Fineberg, N; Fogel, RI; Herre, JM; Kopelman, HA; Kowey, PR; Prystowsky, EN; Trohman, RG, 2000) |
| "In survivors of sudden cardiac deaths and other selected groups of patients, implantable cardioverter-defibrillators (ICDs) have been shown to have significant survival benefits in randomized controlled trials." | 1.31 | Are implantable cardioverter- defibrillators cost-effective? ( Naik, AM; Peter, CT, 2000) |
| "Amiodarone was effective in suppressing polymorphic ventricular tachycardia, which might provide an example of successful pharmacological intervention in aconitine induced ventricular tachyarrhythmia." | 1.31 | Successful treatment of aconitine induced life threatening ventricular tachyarrhythmia with amiodarone. ( Chiang, FT; Huang, SK; Yeih, DF, 2000) |
| "Sustained ventricular tachycardia (VT) can be unstable, can be associated with serious symptoms, or can be stable and relatively free of symptoms." | 1.31 | "Stable" ventricular tachycardia is not a benign rhythm : insights from the antiarrhythmics versus implantable defibrillators (AVID) registry. ( Epstein, AE; Hallstrom, AP; Jadonath, RL; Lancaster, SE; McAnulty, JH; Mounsey, P; Raitt, MH; Renfroe, EG; Steinberg, JS, 2001) |
| "Of six patients with non-sustained ventricular tachycardia, five had sustained ventricular tachycardia or fibrillation induced after amiodarone infusion." | 1.31 | Effects of intravenous amiodarone on ventricular refractoriness, intraventricular conduction, and ventricular tachycardia induction. ( Ceremuzyński, L; Karczmarewicz, S; Karpiński, G; Kułakowski, P; Soszyńska, M, 2000) |
| "We report cases of serious arrhythmias associated with apical hypertrophic cardiomyopathy (AHCM)." | 1.31 | Serious arrhythmias in patients with apical hypertrophic cardiomyopathy. ( Azegami, K; Itoh, K; Okishige, K; Sasano, T; Suzuki, K; Yano, K, 2001) |
| "In patients with ischemic heart disease, recurrences of VT or VF peaked in the morning." | 1.31 | Absence of a morning peak in ventricular tachycardia and fibrillation events in nonischemic heart disease: analysis of therapies by implantable cardioverter defibrillators. ( Aizawa, Y; Taneda, K, 2001) |
| "Persistent ventricular tachycardia inducibility after catheter ablation requires an ICD implant and/or repeat ablation." | 1.31 | Catheter ablation and antiarrhythmic drugs for haemodynamically tolerated post-infarction ventricular tachycardia; long-term outcome in relation to acute electrophysiological findings. ( Carbucicchio, C; De Ponti, R; Della Bella, P; Klersy, C; Longobardi, M; Riva, S; Storti, C; Tondo, C; Uriarte, JA, 2002) |
| "Amiodarone hydrochloride has been in use for two decades for the control of ventricular and supraventricular arrhythmias." | 1.30 | Long-term low-dose amiodarone therapy in the management of ventricular and supraventricular tachyarrhythmias: efficacy and safety. ( Lee, KL; Tai, YT, 1997) |
| "4 months after implantation bursts of ventricular tachycardia recurred every few minutes that responded to renewed amiodarone administration." | 1.30 | [Implantation of a transvenous defibrillation system in isolated persistent left superior vena cava]. ( Kowallik, P; Krein, A; Meesmann, M; Peters, W; Wittenberg, G, 1997) |
| "Among these arrhythmias, ventricular tachycardia may be resistant to treatment." | 1.30 | Sustained ventricular tachycardia in cardiac hemochromatosis treated with amiodarone. ( Kumbasar, SD; Paksoy, N; Semiz, E; Tosun, Z; Yalçinkaya, S, 1997) |
| "Patients with a history of sustained ventricular tachyarrhythmias form an extremely inhomogeneous group with respect to presenting arrhythmia, underlying cardiac disease, and therefore, risk of dying suddenly." | 1.30 | Management of patients with life-threatening ventricular tachyarrhythmias in the defibrillator era: the need to differentiate. ( Haberl, R; Hoffman, E; Steinbeck, G, 1997) |
| "Recurrent ventricular tachycardia followed by pre-syncope occurred from August 23, 1996, and the patient underwent emergency coronary artery bypass surgery to the left anterior descending artery and circumflex artery using saphenous vein grafts." | 1.30 | [Effective low-dose amiodarone therapy for ventricular tachycardia complicated with ischemic heart disease and poor left ventricular function in an elderly patient]. ( Abe, M; Hayashi, Y; Joh, T; Kazatani, Y; Kikuchi, S; Kubo, M; Makita, M; Matsunaka, T; Tatsuno, H, 1997) |
| "The most common mechanism of sustained ventricular tachycardia (VT) is re-entry with an excitable gap, but the electrophysiologic properties and response to antiarrhythmic drugs in the area of slow conduction are not yet fully known." | 1.30 | Effects of class I and III antiarrhythmic drugs on ventricular tachycardia-interrupting critical paced cycle length with rapid pacing. ( Aizawa, Y; Naitoh, N; Takahashi, K; Washizuka, T, 1998) |
| " The dosage of amiodarone was reduced from 400 mg/day to 200 mg/day without reduction of mexiletine or disopyramide and the patient's symptoms diminished." | 1.30 | A case report of myolysis during high-dose amiodarone therapy for uncontrolled ventricular tachycardia. ( Hotta, N; Itoh, K; Kato, R, 1998) |
| "Amiodarone has been reported to reduce the likelihood of sudden death in patients with hypertrophic cardiomyopathy (HCM)." | 1.30 | Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population. ( Cecchi, F; Dolara, A; Maron, BJ; Montereggi, A; Olivotto, I; Squillatini, G, 1998) |
| "Hyperthyroidism is a reason for immediately suspending treatment for 90% of the cardiologists, only 5% would continue and 16% would prescribe antithyroid drugs." | 1.30 | [Amiodarone and thyroid function: clinical implications]. ( Binz, K; Burger, A; Vallotton, MB, 1998) |
| "Ventricular tachycardia is rare and poorly understood in the neonate." | 1.30 | [Neonatal ventricular tachycardia]. ( Acar, P; Aggoun, Y; Bonnet, D; Butera, G; Kachaner, J; Villain, E, 1998) |
| " However, in this patient, effective control of the arrhythmia was achieved with a moderate dosage of oral amiodarone (600 mg daily for 4 weeks, then 400 mg daily), and he had no further episodes of presyncope." | 1.30 | Amiodarone for control of recurrent ventricular tachycardia secondary to cardiac metastasis. ( Leak, D, 1998) |
| "Ventricular tachycardia has been reported after blunt cardiac trauma in both children and adults." | 1.30 | Ventricular tachycardia during repair of gastroschisis. ( el Said, H; Fenrich, AL; Friedman, RA; Nuchtern, JG; Saidi, AS, 1998) |
| "Amiodarone was effective in preventing VT recurrence." | 1.30 | Hyperkalemia probably reverses the antiarrhythmic effects of amiodarone: a case report. ( Akiyama, J; Morishima, A; Tomizawa, T; Umezawa, S, 1999) |
| "Amiodarone is a powerful suppressant of VPCs, but Holter suppression of this ectopic activity is not predictive of clinical outcome." | 1.29 | Usefulness of Holter monitoring in predicting efficacy of amiodarone therapy for sustained ventricular tachycardia associated with coronary artery disease. ( Doyle, TK; Nasir, N; Pacifico, A; Wheeler, SH, 1994) |
| "In 8 patients paroxysmal atrial fibrillation (AF), in 2 patients chronic AF, in 1 patient atrial flutter, and in 3 patients sinus tachycardia triggered antitachycardia pacing functions (12 patients) or internal defibrillation (2 patients)." | 1.29 | Significance of supraventricular tachyarrhythmias in patients with implanted pacing cardioverter defibrillators. ( Melichercik, J; Montero, M; Schmitt, C, 1994) |
| "Although most hepatic adverse effects associated with amiodarone are transient and reversible with time, deaths resulting from amiodarone-induced hepatotoxicity have been reported." | 1.29 | Fatal hepatotoxicity following oral administration of amiodarone. ( Richer, M; Robert, S, 1995) |
| "Fifteen patients with spontaneous ventricular tachyarrhythmias underwent electrophysiologic studies at baseline and during therapy with quinidine and amiodarone." | 1.29 | Comparison of electrophysiologic effects of quinidine and amiodarone in sustained ventricular tachyarrhythmias associated with coronary artery disease. ( Almendral, JM; Arenal, A; Delcán, JL; Lorca, MT; Pastor, A, 1993) |
| "We present a case with dilated cardiomyopathy and recurrent sustained monomorphic ventricular tachycardia who received an automatic implantable cardioverter defibrillator (AICD) while under long-term amiodarone treatment." | 1.29 | Is there an effect of amiodarone on the defibrillation threshold? ( Akalin, H; Akyol, T; Bayar, M; Güldal, M; Karaoguz, R, 1993) |
| " Following CsA dosage reduction, concentrations returned to the desired range." | 1.29 | Cyclosporine-amiodarone interaction. ( Abdul-Haqq, AJ; Chitwood, KK; Heim-Duthoy, KL, 1993) |
| "The increase in induced sustained ventricular tachycardia cycle length in group A patients after amiodarone loading was significantly correlated with the increase in VERP (r = ." | 1.29 | Frequency-dependent electrophysiologic effects of amiodarone in humans. ( Antimisiaris, M; Follmer, C; Pruitt, C; Sager, PT; Singh, BN; Uppal, P, 1993) |
| "In group II (n = 30), with clinical ventricular tachycardia, inducibility was in 22 patients using the standard test, and in 23 patients using the new test." | 1.29 | A three-site programmed electrical stimulation protocol in patients with and without ventricular tachyarrhythmias. ( Bicík, V; Bytesník, J; Krausová, R; Lefflerová, K, 1993) |
| "Of these, 10 had monomorphic ventricular tachycardia (VT) when first seen, five had polymorphous VT or ventricular fibrillation (VF), and three had both." | 1.29 | Electrophysiologic testing in patients who respond acutely to intravenous amiodarone for incessant ventricular tachyarrhythmias. ( Kowey, PR; Marinchak, RA; Rials, SJ; Rubin, AM; Smith, L, 1993) |
| "Surprisingly, arrhythmia recurrence rates were not significantly different by the method of determining an efficacy prediction." | 1.29 | Contemporary clinical trials in ventricular tachycardia and fibrillation: implications of ESVEM, CASCADE, and CASH for clinical management. ( Anderson, JL, 1995) |
| "Amiodarone has been shown to improve survival in patients with impaired left ventricular function and ventricular trachyarrhythmias." | 1.29 | [Symptomatic bradycardia with amiodarone in patients with pre-existing conduction disorders]. ( Hofmann, R; Leisch, F, 1995) |
| "Occurrence rates of arrhythmias treated with drugs tested for efficacy either by suppression of inducible arrhythmias or by suppression of spontaneous ectopy were higher and equivalent for both testing methods." | 1.29 | From first class to third class: recent upheaval in antiarrhythmic therapy--lessons from clinical trials. ( Lazzara, R, 1996) |
| "Celiprolol is a cardioselective beta-blocker with a partial beta-2 agonist activity and an alpha-2 blocking activity, with a minimal depressant effect on heart rate." | 1.29 | [Combination of celiprolol and amiodarone in the treatment of recurrent ventricular tachycardia]. ( Coutte, R; Frank, R; Hidden, F; Himbert, C; Naditch, L; Tonet, J, 1996) |
| "Amiodarone was prescribed orally at degressive doses." | 1.29 | [Predictive factors of induction of ventricular arrhythmia under amiodarone]. ( Bellon, C; Bonnefoy, E; Bouchayer, D; Bourret, N; Chevalier, P; Kirkorian, G; Richalet, C; Touboul, P, 1996) |
| "He was found to have incessant ventricular tachycardia, impaired left ventricular contraction (ejection fraction 9%), and nonobstructive hypertrophic cardiomyopathy." | 1.28 | Suppression of incessant ventricular tachycardia in hypertrophic cardiomyopathy associated with improvement of severe left ventricular dysfunction. ( Fananapazir, L; McAreavey, D, 1992) |
| "Amiodarone was then reintroduced and four years later, the patient developed hepatomegaly, worsening liver biochemistry and histopathological changes consistent with early cirrhosis." | 1.28 | Hepatotoxicity of amiodarone. ( Jeyamalar, R; Kannan, P; Pathmanathan, R; Wong, D, 1992) |
| "The authors report a case of syncopal ventricular tachycardia in a patient with a respiratory-dependent rate responsive pacemaker, followed-up for valvular heart disease with severe left ventricular dysfunction and sustained atrial and ventricular arrhythmias." | 1.28 | [Ventricular tachycardia in a patient with rate-responsive cardiac pacemaker]. ( Busquet, P; Coutte, R; Frank, R; Grosgogeat, Y; Himbert, C; Lascault, G; Tonet, J, 1992) |
| "Non-sustained ventricular tachycardia occurs in 20% of patients and is the single best predictor of sudden death in adults." | 1.28 | Arrhythmia and hypertrophic cardiomyopathy. ( Keeling, PJ; McKenna, WJ; Shakespeare, CF; Slade, AK, 1992) |
| "A case of severe dilated cardiomyopathy in a young boy presenting with incessant ventricular tachycardia, who had been referred for heart transplantation is reported." | 1.28 | [Cardiomyopathy induced by incessant ventricular tachycardia ("tachycardiomyopathy"): cure after control of arrhythmia]. ( Bahia, FC; Gontijo Filho, B; Sternick, EB; Vrandecic, MO, 1992) |
| "Oral amiodarone was administered to 38 patients (25 males, 13 females) with mean age of 43." | 1.28 | Adverse effects of oral amiodarone therapy. ( Avasthey, P; Dube, S; Gupta, PR; Sinha, PR; Somani, PN, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 207 (37.57) | 18.2507 |
| 2000's | 180 (32.67) | 29.6817 |
| 2010's | 128 (23.23) | 24.3611 |
| 2020's | 36 (6.53) | 2.80 |
| Authors | Studies |
|---|---|
| Gupta, S | 1 |
| Yadav, A | 1 |
| Gupta, A | 2 |
| Deyell, MW | 3 |
| Doucette, S | 3 |
| Parkash, R | 5 |
| Nault, I | 3 |
| Gula, L | 2 |
| Gray, C | 3 |
| Gardner, M | 3 |
| Sterns, LD | 4 |
| Healey, JS | 5 |
| Essebag, V | 5 |
| Sapp, JL | 5 |
| Cay, S | 2 |
| Kara, M | 2 |
| Ozcan, F | 2 |
| Ozeke, O | 3 |
| Aksu, T | 1 |
| Aras, D | 3 |
| Topaloglu, S | 3 |
| Arenal, Á | 3 |
| Ávila, P | 1 |
| Jiménez-Candil, J | 1 |
| Tercedor, L | 1 |
| Calvo, D | 1 |
| Arribas, F | 2 |
| Fernández-Portales, J | 1 |
| Merino, JL | 2 |
| Hernández-Madrid, A | 1 |
| Fernández-Avilés, FJ | 1 |
| Berruezo, A | 2 |
| Liao, PH | 1 |
| Cheng, YC | 1 |
| Liu, PY | 1 |
| Lee, IT | 1 |
| Farkowski, MM | 1 |
| Karlinski, M | 1 |
| Pytkowski, M | 1 |
| de Asmundis, C | 1 |
| Lewandowski, M | 1 |
| Mugnai, G | 2 |
| Conte, G | 1 |
| Marijon, E | 1 |
| Anic, A | 1 |
| Boveda, S | 1 |
| Providencia, R | 1 |
| Reiffel, JA | 3 |
| Zeppenfeld, K | 2 |
| Wijnmaalen, AP | 1 |
| Ebert, M | 1 |
| Baldinger, SH | 1 |
| Catto, V | 1 |
| Vaseghi, M | 2 |
| Arya, A | 2 |
| Kumar, S | 2 |
| de Riva, M | 1 |
| Deneke, T | 1 |
| Gaspar, T | 1 |
| Soejima, K | 2 |
| van Rein, N | 1 |
| Tedrow, UB | 2 |
| Piorkowski, C | 1 |
| Shivkumar, K | 2 |
| Carbucicchio, C | 2 |
| Hindricks, G | 1 |
| Stevenson, WG | 7 |
| Purtell, C | 1 |
| Mehta, M | 1 |
| Steele, R | 1 |
| Schoenfeld, M | 1 |
| Kishihara, Y | 1 |
| Kashiura, M | 1 |
| Amagasa, S | 1 |
| Fukushima, F | 1 |
| Yasuda, H | 1 |
| Moriya, T | 1 |
| Wiedmann, F | 2 |
| Ince, H | 2 |
| Stellbrink, C | 2 |
| Kleemann, T | 2 |
| Eckardt, L | 5 |
| Brachmann, J | 2 |
| Gonska, BD | 2 |
| Kääb, S | 2 |
| Perings, CA | 2 |
| Jung, W | 4 |
| Lugenbiel, P | 2 |
| Hochadel, M | 2 |
| Senges, J | 3 |
| Frey, N | 2 |
| Schmidt, C | 2 |
| Liu, Q | 2 |
| Li, J | 5 |
| Yang, L | 2 |
| Larson, J | 2 |
| Gondi, K | 2 |
| Chou, A | 2 |
| Deshmukh, A | 2 |
| Cascino, TM | 2 |
| Ghannam, M | 2 |
| Judge, EC | 2 |
| Latchamsetty, R | 2 |
| Jongnarangsin, K | 2 |
| Aaronson, KD | 2 |
| Pagani, FD | 2 |
| Bogun, F | 2 |
| Liang, JJ | 3 |
| Bennett, RG | 1 |
| Garikapati, K | 1 |
| Campbell, TG | 1 |
| Kotake, Y | 2 |
| Turnbull, S | 1 |
| Bhaskaran, A | 1 |
| De Silva, K | 1 |
| Kanawati, J | 1 |
| Zhou, J | 1 |
| Wong, MS | 1 |
| Samuel, M | 1 |
| Hruczkowski, T | 2 |
| Bracy, CL | 1 |
| Kobres, PY | 1 |
| Hockstein, MJ | 1 |
| Rao, SD | 1 |
| Gupta, R | 1 |
| Lam, PH | 1 |
| Sheikh, FH | 1 |
| Hockstein, MA | 1 |
| Kawji, MM | 1 |
| Glancy, DL | 1 |
| Rassi, FM | 1 |
| Minohara, L | 1 |
| Rassi, A | 2 |
| Correia, LCL | 1 |
| Marin-Neto, JA | 2 |
| da Silva Menezes, A | 1 |
| Korkmaz, A | 1 |
| Karimli, E | 1 |
| Simsek, E | 1 |
| Bartos, JA | 1 |
| Grunau, B | 1 |
| Carlson, C | 1 |
| Duval, S | 1 |
| Ripeckyj, A | 1 |
| Kalra, R | 1 |
| Raveendran, G | 1 |
| John, R | 1 |
| Conterato, M | 1 |
| Frascone, RJ | 1 |
| Trembley, A | 1 |
| Aufderheide, TP | 2 |
| Yannopoulos, D | 1 |
| Mazzanti, A | 1 |
| Guz, D | 1 |
| Trancuccio, A | 1 |
| Pagan, E | 1 |
| Kukavica, D | 1 |
| Chargeishvili, T | 1 |
| Olivetti, N | 1 |
| Biernacka, EK | 1 |
| Sacilotto, L | 1 |
| Sarquella-Brugada, G | 1 |
| Campuzano, O | 1 |
| Nof, E | 1 |
| Anastasakis, A | 1 |
| Sansone, VA | 1 |
| Jimenez-Jaimez, J | 1 |
| Cruz, F | 1 |
| Sánchez-Quiñones, J | 1 |
| Hernandez-Afonso, J | 1 |
| Fuentes, ME | 1 |
| Średniawa, B | 1 |
| Garoufi, A | 1 |
| Andršová, I | 1 |
| Izquierdo, M | 1 |
| Marinov, R | 1 |
| Danon, A | 1 |
| Expósito-García, V | 1 |
| Garcia-Fernandez, A | 1 |
| Muñoz-Esparza, C | 1 |
| Ortíz, M | 2 |
| Zienciuk-Krajka, A | 1 |
| Tavazzani, E | 1 |
| Monteforte, N | 1 |
| Bloise, R | 1 |
| Marino, M | 1 |
| Memmi, M | 1 |
| Napolitano, C | 1 |
| Zorio, E | 1 |
| Monserrat, L | 1 |
| Bagnardi, V | 1 |
| Priori, SG | 1 |
| Frutos-López, M | 1 |
| Pedrote, A | 1 |
| Acosta-Martínez, J | 1 |
| Arana-Rueda, E | 1 |
| Berlin, N | 1 |
| Ohad, DG | 1 |
| Maiorkis, I | 1 |
| Kelmer, E | 1 |
| Vriz, O | 1 |
| Ahmed, MM | 1 |
| Kharabsheha, S | 1 |
| Aladmawi, M | 1 |
| Alamro, B | 1 |
| AlSomali, A | 1 |
| Fawzy, N | 1 |
| ALsanei, A | 1 |
| Echahidi, NM | 1 |
| Árpádffy-Lovas, T | 1 |
| Husti, Z | 1 |
| Baczkó, I | 1 |
| Varró, A | 1 |
| Virág, L | 1 |
| El-Khatib, L | 1 |
| Alrayes, H | 1 |
| Sallam, O | 1 |
| Elbanna, A | 1 |
| Gomes, AC | 1 |
| Lopes, LR | 1 |
| Cruz, I | 1 |
| Almeida, AR | 1 |
| Miranda, R | 1 |
| Almeida, S | 1 |
| Brandão, L | 1 |
| Pereira, H | 1 |
| Schupp, T | 2 |
| Behnes, M | 2 |
| Kim, SH | 1 |
| Müller, J | 1 |
| Weidner, K | 1 |
| Reiser, L | 2 |
| Huseynov, A | 1 |
| Bollow, A | 2 |
| Borggrefe, M | 5 |
| Taton, G | 2 |
| Reichelt, T | 2 |
| Ellguth, D | 2 |
| Engelke, N | 2 |
| Akin, M | 2 |
| Große Meininghaus, D | 1 |
| Bertsch, T | 2 |
| Akin, I | 2 |
| Kobiki, J | 1 |
| Taki, T | 1 |
| Yanagi, S | 1 |
| Tamura, N | 1 |
| Oladiran, O | 1 |
| Oladunjoye, A | 1 |
| Oladunjoye, OO | 1 |
| Paudel, A | 1 |
| Oke, I | 1 |
| Motz, L | 1 |
| Luber, S | 1 |
| Licata, A | 1 |
| Donthi, N | 1 |
| Chandrabhatla, T | 1 |
| Genovese, L | 1 |
| deFilippi, C | 1 |
| Di Biase, L | 2 |
| Romero, J | 2 |
| Du, X | 1 |
| Mohanty, S | 1 |
| Trivedi, C | 1 |
| Della Rocca, DG | 1 |
| Patel, K | 1 |
| Sanchez, J | 1 |
| Yang, R | 1 |
| Alviz, I | 1 |
| Mohanty, P | 1 |
| Gianni, C | 1 |
| Tarantino, N | 1 |
| Zhang, XD | 1 |
| Horton, R | 1 |
| Al-Ahmad, A | 1 |
| Lakkireddy, D | 2 |
| Burkhardt, DJ | 1 |
| Chen, M | 1 |
| Natale, A | 2 |
| Christidis, G | 1 |
| Lammert, F | 1 |
| Krawczyk, M | 1 |
| Sanchez, JM | 1 |
| Tzou, WS | 2 |
| Reddy, SA | 1 |
| Nethercott, SL | 1 |
| Khialani, BV | 1 |
| Grace, AA | 1 |
| Martin, CA | 1 |
| Shannon, K | 1 |
| Saltzman, D | 1 |
| Li, I | 1 |
| Mokszycki, R | 1 |
| Galletta, G | 1 |
| Paolini, C | 1 |
| Cavedon, S | 1 |
| Mecenero, A | 1 |
| Perrone, C | 1 |
| Bilato, C | 1 |
| Pokorney, SD | 1 |
| Mi, X | 1 |
| Hammill, BG | 1 |
| Allen LaPointe, NM | 1 |
| Curtis, LH | 1 |
| Al-Khatib, SM | 2 |
| Seto, AH | 1 |
| Abbott, NJ | 1 |
| Makkar, RR | 2 |
| Salazar, MA | 1 |
| Nkoke, C | 1 |
| Luchuo, EB | 1 |
| Dikoume, L | 1 |
| Tung, R | 1 |
| Frankel, DS | 3 |
| Santangeli, P | 3 |
| Bunch, TJ | 2 |
| Weiss, JP | 3 |
| Tholakanahalli, VN | 1 |
| Vunnam, R | 1 |
| Dickfeld, T | 1 |
| Mathuria, N | 1 |
| Tedrow, U | 1 |
| Vergara, P | 1 |
| Vakil, K | 1 |
| Nakahara, S | 2 |
| Burkhardt, JD | 1 |
| Callans, DJ | 3 |
| Della Bella, P | 3 |
| Marchlinski, FE | 6 |
| Sauer, WH | 1 |
| Haverkamp, W | 5 |
| Israel, C | 1 |
| Parwani, A | 1 |
| Yan, S | 2 |
| Yu, J | 1 |
| Xia, Z | 1 |
| Zhu, B | 1 |
| Hu, J | 1 |
| Evans, WN | 1 |
| Acherman, RJ | 1 |
| Law, IH | 1 |
| Von Bergen, NH | 2 |
| Samson, RA | 2 |
| Restrepo, H | 1 |
| Simonen, P | 1 |
| Lehtonen, J | 2 |
| Lampi, AM | 1 |
| Piironen, V | 1 |
| Stenman, UH | 1 |
| Kupari, M | 2 |
| Gylling, H | 1 |
| Drigalla, D | 1 |
| Essler, SE | 1 |
| Stone, CK | 1 |
| AbdelWahab, A | 1 |
| Sapp, J | 1 |
| Sato, S | 1 |
| Zamami, Y | 1 |
| Imai, T | 2 |
| Tanaka, S | 1 |
| Koyama, T | 2 |
| Niimura, T | 1 |
| Chuma, M | 1 |
| Koga, T | 1 |
| Takechi, K | 1 |
| Kurata, Y | 1 |
| Kondo, Y | 1 |
| Izawa-Ishizawa, Y | 1 |
| Sendo, T | 1 |
| Nakura, H | 1 |
| Ishizawa, K | 1 |
| Inoue, K | 1 |
| Saito, J | 1 |
| Kondo, T | 1 |
| Miki, K | 1 |
| Sugisawa, C | 1 |
| Tsurutani, Y | 1 |
| Hasegawa, N | 1 |
| Kowase, S | 1 |
| Kakuta, Y | 1 |
| Omura, M | 1 |
| Nishikawa, T | 1 |
| Rambarat, CA | 1 |
| Winchester, DE | 1 |
| Gula, LJ | 1 |
| Leong-Sit, P | 3 |
| Tang, ASL | 1 |
| Sarrazin, JF | 2 |
| Thibault, B | 2 |
| Tung, SK | 2 |
| Raymond, JM | 2 |
| Lane, C | 1 |
| Nery, PB | 3 |
| Veenhuyzen, GD | 2 |
| Redfearn, DP | 1 |
| Roux, JF | 2 |
| Giddens, K | 1 |
| Steinberg, C | 1 |
| Rivard, L | 2 |
| Fürnkranz, A | 1 |
| Makimoto, H | 2 |
| Soar, J | 1 |
| Tsuda, T | 1 |
| Tada, H | 1 |
| Tanaka, Y | 1 |
| Nishida, N | 1 |
| Yoshida, T | 1 |
| Sawada, T | 1 |
| Sakata, K | 1 |
| Hayashi, K | 2 |
| Kawashiri, MA | 1 |
| Oyama, T | 1 |
| Sasaki, M | 1 |
| Kurose, N | 1 |
| Yamagishi, M | 1 |
| Duan, H | 1 |
| Lu, Y | 1 |
| Qiao, L | 1 |
| Hua, Y | 1 |
| Li, Y | 2 |
| Zhou, K | 1 |
| Wang, C | 1 |
| Yang, W | 1 |
| Schaller, RD | 1 |
| Supple, GE | 1 |
| Hutchinson, MD | 1 |
| Garcia, F | 1 |
| Lin, D | 1 |
| Dixit, S | 1 |
| Epstein, AE | 10 |
| Gerstenfeld, EP | 2 |
| Walters, T | 1 |
| Foerster, CR | 1 |
| Andrew, E | 1 |
| Smith, K | 1 |
| Bernard, S | 1 |
| deSouza, IS | 3 |
| Münkler, P | 1 |
| Wutzler, A | 1 |
| Attanasio, P | 1 |
| Huemer, M | 1 |
| Parwani, AS | 1 |
| Meyer, C | 1 |
| Boldt, LH | 1 |
| Robinson, D | 1 |
| Hand, G | 1 |
| Ausman, J | 1 |
| Hackett, A | 1 |
| Schlesinger-Irsch, UR | 1 |
| Perlewitz, O | 1 |
| Nelles, M | 1 |
| Ansari, U | 1 |
| El-Battrawy, I | 1 |
| Weiß, C | 1 |
| Nienaber, C | 1 |
| Lang, S | 1 |
| Mashayekhi, K | 1 |
| Faiella, W | 1 |
| Bessoudo, R | 1 |
| Panchal, AR | 1 |
| Berg, KM | 1 |
| Kudenchuk, PJ | 3 |
| Del Rios, M | 1 |
| Hirsch, KG | 1 |
| Link, MS | 1 |
| Kurz, MC | 1 |
| Chan, PS | 1 |
| Cabañas, JG | 1 |
| Morley, PT | 1 |
| Hazinski, MF | 3 |
| Donnino, MW | 1 |
| Duff, JP | 1 |
| Topjian, A | 1 |
| Berg, MD | 2 |
| Chan, M | 1 |
| Haskell, SE | 1 |
| Joyner, BL | 1 |
| Lasa, JJ | 1 |
| Ley, SJ | 1 |
| Raymond, TT | 1 |
| Sutton, RM | 1 |
| Atkins, DL | 1 |
| Viskin, S | 1 |
| Chorin, E | 1 |
| Viskin, D | 1 |
| Hochstadt, A | 1 |
| Halkin, A | 1 |
| Tovia-Brodie, O | 1 |
| Lee, JK | 1 |
| Asher, E | 1 |
| Laish-Farkash, A | 1 |
| Amit, G | 1 |
| Havakuk, O | 1 |
| Belhassen, B | 1 |
| Rosso, R | 1 |
| Maghrabi, K | 1 |
| Uzun, O | 1 |
| Kirsh, JA | 1 |
| Balaji, S | 1 |
| Sanatani, S | 1 |
| Osman, W | 1 |
| Hanson, M | 1 |
| Baranchuk, A | 1 |
| Wang, CH | 1 |
| Chang, WT | 1 |
| Huang, CH | 2 |
| Tsai, MS | 1 |
| Yu, PH | 1 |
| Wu, YW | 2 |
| Liu, YB | 2 |
| Chen, WJ | 2 |
| Riaz, A | 1 |
| Hieb, H | 1 |
| Foley, B | 1 |
| Mulvihill, N | 1 |
| Crean, P | 1 |
| Murphy, RT | 1 |
| Daly, C | 1 |
| Boyle, N | 1 |
| Gao, D | 1 |
| Van Herendael, H | 2 |
| Alshengeiti, L | 1 |
| Dorian, P | 11 |
| Mangat, I | 3 |
| Korley, V | 3 |
| Ahmad, K | 2 |
| Golovchiner, G | 1 |
| Aves, T | 1 |
| Pinter, A | 3 |
| Joukar, S | 1 |
| Ghasemipour-Afshar, E | 1 |
| Sheibani, M | 1 |
| Naghsh, N | 1 |
| Bashiri, A | 1 |
| Kosior, DA | 1 |
| Krzykwa, A | 1 |
| Postuła, M | 1 |
| Li, T | 1 |
| Wei, X | 1 |
| Watkins, AC | 1 |
| Sanchez, PG | 1 |
| Wu, ZJ | 1 |
| Griffith, BP | 1 |
| Simşek, H | 1 |
| Doğan, A | 1 |
| Sahin, M | 1 |
| Gümrükçüoğlu, HA | 1 |
| Chiladakis, J | 1 |
| Zagkli, F | 1 |
| Alexopoulos, D | 1 |
| Akpınar, O | 1 |
| Kurt, K | 1 |
| Kanadaşı, M | 1 |
| Spina, R | 1 |
| Granger, E | 1 |
| Walker, B | 1 |
| Subbiah, RN | 1 |
| Averin, K | 1 |
| Lorts, A | 1 |
| Connor, C | 1 |
| Valdes, SO | 1 |
| Donoghue, AJ | 1 |
| Hoyme, DB | 1 |
| Hammond, R | 1 |
| Berg, RA | 1 |
| Passaloglou, IT | 1 |
| Sabashnikov, A | 1 |
| Zeriouh, M | 1 |
| Reutter, S | 1 |
| Fatullayev, J | 1 |
| Choi, YH | 1 |
| Wahlers, T | 1 |
| Gali, WL | 1 |
| Sarabanda, AV | 1 |
| Baggio, JM | 1 |
| Ferreira, LG | 1 |
| Gomes, GG | 1 |
| Junqueira, LF | 1 |
| Piers, SR | 1 |
| Silva, Mde R | 1 |
| Kapel, GF | 1 |
| Trines, SA | 1 |
| Schalij, MJ | 1 |
| Páez, JL | 1 |
| Doiny, D | 1 |
| Estrada, A | 1 |
| Figueroa, J | 1 |
| Filgueiras-Rama, D | 1 |
| Israel, CW | 1 |
| Manegold, JC | 1 |
| Yoshie, K | 1 |
| Tomita, T | 1 |
| Takeuchi, T | 1 |
| Okada, A | 1 |
| Miura, T | 1 |
| Motoki, H | 1 |
| Ikeda, U | 1 |
| Liu, B | 1 |
| Li, S | 1 |
| Su, Y | 1 |
| Xiong, M | 1 |
| Xu, Y | 1 |
| Franz, MR | 2 |
| Gray, RA | 1 |
| Karasik, P | 1 |
| Moore, HJ | 1 |
| Singh, SN | 5 |
| Kurita, T | 6 |
| Akaiwa, Y | 1 |
| Yasuoka, R | 1 |
| Motoki, K | 1 |
| Kobuke, K | 1 |
| Iwanaga, Y | 1 |
| Miyazaki, S | 1 |
| Beaty, EH | 1 |
| Ballany, W | 1 |
| Trohman, RG | 3 |
| Madias, C | 1 |
| De Maria, E | 1 |
| Patrizi, G | 1 |
| Cappelli, S | 1 |
| Brescia, L | 1 |
| Benoit, A | 1 |
| Betea, D | 1 |
| Delvenne, P | 1 |
| Hamoir, E | 1 |
| Beckers, A | 1 |
| Agarwal, AK | 1 |
| Ram, J | 1 |
| Murata, H | 1 |
| Miyauchi, Y | 1 |
| Hayashi, M | 1 |
| Iwasaki, YK | 1 |
| Yodogawa, K | 1 |
| Ueno, A | 1 |
| Hayashi, H | 1 |
| Tsuboi, I | 1 |
| Uetake, S | 1 |
| Takahashi, K | 2 |
| Yamamoto, T | 2 |
| Maruyama, M | 1 |
| Akutsu, K | 1 |
| Kobayashi, Y | 3 |
| Tanaka, K | 1 |
| Atarashi, H | 1 |
| Katoh, T | 2 |
| Shimizu, W | 5 |
| Chandelia, S | 1 |
| Kundal, M | 1 |
| Dubey, NK | 1 |
| Dhikav, V | 1 |
| Cannavà, G | 1 |
| Currò, A | 1 |
| Witkowski, M | 1 |
| Mochmann, HC | 1 |
| Rauch, U | 1 |
| Knie, W | 1 |
| Landmesser, U | 1 |
| Skurk, C | 1 |
| Jolly, U | 1 |
| Klein, G | 1 |
| Brown, SP | 1 |
| Daya, M | 1 |
| Rea, T | 1 |
| Nichol, G | 1 |
| Morrison, LJ | 1 |
| Leroux, B | 1 |
| Vaillancourt, C | 1 |
| Wittwer, L | 1 |
| Callaway, CW | 1 |
| Christenson, J | 1 |
| Egan, D | 1 |
| Ornato, JP | 1 |
| Weisfeldt, ML | 2 |
| Stiell, IG | 1 |
| Idris, AH | 1 |
| Dunford, JV | 1 |
| Colella, MR | 1 |
| Vilke, GM | 1 |
| Brienza, AM | 1 |
| Desvigne-Nickens, P | 1 |
| Gray, PC | 1 |
| Gray, R | 1 |
| Seals, N | 1 |
| Straight, R | 1 |
| Chen, CY | 1 |
| Tsai, J | 1 |
| Hsu, TY | 1 |
| Lai, WY | 1 |
| Chen, WK | 1 |
| Muo, CH | 1 |
| Kao, CH | 1 |
| Wells, GA | 1 |
| Blier, L | 1 |
| Redfearn, D | 1 |
| Tang, AS | 1 |
| Hori, Y | 1 |
| Mine, S | 1 |
| Anjo, N | 1 |
| Fujii, A | 1 |
| Ueda, Y | 1 |
| Taguchi, I | 1 |
| Martín, A | 1 |
| Coll-Vinent, B | 1 |
| Del Arco, C | 1 |
| Peinado, R | 2 |
| Almendral, J | 1 |
| Ekström, K | 1 |
| Kandolin, R | 1 |
| Räisänen-Sokolowski, A | 1 |
| Salmenkivi, K | 1 |
| Rizkallah, J | 1 |
| Kuriachan, V | 1 |
| Brent Mitchell, L | 1 |
| Bruña, V | 1 |
| Díez-Villanueva, P | 1 |
| Martínez-Sellés, M | 1 |
| Datino, T | 1 |
| Fernández-Avilés, F | 1 |
| Nouri, SN | 1 |
| Block, BL | 1 |
| Rosini, JM | 1 |
| Zizza, L | 1 |
| Tak, S | 1 |
| Lakhotia, M | 1 |
| Sagar, A | 1 |
| Bohra, G | 1 |
| Bajari, R | 1 |
| Long, B | 1 |
| Koyfman, A | 1 |
| Gibson, AE | 1 |
| Jaeschke, R | 1 |
| Bobbo, M | 1 |
| Pinamonti, B | 1 |
| Merlo, M | 1 |
| Stolfo, D | 1 |
| Iorio, A | 1 |
| Ramani, F | 1 |
| Barbati, G | 1 |
| Carriere, C | 1 |
| Massa, L | 1 |
| Poli, S | 1 |
| Scapol, S | 1 |
| Gigli, M | 1 |
| Di Lenarda, A | 1 |
| Sinagra, G | 1 |
| Mouyis, K | 1 |
| Metaxa, S | 1 |
| Missouris, C | 1 |
| Beyer, A | 1 |
| Ganti, B | 1 |
| Majkrzak, A | 1 |
| Theyyunni, N | 1 |
| Haas, NA | 1 |
| Camphausen, CK | 1 |
| Kuruma, T | 1 |
| Maruyama, T | 1 |
| Hiramatsu, S | 1 |
| Yasuda, Y | 1 |
| Yasuda, S | 1 |
| Odashiro, K | 1 |
| Harada, M | 2 |
| Kurt, IH | 1 |
| Yigit, T | 1 |
| Karademir, BM | 1 |
| Manolis, AG | 3 |
| Kourouklis, S | 1 |
| Chatzis, D | 1 |
| Kouvelas, K | 1 |
| Kyriakides, Z | 1 |
| Nadkarni, PJ | 1 |
| Sharma, M | 1 |
| Zinsmeister, B | 1 |
| Wartofsky, L | 1 |
| Burman, KD | 1 |
| Maeda, K | 1 |
| Takagi, M | 1 |
| Tatsumi, H | 1 |
| Nakagawa, E | 1 |
| Yoshiyama, M | 1 |
| Kalimullah, EA | 1 |
| Bryant, SM | 1 |
| Hirasawa, Y | 1 |
| Nakagomi, A | 1 |
| Mizuno, K | 1 |
| Bestetti, R | 1 |
| Cardinalli-Neto, A | 1 |
| Nakaya, H | 1 |
| Pierog, J | 1 |
| Kane, B | 1 |
| Kane, K | 1 |
| Donovan, JW | 1 |
| Heisel, A | 1 |
| Berg, M | 1 |
| Stopp, M | 1 |
| Ukena, D | 1 |
| Schieffer, H | 1 |
| Siu, CW | 1 |
| Lau, CP | 1 |
| Lee, WL | 1 |
| Lam, KF | 1 |
| Tse, HF | 1 |
| Fishberger, SB | 1 |
| Hannan, RL | 1 |
| Welch, EM | 1 |
| Rossi, AF | 1 |
| Marcus, GM | 1 |
| Glidden, DV | 1 |
| Polonsky, B | 1 |
| Zareba, W | 1 |
| Smith, LM | 1 |
| Cannom, DS | 3 |
| Estes, NA | 1 |
| Marcus, F | 1 |
| Scheinman, MM | 5 |
| Mitchell, LB | 5 |
| Yusu, S | 1 |
| Ikeda, T | 1 |
| Mera, H | 1 |
| Miyakoshi, M | 1 |
| Miwa, Y | 1 |
| Abe, A | 1 |
| Tsukada, T | 1 |
| Ishiguro, H | 1 |
| Shimizu, H | 1 |
| Yoshino, H | 1 |
| Lü, HS | 1 |
| He, BB | 1 |
| Huang, GH | 1 |
| Shimada, YJ | 1 |
| Sato, K | 2 |
| Hanon, S | 2 |
| Schweitzer, P | 1 |
| Radulescu, B | 1 |
| Imperiale, A | 1 |
| Germain, P | 1 |
| Ohlmann, P | 1 |
| Eroğlu, S | 1 |
| Ozin, B | 1 |
| Ozbiçer, S | 1 |
| Müderrisoğlu, H | 1 |
| Mishkin, JD | 1 |
| Saxonhouse, SJ | 1 |
| Woo, GW | 1 |
| Burkart, TA | 1 |
| Miles, WM | 1 |
| Conti, JB | 2 |
| Schofield, RS | 1 |
| Sears, SF | 1 |
| Aranda, JM | 1 |
| Yoshioka, K | 1 |
| Amino, M | 1 |
| Matsuzaki, A | 1 |
| Shima, M | 1 |
| Fujii, T | 1 |
| Kanda, S | 1 |
| Deguchi, Y | 1 |
| Kodama, I | 5 |
| Tanabe, T | 1 |
| Kaky, GK | 1 |
| Makosso, E | 1 |
| Fiala, M | 1 |
| Januska, J | 1 |
| Bulková, V | 1 |
| Pleva, M | 1 |
| Dhesi, P | 1 |
| Ng, R | 1 |
| Shehata, MM | 1 |
| Shah, PK | 1 |
| Inada, K | 1 |
| Roberts-Thomson, KC | 1 |
| Seiler, J | 1 |
| Steven, D | 1 |
| Koplan, BA | 1 |
| Marill, KA | 2 |
| Nishijima, DK | 2 |
| Senecal, EL | 1 |
| Setnik, GS | 2 |
| Stair, TO | 2 |
| Ruskin, JN | 2 |
| Ellinor, PT | 1 |
| Gassanov, N | 1 |
| Dietlein, M | 1 |
| Caglayan, E | 1 |
| Erdmann, E | 1 |
| Er, F | 1 |
| Ross, JJ | 1 |
| Britton, KA | 2 |
| Desai, AS | 1 |
| Levy, BD | 1 |
| Katz, JT | 1 |
| Loscalzo, J | 1 |
| Shaaraoui, M | 1 |
| Freudenberger, R | 1 |
| Levin, V | 2 |
| Nakagawa, H | 2 |
| Honjo, H | 2 |
| Ishiguro, YS | 1 |
| Yamazaki, M | 2 |
| Okuno, Y | 2 |
| Takanari, H | 1 |
| Sakuma, I | 2 |
| Kamiya, K | 3 |
| Lopez, KN | 1 |
| Decker, JA | 1 |
| Friedman, RA | 4 |
| Kim, JJ | 1 |
| Piccini, JP | 1 |
| Schulte, PJ | 1 |
| Pieper, KS | 1 |
| Mehta, RH | 1 |
| White, HD | 1 |
| Van de Werf, F | 1 |
| Ardissino, D | 1 |
| Califf, RM | 1 |
| Granger, CB | 1 |
| Ohman, EM | 1 |
| Alexander, JH | 1 |
| Fink, A | 1 |
| Duray, GZ | 1 |
| Hohnloser, SH | 4 |
| Zitron, E | 1 |
| Katus, HA | 1 |
| Becker, R | 1 |
| Dizon, J | 1 |
| Chen, K | 1 |
| Dizon, S | 1 |
| Biviano, A | 1 |
| Whang, W | 1 |
| Ehlert, F | 1 |
| Vazquez, J | 1 |
| Nazif, T | 1 |
| Garan, H | 1 |
| Auer, J | 1 |
| Lamm, G | 1 |
| Akhtari, S | 1 |
| O'Connell, T | 1 |
| O'Donnell, S | 1 |
| Posan, E | 1 |
| Newman, D | 4 |
| Ayalloore, SG | 1 |
| LeLorier, P | 1 |
| Mountantonakis, SE | 1 |
| Robinson, MR | 1 |
| Zado, ES | 2 |
| Derejko, M | 1 |
| Derejko, P | 2 |
| Przybylski, A | 2 |
| Niewiadomska, M | 1 |
| Antczak, J | 1 |
| Banach, M | 1 |
| Rakowicz, M | 1 |
| Szumowski, Ł | 2 |
| Walczak, F | 2 |
| Lim, SL | 1 |
| Teo, SG | 1 |
| Kireyev, D | 1 |
| Poh, KK | 1 |
| Jurado Román, A | 1 |
| Rubio Alonso, B | 1 |
| Martín Asenjo, R | 1 |
| Salguero Bodes, R | 1 |
| López Gil, M | 1 |
| Arribas Ynsaurriaga, F | 1 |
| Drafts, BC | 1 |
| Sutton, BJ | 1 |
| Dubose, TD | 1 |
| Thohan, V | 1 |
| Mizzi, A | 1 |
| Tran, T | 1 |
| Mangar, D | 1 |
| Camporesi, EM | 1 |
| Smith, W | 1 |
| Mahapatra, S | 1 |
| Murdock, D | 1 |
| Molden, J | 1 |
| May, HT | 1 |
| Bair, TL | 1 |
| Mader, KM | 1 |
| Crandall, BG | 1 |
| Day, JD | 2 |
| Osborn, JS | 1 |
| Muhlestein, JB | 1 |
| Lappe, DL | 1 |
| Anderson, JL | 3 |
| Michalski, T | 1 |
| Noda, T | 2 |
| Nakajima, I | 1 |
| Yokoyama, T | 1 |
| Doi, A | 1 |
| Yamada, Y | 2 |
| Okamura, H | 2 |
| Satomi, K | 4 |
| Aiba, T | 4 |
| Suyama, K | 4 |
| Aihara, N | 4 |
| Kamakura, S | 4 |
| Milberg, P | 1 |
| Pott, C | 1 |
| Frommeyer, G | 1 |
| Fink, M | 1 |
| Ruhe, M | 1 |
| Matsuda, T | 1 |
| Baba, A | 1 |
| Klocke, R | 1 |
| Quang, TH | 1 |
| Nikol, S | 1 |
| Stypmann, J | 1 |
| Osada, N | 1 |
| Müller, FU | 1 |
| Breithardt, G | 7 |
| Noble, D | 1 |
| Kowey, PR | 10 |
| Crijns, HJ | 2 |
| Aliot, EM | 1 |
| Capucci, A | 1 |
| Kulakowski, P | 1 |
| Radzik, D | 1 |
| Roy, D | 3 |
| Connolly, SJ | 6 |
| Inaba, H | 1 |
| Suzuki, S | 1 |
| Takeda, T | 1 |
| Kobayashi, S | 1 |
| Akamizu, T | 1 |
| Komatsu, M | 1 |
| Pedro, B | 1 |
| López-Alvarez, J | 1 |
| Fonfara, S | 1 |
| Stephenson, H | 1 |
| Dukes-McEwan, J | 1 |
| Nathan, AT | 1 |
| Naim, M | 1 |
| Montenegro, LM | 1 |
| Vetter, VL | 1 |
| Erdogan, HI | 1 |
| Gul, EE | 1 |
| Gok, H | 1 |
| Nikus, KC | 1 |
| Modi, S | 1 |
| Foster, W | 1 |
| Todd, DM | 1 |
| Klein, GJ | 4 |
| Jindal, G | 1 |
| Singh, S | 5 |
| Suri, D | 1 |
| Rawat, A | 1 |
| Rohit, M | 1 |
| Surber, R | 1 |
| Prochnau, D | 1 |
| Kühnert, H | 1 |
| Figulla, HR | 2 |
| Hudzik, B | 1 |
| Polonski, L | 1 |
| Chow, J | 1 |
| Kam, R | 1 |
| Horovitz, A | 1 |
| van Geldorp, IE | 1 |
| Roubertie, F | 1 |
| Thambo, JB | 1 |
| Rosman, J | 1 |
| Hoffmeister, P | 2 |
| Reynolds, M | 1 |
| Peralta, A | 1 |
| Bao, H | 1 |
| Hong, K | 1 |
| Cheng, X | 1 |
| Verrier, RL | 1 |
| Pagotto, VP | 1 |
| Kanas, AF | 1 |
| Sobrado, MF | 1 |
| Nearing, BD | 1 |
| Zeng, D | 1 |
| Belardinelli, L | 1 |
| Hein, W | 1 |
| Ellringmann, U | 1 |
| Vollmann, D | 1 |
| Rostock, T | 1 |
| Schott, P | 1 |
| Bhavnani, SP | 1 |
| Clyne, CA | 1 |
| Nanda, S | 1 |
| Martinez, MW | 1 |
| Yonezawa, M | 1 |
| Komuro, I | 1 |
| Ohnishi, S | 6 |
| Spivack, C | 1 |
| Gregory, SA | 1 |
| Webster, JB | 1 |
| Chapman, GD | 1 |
| Singh, BN | 10 |
| Hsu, J | 1 |
| Uratsu, C | 1 |
| Truman, A | 1 |
| Quesenberry, C | 1 |
| McDonald, KM | 2 |
| Hlatky, MA | 3 |
| Selby, J | 1 |
| Owens, DK | 1 |
| Sanders, GD | 1 |
| Heidenreich, PA | 1 |
| Somberg, JC | 1 |
| Bailin, SJ | 1 |
| Haffajee, CI | 1 |
| Paladino, WP | 1 |
| Kerin, NZ | 1 |
| Bridges, D | 1 |
| Timar, S | 1 |
| Molnar, J | 1 |
| Sharma, H | 1 |
| Sharma, N | 1 |
| Burke, JF | 1 |
| Yan, GX | 2 |
| Briassoulis, G | 1 |
| Stefanaki, K | 1 |
| Peristeri, I | 1 |
| Endoh, Y | 4 |
| Hatzis, T | 1 |
| Knowles, S | 1 |
| Wilkoff, BL | 1 |
| Cook, JR | 2 |
| Greene, HL | 8 |
| Hallstrom, AP | 7 |
| Hsia, H | 1 |
| Kutalek, SP | 1 |
| Sharma, A | 2 |
| Willan, AR | 1 |
| Chen, EB | 1 |
| Cook, RJ | 1 |
| Lin, DY | 1 |
| Taylor, SE | 1 |
| Pollak, PT | 1 |
| You, YD | 1 |
| Suzuki, T | 3 |
| Shiga, T | 4 |
| Wakaumi, M | 4 |
| Matsuda, N | 4 |
| Ishizuka, N | 1 |
| Kasanuki, H | 11 |
| Moulik, PK | 1 |
| Attar, MN | 1 |
| Rose, EL | 1 |
| Khaleeli, AA | 1 |
| Strickberger, SA | 4 |
| Hummel, JD | 3 |
| Bartlett, TG | 1 |
| Frumin, HI | 1 |
| Schuger, CD | 1 |
| Beau, SL | 1 |
| Bitar, C | 1 |
| Morady, F | 4 |
| Shaikh, S | 1 |
| Shaikh, N | 1 |
| Chun, SH | 1 |
| Spin, JM | 1 |
| Blumenkranz, MS | 1 |
| Marmor, MF | 1 |
| Naik, N | 2 |
| Talwar, KK | 2 |
| Leite, LR | 1 |
| Fenelon, G | 1 |
| Simoes, A | 1 |
| Silva, GG | 1 |
| Friedman, PA | 1 |
| de Paola, AA | 1 |
| Exner, DV | 2 |
| Franks, AM | 1 |
| Watterson, KS | 1 |
| Leenhardt, A | 2 |
| Sadoul, N | 1 |
| Mabo, P | 1 |
| Kacet, S | 2 |
| Lavergne, T | 2 |
| Saoudi, N | 1 |
| Iscolo, N | 1 |
| Alyan, O | 2 |
| Arda, K | 1 |
| Ozdemir, O | 2 |
| Acu, B | 1 |
| Soylu, M | 2 |
| Demirkan, D | 1 |
| Srivatsa, UN | 1 |
| Ebrahimi, R | 1 |
| El-Bialy, A | 1 |
| Wachsner, RY | 1 |
| Trappe, HJ | 1 |
| Brandts, B | 1 |
| Weismueller, P | 1 |
| Wang, JD | 1 |
| Fu, YC | 1 |
| Jan, SL | 1 |
| Chi, CS | 1 |
| Kluger, J | 3 |
| White, CM | 2 |
| Hosaka, F | 2 |
| Tanizaki, K | 1 |
| Kajimoto, K | 1 |
| Shoda, M | 4 |
| Hagiwara, N | 3 |
| Shinde, AA | 1 |
| Juneman, EB | 1 |
| Mitchell, B | 1 |
| Pierce, MK | 1 |
| Gaballa, MA | 1 |
| Goldman, S | 1 |
| Thai, H | 1 |
| Izawa, A | 1 |
| Kinoshita, O | 1 |
| Shiba, Y | 1 |
| Takahashi, W | 1 |
| Uchikawa, S | 1 |
| Imamura, H | 1 |
| Owa, M | 1 |
| Kubo, K | 1 |
| Bianconcini, M | 1 |
| Giannini, AL | 1 |
| Guerra, JM | 1 |
| Wu, J | 1 |
| Miller, JM | 1 |
| Groh, WJ | 1 |
| Khan, MH | 1 |
| Jin, ZH | 1 |
| Chu, N | 1 |
| Wang, ZR | 1 |
| Zhang, J | 1 |
| Lu, YR | 1 |
| Kulasingam, SL | 1 |
| Akiyama, T | 2 |
| Mounsey, JP | 1 |
| Ledingham, R | 2 |
| Sivasubramonian, S | 1 |
| Rosenthal, E | 1 |
| Hermida, JS | 2 |
| Tcheng, E | 2 |
| Jarry, G | 2 |
| Moullart, V | 2 |
| Arlot, S | 2 |
| Rey, JL | 2 |
| Delonca, J | 1 |
| Schvartz, C | 2 |
| Ryan, LE | 1 |
| Braverman, LE | 1 |
| Cooper, DS | 1 |
| Ladenson, PW | 1 |
| Kloos, RT | 1 |
| Cawley, PJ | 1 |
| Lien, WC | 1 |
| Takemoto, M | 1 |
| Sakamoto, M | 1 |
| Kawagoe, J | 1 |
| Goto, K | 1 |
| Baba, H | 1 |
| Noma, M | 1 |
| Origuchi, H | 1 |
| Yoshimura, H | 1 |
| Sese, A | 1 |
| Yamamoto, H | 1 |
| Lau, EW | 1 |
| Griffith, MJ | 2 |
| Pathmanathan, RK | 1 |
| Ng, GA | 1 |
| Clune, MM | 1 |
| Cooper, J | 1 |
| Marshall, HJ | 1 |
| Forsey, PR | 1 |
| Stafford, PJ | 1 |
| Gray, RG | 1 |
| Skehan, JD | 1 |
| Garratt, CJ | 1 |
| Aslam, MK | 1 |
| Gnaim, C | 1 |
| Kutnick, J | 1 |
| Kowal, RC | 1 |
| McGuire, DK | 1 |
| Goernig, M | 1 |
| Kirmeier, T | 1 |
| Krack, A | 1 |
| Hartog, CS | 1 |
| Leder, U | 1 |
| Bokhari, F | 1 |
| Greene, M | 2 |
| Wellens, HJ | 1 |
| Inagaki, M | 1 |
| Taguchi, A | 3 |
| Sunagawa, K | 1 |
| Scaglione, J | 1 |
| Socas, AG | 1 |
| De Palma, C | 1 |
| Kreutzer, E | 1 |
| Kobayashi, A | 1 |
| Nomura, M | 1 |
| Sawa, Y | 1 |
| Kawaguchi, T | 1 |
| Koshiba, K | 1 |
| Yamaguchi, K | 1 |
| Kawano, T | 1 |
| Wakatsuki, T | 1 |
| Tabata, T | 1 |
| Nisikado, A | 1 |
| Ito, S | 1 |
| Nakaya, Y | 1 |
| Rajawat, YS | 1 |
| Patel, VV | 1 |
| Nayak, H | 2 |
| Rajappan, K | 1 |
| Lefroy, D | 1 |
| Vijayaraman, P | 1 |
| Lee, BP | 1 |
| Rhee, B | 1 |
| Ellenbogen, KA | 2 |
| Tsagalou, EP | 1 |
| Kanakakis, J | 1 |
| Rokas, S | 1 |
| Anastasiou-Nana, MI | 1 |
| Machado, MN | 1 |
| Suzuki, FA | 1 |
| Mouco, OC | 1 |
| Hernandes, ME | 1 |
| Lemos, MA | 1 |
| Maia, LN | 1 |
| Herre, JM | 4 |
| Klein, RC | 1 |
| Platia, EV | 3 |
| Wilkoff, B | 1 |
| Ledingham, RB | 1 |
| Hunter, R | 1 |
| Frangini, P | 1 |
| Vergara, I | 1 |
| Fajuri, A | 1 |
| González, R | 1 |
| Baeza, M | 1 |
| Haghjoo, M | 1 |
| Sadr-Ameli, MA | 1 |
| Aljitawi, O | 1 |
| Shabaneh, B | 1 |
| Whitaker, J | 1 |
| Shukla, G | 1 |
| Chaudhry, GM | 1 |
| Orlov, M | 1 |
| Haffajee, C | 1 |
| You, B | 1 |
| Pu, J | 1 |
| Liu, N | 1 |
| Yu, R | 1 |
| Ruan, Y | 1 |
| Wang, L | 1 |
| Ishiguro, Y | 1 |
| Azzam, I | 1 |
| Tov, N | 1 |
| Elias, N | 1 |
| Naschitz, JE | 1 |
| Cummins, RO | 1 |
| Yuge, M | 1 |
| Niwano, S | 1 |
| Moriguchi, M | 1 |
| Sasaki, T | 1 |
| Hirasawa, S | 1 |
| Imaki, R | 1 |
| Sato, D | 1 |
| Izumi, T | 1 |
| Mitamura, H | 1 |
| Aizawa, Y | 4 |
| Nitta, T | 1 |
| Aonuma, K | 1 |
| Tsuboi, N | 1 |
| Chinushi, M | 2 |
| Furushima, H | 1 |
| Ohe, T | 2 |
| Ogawa, S | 1 |
| Ohtsu, H | 1 |
| Yamazaki, T | 1 |
| Sugi, K | 1 |
| Rea, RS | 1 |
| Kane-Gill, SL | 1 |
| Rudis, MI | 1 |
| Seybert, AL | 1 |
| Oyen, LJ | 1 |
| Ou, NN | 1 |
| Stauss, JL | 1 |
| Kirisci, L | 1 |
| Idrees, U | 1 |
| Henderson, SO | 1 |
| Trombert, V | 2 |
| Graf, C | 1 |
| Iskandar, SB | 1 |
| Abi-Saleh, B | 1 |
| Keith, RL | 1 |
| Byrd, RP | 1 |
| Roy, TM | 1 |
| Fukumoto, Y | 1 |
| Yamada, A | 1 |
| Ando, H | 1 |
| Sobashima, A | 1 |
| Kuwata, K | 1 |
| Yamawaki, T | 1 |
| Nakamura, R | 1 |
| Eto, Y | 1 |
| Kishi, T | 1 |
| Ikeuchi, M | 1 |
| Sekiya, M | 1 |
| Ozawa, M | 1 |
| Okamatsu, S | 1 |
| Yeo, KK | 1 |
| Cruz, L | 1 |
| Hong, R | 1 |
| Hagège, AA | 1 |
| Marolleau, JP | 1 |
| Vilquin, JT | 1 |
| Alhéritière, A | 1 |
| Peyrard, S | 1 |
| Duboc, D | 1 |
| Abergel, E | 1 |
| Messas, E | 1 |
| Mousseaux, E | 1 |
| Schwartz, K | 1 |
| Desnos, M | 1 |
| Menasché, P | 1 |
| Wood, MA | 1 |
| Showkathali, R | 1 |
| Earley, MJ | 1 |
| Sporton, S | 1 |
| Iwanek, M | 1 |
| Urbanek, P | 1 |
| Kepski, R | 1 |
| Grzybowski, J | 1 |
| Chojnowska, L | 1 |
| Szwed, H | 1 |
| Lin, JA | 1 |
| Borel, CO | 1 |
| Wang, WB | 1 |
| Wong, CS | 1 |
| Yeh, CC | 1 |
| Yang, CP | 1 |
| Wu, CT | 1 |
| Lang, E | 1 |
| Al Raisi, M | 1 |
| Rakovec, P | 1 |
| Kozak, M | 1 |
| Sebestjen, M | 1 |
| Cheng, MF | 1 |
| Huang, PJ | 1 |
| Tzen, KY | 1 |
| Yen, RF | 1 |
| Kukla, P | 1 |
| Bryniarski, L | 1 |
| Dragan, J | 1 |
| Słowiak-Lewińska, T | 1 |
| Czamara, M | 1 |
| Bromblik, A | 1 |
| Szczuka, K | 1 |
| Riera, M | 1 |
| Herrero, J | 1 |
| Antón, E | 1 |
| Fiol, M | 1 |
| Karaoguz, R | 2 |
| Maydanozcu, S | 1 |
| Altun, T | 1 |
| Güldal, M | 2 |
| Akyürek, O | 1 |
| Erol, C | 1 |
| Pollet, P | 1 |
| Goethals, M | 1 |
| Palanca, V | 1 |
| Quesada, A | 1 |
| Trigo, A | 1 |
| Jiménez, J | 1 |
| Coban, S | 1 |
| Köklü, S | 1 |
| Sencer, H | 1 |
| Ekiz, F | 1 |
| Ormeci, N | 1 |
| Kimura, M | 1 |
| Ogawa, H | 1 |
| Wakeyama, T | 1 |
| Takaki, A | 1 |
| Iwami, T | 1 |
| Hadano, Y | 1 |
| Miyazaki, Y | 1 |
| Shimizu, A | 1 |
| Matsuzaki, M | 1 |
| Sahin, O | 1 |
| Ergun, K | 1 |
| Deveci, B | 1 |
| Yildiz, A | 1 |
| Demir, AD | 1 |
| Kisacik, HL | 1 |
| Korkmaz, S | 1 |
| Agelaki, MG | 2 |
| Pantos, C | 2 |
| Korantzopoulos, P | 1 |
| Tsalikakis, DG | 1 |
| Baltogiannis, GG | 2 |
| Fotopoulos, A | 2 |
| Kolettis, TM | 2 |
| Mykytsey, A | 1 |
| Bauman, JL | 2 |
| Razminia, M | 1 |
| Zheutlin, T | 1 |
| Wang, T | 1 |
| Saleem, M | 1 |
| Leal, S | 1 |
| Kehoe, RF | 1 |
| Mori, M | 1 |
| Rachko, M | 1 |
| Joshi, S | 1 |
| Raiszadeh, F | 1 |
| Pierce, W | 1 |
| Steinberg, JS | 2 |
| Foley, P | 1 |
| Kalra, P | 1 |
| Andrews, N | 1 |
| Goldschlager, N | 1 |
| Naccarelli, GV | 4 |
| Olshansky, B | 3 |
| Singh, B | 2 |
| Collard, HR | 1 |
| Murphy, E | 1 |
| Eksik, A | 1 |
| Akyol, A | 1 |
| Norgaz, T | 1 |
| Aksu, H | 1 |
| Erdinler, I | 1 |
| Cakmak, N | 1 |
| Alper, AT | 1 |
| Cinar, B | 1 |
| Yildirim, A | 1 |
| Gürkan, K | 1 |
| Sharma, JR | 1 |
| Sathanandam, S | 1 |
| Rao, SP | 1 |
| Acharya, S | 1 |
| Flood, V | 1 |
| Parsai, C | 1 |
| Bonvini, RF | 1 |
| Schnetzler, B | 1 |
| Sunthorn, H | 1 |
| Vlahos, AP | 1 |
| Mourouzis, I | 1 |
| Daccarett, M | 1 |
| Segerson, NM | 1 |
| Ghedira, M | 1 |
| Davis, JE | 1 |
| Curtis, LA | 1 |
| Rashid, H | 1 |
| Nägele, H | 1 |
| Behrens, S | 2 |
| Castel, A | 1 |
| Tomlinson, DR | 1 |
| Cherian, P | 1 |
| Betts, TR | 1 |
| Bashir, Y | 2 |
| Yamagata, K | 1 |
| Sinha, SK | 1 |
| Erdurmus, M | 1 |
| Selcoki, Y | 1 |
| Yagci, R | 1 |
| Hepsen, IF | 1 |
| Lima, CE | 1 |
| Martinelli Filho, M | 1 |
| Silva, RT | 1 |
| Tamaki, WT | 1 |
| Oliveira, JC | 1 |
| Martins, DC | 1 |
| Nishióka, SA | 1 |
| Pedrosa, AA | 1 |
| Siqueira, SF | 1 |
| Costa, R | 1 |
| Coceani, M | 1 |
| Martínez-Rubio, A | 1 |
| Shenasa, M | 1 |
| Chen, X | 1 |
| Wichter, T | 1 |
| Nasir, N | 1 |
| Doyle, TK | 1 |
| Wheeler, SH | 1 |
| Pacifico, A | 3 |
| Singer, I | 1 |
| Schmitt, C | 1 |
| Montero, M | 1 |
| Melichercik, J | 1 |
| Mahmarian, JJ | 1 |
| Smart, FW | 1 |
| Moyé, LA | 1 |
| Young, JB | 1 |
| Francis, MJ | 1 |
| Kingry, CL | 1 |
| Verani, MS | 1 |
| Pratt, CM | 1 |
| Cui, G | 1 |
| Sen, L | 1 |
| Sager, P | 1 |
| Uppal, P | 3 |
| Pitton, MB | 1 |
| Schweden, F | 1 |
| Lenci, G | 1 |
| Lim, ST | 1 |
| Teo, WS | 1 |
| Terada, Y | 1 |
| Mitsui, T | 1 |
| Yoshimura, Y | 1 |
| Osaka, M | 1 |
| Mihara, W | 1 |
| Jalal, S | 1 |
| Levine, JH | 3 |
| Lindsay, BD | 1 |
| Plumb, VJ | 1 |
| Janosik, DL | 1 |
| Kopelman, HA | 3 |
| Friehling, T | 1 |
| Chilson, DA | 2 |
| Wilber, DJ | 4 |
| Szabó, BM | 1 |
| Wiesfeld, AC | 1 |
| van Veldhuisen, DJ | 1 |
| Hillege, HL | 1 |
| Lie, KI | 1 |
| Williamson, BD | 2 |
| Hummel, J | 1 |
| Niebauer, M | 2 |
| Man, KC | 3 |
| Daoud, E | 2 |
| Garguichevich, JJ | 1 |
| Ramos, JL | 1 |
| Gambarte, A | 1 |
| Gentile, A | 1 |
| Hauad, S | 1 |
| Scapin, O | 2 |
| Sirena, J | 1 |
| Tibaldi, M | 1 |
| Toplikar, J | 1 |
| Richer, M | 1 |
| Robert, S | 1 |
| Ahmad, S | 1 |
| Siebels, J | 4 |
| Cappato, R | 3 |
| Rüppel, R | 2 |
| Schneider, MA | 2 |
| Kuck, KH | 6 |
| Mletzko, R | 1 |
| Manz, M | 2 |
| Nitsch, J | 1 |
| Lüderitz, B | 2 |
| Inaba, T | 1 |
| Ohnisi, S | 1 |
| Matuda, N | 1 |
| Hosoda, S | 3 |
| Kopp, DE | 2 |
| Blakeman, BP | 1 |
| Kall, JG | 2 |
| Kinder, CA | 1 |
| Seidl, K | 1 |
| Hauer, B | 1 |
| Schwick, N | 1 |
| Buechele, T | 1 |
| Schilling, I | 1 |
| Ozdil, E | 1 |
| Carlson, TA | 1 |
| Massumi, A | 2 |
| Roberts, SA | 1 |
| Viana, MA | 1 |
| Nazari, J | 1 |
| Wyse, DG | 2 |
| Zipes, D | 1 |
| Domanski, MJ | 2 |
| Schron, EB | 2 |
| Ferrick, KJ | 1 |
| Roth, JA | 1 |
| Kim, SG | 1 |
| Fisher, JD | 1 |
| Cheng, TO | 1 |
| Fenrich, AL | 3 |
| Perry, JC | 2 |
| Sager, PT | 2 |
| Follmer, C | 2 |
| Pruitt, C | 2 |
| Godfrey, R | 1 |
| Besser, R | 1 |
| Treese, N | 1 |
| Bohl, J | 1 |
| Goebel, HH | 1 |
| Candinas, R | 1 |
| Bauersfeld, U | 1 |
| Antimisiaris, M | 2 |
| Sarma, JS | 1 |
| Schoenbaum, MP | 1 |
| Sharma, PP | 1 |
| Venkataraman, K | 1 |
| Mickleborough, LL | 1 |
| Maruyama, H | 1 |
| Mohamed, S | 1 |
| Rappaport, DC | 1 |
| Downar, E | 1 |
| Butany, J | 1 |
| Sun, Z | 1 |
| Bakr, O | 1 |
| Kou, W | 1 |
| Klingenheben, T | 1 |
| Figa, FH | 1 |
| Gow, RM | 1 |
| Hamilton, RM | 1 |
| Freedom, RM | 1 |
| Frank, R | 3 |
| Tonet, J | 3 |
| Gallais, Y | 1 |
| Lazraq, S | 1 |
| Fellat, R | 1 |
| Fontaine, G | 1 |
| Gutiérrez-Larraya, F | 1 |
| Jabón, A | 1 |
| Ahmed, R | 1 |
| Buja, G | 1 |
| Miorelli, M | 1 |
| Turrini, P | 1 |
| Melacini, P | 1 |
| Nava, A | 1 |
| Kochs, M | 1 |
| Eggeling, T | 1 |
| Hombach, V | 1 |
| Kalbfleisch, SJ | 1 |
| Williamson, B | 1 |
| Vorperian, V | 1 |
| Hasse, C | 1 |
| Calkins, H | 1 |
| Langberg, JJ | 1 |
| Fromm, BS | 1 |
| Steinman, RT | 1 |
| Meissner, MD | 1 |
| Lehmann, MH | 1 |
| Gent, M | 3 |
| Roberts, RS | 3 |
| Green, MS | 2 |
| Sheldon, RS | 3 |
| Nora, M | 1 |
| Zipes, DP | 2 |
| Fletcher, RD | 5 |
| Fisher, S | 2 |
| Lazzeri, D | 1 |
| Deedwania, P | 2 |
| Lewis, D | 2 |
| Massie, B | 2 |
| Colling, C | 1 |
| Proclemer, A | 1 |
| Facchin, D | 1 |
| Vanuzzo, D | 1 |
| Feruglio, GA | 1 |
| Shinmura, K | 1 |
| Hasegawa, H | 1 |
| Ishida, H | 1 |
| Shimizu, K | 1 |
| Ebihara, Y | 1 |
| Iwanaga, S | 1 |
| Honma, S | 1 |
| Tani, M | 1 |
| Handa, S | 1 |
| Pastor, A | 2 |
| Almendral, JM | 2 |
| Lorca, MT | 1 |
| Delcán, JL | 2 |
| Russo, AM | 1 |
| Beauregard, LM | 1 |
| Waxman, HL | 1 |
| Khanderia, U | 1 |
| Jaffe, CA | 1 |
| Theisen, V | 1 |
| Sadek, I | 1 |
| Biron, P | 1 |
| Kus, T | 1 |
| Ormaetxe, J | 1 |
| Martínez-Alday, JD | 1 |
| Villacastin, JP | 1 |
| Medina, O | 1 |
| Witt, DM | 1 |
| Ellsworth, AJ | 1 |
| Leversee, JH | 1 |
| Akalin, H | 1 |
| Bayar, M | 1 |
| Akyol, T | 1 |
| Delany, SG | 1 |
| Taylor, DR | 1 |
| Restieaux, N | 1 |
| Doyle, TC | 1 |
| McCollam, PL | 1 |
| Nappi, JM | 1 |
| Chitwood, KK | 1 |
| Abdul-Haqq, AJ | 1 |
| Heim-Duthoy, KL | 1 |
| Bytesník, J | 1 |
| Bicík, V | 1 |
| Krausová, R | 1 |
| Lefflerová, K | 1 |
| Curtis, AB | 1 |
| Hii, JT | 1 |
| Gillis, AM | 1 |
| Duff, HJ | 2 |
| Olson, PJ | 1 |
| Woelfel, A | 1 |
| Simpson, RJ | 1 |
| Foster, JR | 1 |
| Marinchak, RA | 4 |
| Rials, SJ | 3 |
| Rubin, AM | 1 |
| Smith, L | 1 |
| Knilans, TK | 1 |
| Marlow, D | 1 |
| Denfield, SW | 1 |
| Winkle, RA | 1 |
| Gomes, A | 1 |
| Woosley, RL | 1 |
| Chendrasekhar, A | 1 |
| Barke, RA | 1 |
| Druck, P | 1 |
| Brooks, MM | 1 |
| Hallstrom, A | 1 |
| Peckova, M | 1 |
| Finance, O | 1 |
| Manning, A | 1 |
| Chatelain, P | 1 |
| Hofmann, R | 1 |
| Leisch, F | 1 |
| Wood, MK | 1 |
| Mazur, A | 1 |
| Strasberg, B | 1 |
| Kusniec, J | 1 |
| Sclarovsky, S | 1 |
| Kubik, L | 1 |
| Michałkiewicz, D | 1 |
| Fleurant, E | 1 |
| Lacroix, D | 1 |
| Klug, D | 1 |
| Warembourg, H | 1 |
| Lekieffre, J | 1 |
| Painvin, I | 1 |
| Dupuis, JM | 1 |
| Victor, J | 1 |
| Rohmer, V | 1 |
| Ronceray, J | 1 |
| Tadéi, A | 1 |
| Lazzara, R | 1 |
| Iervasi, G | 1 |
| Clerico, A | 1 |
| Berti, S | 1 |
| Pilo, A | 1 |
| Biagini, A | 1 |
| Bianchi, R | 1 |
| Donato, L | 1 |
| Hidden, F | 1 |
| Naditch, L | 1 |
| Coutte, R | 2 |
| Himbert, C | 2 |
| Fogoros, RN | 3 |
| Bourret, N | 1 |
| Kirkorian, G | 1 |
| Chevalier, P | 1 |
| Bellon, C | 1 |
| Richalet, C | 1 |
| Bouchayer, D | 1 |
| Bonnefoy, E | 1 |
| Touboul, P | 1 |
| Talard, P | 1 |
| Bonal, J | 1 |
| Cellarier, G | 1 |
| Bouchiat, C | 1 |
| Dussarat, GV | 1 |
| Tsuchiya, M | 1 |
| Takeichi, K | 1 |
| Campbell, TJ | 1 |
| Doval, HC | 2 |
| Nul, DR | 1 |
| Grancelli, HO | 1 |
| Varini, SD | 1 |
| Soifer, S | 1 |
| Corrado, G | 1 |
| Dubner, S | 1 |
| Perrone, SV | 1 |
| Grimm, W | 2 |
| Steder, U | 1 |
| Menz, V | 1 |
| Hoffmann, J | 1 |
| Maisch, B | 2 |
| Scholz, H | 1 |
| Block, M | 2 |
| Böcker, D | 3 |
| Lee, KL | 1 |
| Tai, YT | 1 |
| Peters, W | 1 |
| Krein, A | 1 |
| Kowallik, P | 1 |
| Wittenberg, G | 1 |
| Meesmann, M | 1 |
| Katsivas, A | 1 |
| Lazaris, E | 1 |
| Koutsogeogis, D | 1 |
| Louvros, N | 1 |
| Muratore, C | 1 |
| Rabinovich, R | 1 |
| Iglesias, R | 1 |
| González, M | 1 |
| Darú, V | 1 |
| Liprandi, AS | 1 |
| Filart, RA | 1 |
| Yalçinkaya, S | 1 |
| Kumbasar, SD | 1 |
| Semiz, E | 1 |
| Tosun, Z | 1 |
| Paksoy, N | 1 |
| Winters, SL | 1 |
| Sachs, RG | 1 |
| Curwin, JH | 1 |
| Sone, T | 1 |
| Numaguchi, Y | 1 |
| Kondoh, J | 1 |
| Tsuboi, H | 1 |
| Sassa, H | 1 |
| Brembilla-Perrot, B | 2 |
| Alsagheer, S | 1 |
| Jacquemin, L | 1 |
| Beurrier, D | 2 |
| Retournay, G | 1 |
| Grentzinger, A | 1 |
| Neuzner, J | 1 |
| Bahawar, H | 1 |
| Berkowitsch, A | 1 |
| Michel, U | 1 |
| Schlepper, M | 1 |
| Pitschner, HF | 1 |
| Ney, G | 1 |
| Fisher, SG | 2 |
| Sweeney, MO | 1 |
| Sundelin, K | 1 |
| Norrsell, K | 1 |
| Meierhenrich, R | 1 |
| Helguera, ME | 1 |
| Kidwell, GA | 1 |
| Tebbe, U | 1 |
| Waldo, AL | 1 |
| Giorgberidze, I | 1 |
| Saksena, S | 1 |
| Krol, RB | 1 |
| Munsif, AN | 1 |
| Kolettis, T | 1 |
| Mathew, P | 1 |
| Varanasi, S | 1 |
| Prakash, A | 1 |
| Delfaut, P | 1 |
| Lewis, CB | 1 |
| Tran, HT | 1 |
| Chow, MS | 1 |
| López-Mínguez, JR | 1 |
| Merchán Herrera, A | 1 |
| Cimboria Ortega, A | 1 |
| Millán Núñez, V | 1 |
| García-Andoain, JM | 1 |
| Alvarez Suárez-Bárcenas, JM | 1 |
| Martínez de la Concha, L | 1 |
| Fernández de la Concha, J | 1 |
| Alonso Ruiz, F | 1 |
| Nanthakumar, K | 1 |
| Paquette, M | 1 |
| Rakovich, G | 1 |
| Doig, JC | 1 |
| Schuster, MM | 1 |
| Steinbeck, G | 3 |
| Haberl, R | 1 |
| Hoffman, E | 1 |
| Myerburg, RJ | 2 |
| Castellanos, A | 2 |
| Narasimhan, C | 1 |
| Jazayeri, MR | 1 |
| Sra, J | 2 |
| Dhala, A | 1 |
| Deshpande, S | 1 |
| Biehl, M | 1 |
| Akhtar, M | 2 |
| Blanck, Z | 1 |
| Brugada, J | 1 |
| Brugada, R | 1 |
| Brugada, P | 1 |
| Makita, M | 1 |
| Joh, T | 1 |
| Hayashi, Y | 1 |
| Abe, M | 1 |
| Kazatani, Y | 1 |
| Tatsuno, H | 1 |
| Matsunaka, T | 1 |
| Kubo, M | 1 |
| Kikuchi, S | 1 |
| Naitoh, N | 1 |
| Washizuka, T | 2 |
| Itoh, K | 2 |
| Kato, R | 1 |
| Hotta, N | 1 |
| Cecchi, F | 2 |
| Olivotto, I | 1 |
| Montereggi, A | 2 |
| Squillatini, G | 1 |
| Dolara, A | 2 |
| Maron, BJ | 1 |
| Hutcheson, J | 1 |
| Peters, CA | 1 |
| Diamond, DA | 1 |
| Binz, K | 1 |
| Burger, A | 1 |
| Vallotton, MB | 1 |
| Tresch, DD | 1 |
| Thakur, RK | 1 |
| Villain, E | 1 |
| Butera, G | 1 |
| Bonnet, D | 1 |
| Acar, P | 1 |
| Aggoun, Y | 1 |
| Kachaner, J | 1 |
| Yamada, S | 1 |
| Yamaguchi, I | 2 |
| Carson, PE | 1 |
| Leak, D | 1 |
| Wieckhorst, A | 1 |
| Herse, B | 1 |
| Unterberg, C | 1 |
| Saidi, AS | 1 |
| el Said, H | 1 |
| Nuchtern, JG | 1 |
| Prakash, VS | 1 |
| Tai, CT | 1 |
| Chen, SA | 1 |
| Farré, J | 1 |
| Rubio, JM | 1 |
| Ayala, R | 1 |
| Castro-Dorticós, J | 1 |
| Klein, H | 1 |
| Auricchio, A | 2 |
| Reek, S | 1 |
| Geller, C | 1 |
| López-Gómez, D | 1 |
| Nicolás, J | 1 |
| Frigola, JM | 1 |
| Manito, N | 1 |
| Esplugas, E | 1 |
| Peters, NS | 1 |
| Kovoor, P | 1 |
| Eipper, V | 1 |
| Byth, K | 1 |
| Cooper, MJ | 1 |
| Uther, JB | 1 |
| Ross, DL | 1 |
| Ferrari, R | 1 |
| Cinca, J | 1 |
| Marber, M | 1 |
| Sahu, J | 1 |
| Kavesh, NG | 1 |
| Olsovsky, MR | 1 |
| Freudenberger, RS | 1 |
| Conte, JV | 1 |
| Peters, RW | 1 |
| Shorofsky, SR | 1 |
| Gold, MR | 1 |
| Kothari, SS | 1 |
| Balijepally, S | 1 |
| Taneja, K | 1 |
| Elliott, PM | 1 |
| Sharma, S | 1 |
| Varnava, A | 1 |
| Poloniecki, J | 1 |
| Rowland, E | 1 |
| McKenna, WJ | 2 |
| Castelli, G | 1 |
| Ciaccheri, M | 1 |
| Troiani, V | 1 |
| Nannini, M | 1 |
| Marconi, P | 1 |
| Olivotto, J | 1 |
| Iskander, S | 1 |
| Raible, DG | 1 |
| Brozena, SC | 1 |
| Gaitanaru, DM | 1 |
| Ayala, G | 1 |
| Iskandrian, AE | 1 |
| Aronow, WS | 1 |
| Reiter, MJ | 1 |
| Yao, Q | 3 |
| Follmann, D | 2 |
| Schron, E | 2 |
| Carlson, MD | 1 |
| Brodsky, MA | 2 |
| Baessler, C | 1 |
| Fukushima, KK | 1 |
| Mitani, T | 1 |
| Hashimoto, K | 1 |
| Hosogi, S | 1 |
| Emori, T | 1 |
| Morita, H | 1 |
| Fujimoto, Y | 1 |
| Nakamura, K | 1 |
| Yamanari, H | 1 |
| Akiyama, J | 1 |
| Tomizawa, T | 1 |
| Umezawa, S | 1 |
| Morishima, A | 1 |
| Sakseena, S | 1 |
| Kim, S | 1 |
| Lancaster, S | 3 |
| Powell, J | 1 |
| Ocampo, C | 1 |
| Rosenberg, Y | 1 |
| Naccarella, F | 1 |
| Rolli, A | 1 |
| Carboni, A | 1 |
| Finardi, A | 1 |
| Aurier, E | 1 |
| Favaro, L | 1 |
| Contini, S | 1 |
| Gherli, T | 1 |
| Caponi, D | 1 |
| Maranga, SS | 1 |
| Lepera, G | 1 |
| Bartoletti, A | 1 |
| Toyama, J | 1 |
| Bharucha, DB | 1 |
| Zivin, A | 1 |
| Bardy, GH | 1 |
| Deely, MP | 1 |
| Saligan, J | 1 |
| Ashar, M | 1 |
| Ogunyankin, KO | 1 |
| Yap, YG | 1 |
| Camm, AJ | 2 |
| Dorwarth, U | 1 |
| Hoffmann, E | 1 |
| Uchiyama, H | 1 |
| Nakagawa, I | 1 |
| Wolbrette, DL | 2 |
| Patel, HM | 2 |
| Luck, JC | 2 |
| Dell'Orfano, JT | 1 |
| Hanai, R | 2 |
| Uto, K | 2 |
| Uno, M | 1 |
| Nagashima, H | 1 |
| Takizawa, T | 1 |
| Narimatsu, A | 1 |
| O'Brien, B | 1 |
| Fogel, RI | 1 |
| Fineberg, N | 1 |
| Prystowsky, EN | 1 |
| Pinski, SL | 1 |
| Jadonath, R | 1 |
| Schleich, JM | 1 |
| Bernard Du Haut Cilly, F | 1 |
| Laurent, MC | 1 |
| Almange, C | 1 |
| Copie, X | 1 |
| Piot, O | 1 |
| Said, MA | 1 |
| Ollitrault, J | 1 |
| Guize, L | 1 |
| Le Heuzey, JY | 1 |
| Bänsch, D | 1 |
| Brunn, J | 1 |
| Weber, M | 1 |
| Naik, AM | 1 |
| Peter, CT | 1 |
| Cooley, R | 1 |
| Gomes, JA | 1 |
| Yeih, DF | 1 |
| Chiang, FT | 1 |
| Huang, SK | 1 |
| Yadav, BS | 1 |
| Garg, N | 1 |
| Raj, D | 1 |
| Newton, JL | 1 |
| Konecná, P | 1 |
| Dvorák, R | 1 |
| Semrád, B | 1 |
| Boczor, S | 1 |
| Domanski, M | 1 |
| Iliopoulou, A | 1 |
| Pagou, H | 1 |
| Giannakopoulos, G | 1 |
| Spiropoulos, T | 1 |
| Tanaka, T | 1 |
| Ohta, Y | 1 |
| Erich, J | 1 |
| Nisam, S | 1 |
| Klein, HU | 1 |
| Raitt, MH | 1 |
| Renfroe, EG | 1 |
| McAnulty, JH | 1 |
| Mounsey, P | 1 |
| Lancaster, SE | 1 |
| Jadonath, RL | 1 |
| Stiefelhagen, P | 1 |
| Kułakowski, P | 1 |
| Karczmarewicz, S | 1 |
| Karpiński, G | 1 |
| Soszyńska, M | 1 |
| Ceremuzyński, L | 1 |
| Nkomo, VT | 1 |
| Shen, WK | 1 |
| Okishige, K | 1 |
| Sasano, T | 1 |
| Yano, K | 1 |
| Azegami, K | 1 |
| Suzuki, K | 1 |
| Bigger, T | 1 |
| Wohlrab, J | 1 |
| Fischer, M | 1 |
| Stoldt, G | 1 |
| Marsch, WC | 1 |
| Rochetaing, A | 1 |
| Barbé, C | 1 |
| Kreher, P | 1 |
| Caron, MF | 1 |
| Alter, P | 1 |
| Taneda, K | 1 |
| Marketou, ME | 1 |
| Simantirakis, EN | 1 |
| Manios, EG | 1 |
| Vardas, PE | 1 |
| Katsivas, AG | 1 |
| Vassilopoulos, C | 1 |
| Tsatiris, CG | 1 |
| De Ponti, R | 1 |
| Uriarte, JA | 1 |
| Tondo, C | 1 |
| Klersy, C | 1 |
| Storti, C | 1 |
| Riva, S | 1 |
| Longobardi, M | 1 |
| Claudon, O | 1 |
| Houriez, P | 1 |
| Suty-Selton, C | 1 |
| Schläpfer, J | 1 |
| Rapp, F | 1 |
| Kappenberger, L | 1 |
| Fromer, M | 1 |
| Alboni, P | 1 |
| Sugiura, R | 1 |
| McAreavey, D | 1 |
| Fananapazir, L | 1 |
| Huikuri, HV | 1 |
| Yli-Mäyry, S | 1 |
| Maeda, H | 1 |
| Kurihara, T | 1 |
| Endo, M | 1 |
| Kuga, K | 1 |
| Sugishita, Y | 1 |
| Jeyamalar, R | 1 |
| Pathmanathan, R | 1 |
| Wong, D | 1 |
| Kannan, P | 1 |
| Lascault, G | 1 |
| Busquet, P | 1 |
| Grosgogeat, Y | 1 |
| Shakespeare, CF | 1 |
| Keeling, PJ | 1 |
| Slade, AK | 1 |
| Sternick, EB | 1 |
| Bahia, FC | 1 |
| Gontijo Filho, B | 1 |
| Vrandecic, MO | 1 |
| Colling, CL | 1 |
| O'Brien, BJ | 1 |
| Buxton, MJ | 1 |
| Rushby, JA | 1 |
| Leclercq, JF | 1 |
| Coumel, P | 1 |
| Slama, R | 1 |
| Pizzulli, L | 1 |
| Pfeiffer, D | 1 |
| Paul, VE | 1 |
| Sneddon, JF | 1 |
| Farrell, TG | 1 |
| Ward, DE | 1 |
| Sinha, PR | 1 |
| Dube, S | 1 |
| Gupta, PR | 1 |
| Avasthey, P | 1 |
| Somani, PN | 1 |
| Bach, P | 1 |
| Gonschior, P | 1 |
| Prinz, C | 1 |
| Kreuzer, E | 1 |
| Autenrieth, G | 1 |
| Herms, J | 1 |
| Schneider, M | 1 |
| Zehender, M | 1 |
| Faber, T | 1 |
| Furtwängler, A | 1 |
| Hohnloser, S | 1 |
| Meinertz, T | 1 |
| Just, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Randomized Controlled Phase IV Multicentric Trial, Comparing the Efficacy and Safety of Radiofrequency Substrate Ablation of Monomorphic Ventricular Tachycardia vs. Antiarrhyhtmic Drugs in Patients Experiencing Appropriate ICD Shocks[NCT03734562] | 180 participants (Actual) | Interventional | 2010-07-31 | Completed | |||
| Etiology, Incidence and Survival of Pediatric Out-of-hospital Cardiac Arrests: a Four-year Danish Analysis[NCT04275856] | 300 participants (Anticipated) | Observational [Patient Registry] | 2019-02-01 | Active, not recruiting | |||
| Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation (VF) or Ventricular Tachycardia (VT)[NCT01401647] | Phase 3 | 3,024 participants (Actual) | Interventional | 2012-05-31 | Completed | ||
| Endocardial-Epicardial Radiofrequency Ablation of Ventricular Tachycardia in Patients With Ischemic Cardiomyopathy[NCT04512911] | Early Phase 1 | 0 participants (Actual) | Interventional | 2023-01-31 | Withdrawn (stopped due to IRB approval expired 1/23/2023 and eclipsed the 6 month institutional window where study can be reinitiated via progress report. No enrollment has taken place.) | ||
| STereotactic Ablative Radiosurgery of Recurrent Ventricular Tachycardia in Structural Heart Disease[NCT03819504] | 0 participants (Actual) | Interventional | 2018-08-01 | Withdrawn (stopped due to Change in the design of the study) | |||
| Phase I/II Study of 4-D Navigated Non-invasive Radiosurgical Ablation of Ventricular Tachycardia[NCT03601832] | 10 participants (Actual) | Interventional | 2018-08-01 | Completed | |||
| VOYAGE- Ventricular Tachycardia Ablation and Myocardial Scar Characterization With Magnetic Resonance[NCT04694079] | Phase 3 | 103 participants (Anticipated) | Interventional | 2020-08-03 | Recruiting | ||
| STereotactic Ablative Radiosurgery of Recurrent Ventricular Tachycardia in Structural Heart Disease[NCT04612140] | 100 participants (Actual) | Interventional | 2020-10-01 | Completed | |||
| Ventricular Tachycardia Ablation or Escalated aNtiarrhythmic Drugs in ISchemic Heart Disease[NCT00905853] | Phase 4 | 260 participants (Actual) | Interventional | 2009-05-31 | Completed | ||
| Repeated Endocardial Mapping for Efficacy Assessment After Catheter Ablation for Ischemic Ventricular Tachycardia[NCT05713357] | 20 participants (Anticipated) | Observational | 2023-03-15 | Enrolling by invitation | |||
| Initial Management of Patients Receiving a Single Shock (IMPRESS)[NCT03531502] | 30 participants (Actual) | Interventional | 2018-04-09 | Terminated (stopped due to lack of funding) | |||
| Preventive VT Substrate Ablation in Patients With Chronic Post-MI Scar Showing Arrhythmogenic Characteristics[NCT04675073] | Phase 3 | 58 participants (Anticipated) | Interventional | 2021-06-01 | Recruiting | ||
| Double Blind Placebo Controlled Dose Ranging Study of the Efficacy and Safety of Celivarone at 50, 100 or 300 mg OD With Amiodarone as Calibrator for the Prevention of ICD Interventions or Death[NCT00993382] | Phase 2 | 486 participants (Actual) | Interventional | 2009-09-30 | Completed | ||
| ECG Device for Long QT Syndrome Screening in Newborns[NCT02412709] | Phase 2 | 4,000 participants (Anticipated) | Interventional | 2015-06-30 | Recruiting | ||
| PROSPECTIVE ANALYSIS BETWEEN AMIODARONE Versus LIDOCAINE IN PATIENTS WITH STABLE VENTRICULAR TACHYCARDIA IN THE EMERGENCY ROOM[NCT03299517] | Phase 4 | 80 participants (Anticipated) | Interventional | 2017-08-02 | Recruiting | ||
| Cardiac Resynchronization Therapy With Synchronized RV Pacing to Improve Cardiac Function in Patients With Right Bundle Branch Block and Systolic LV Dysfunction[NCT05936294] | 5 participants (Actual) | Interventional | 2017-09-15 | Terminated (stopped due to Low enrollment) | |||
| CRM and Fusion Beats: Effects of Progressive Fusion on Intra-left Ventricular Mechanical Function[NCT00610896] | 25 participants (Actual) | Observational | 2008-01-31 | Completed | |||
| A Randomized, Prospective Multicenter Study to Determine the Incidence of Atrial Fibrillation and Heart Failure in Correlation to Stimulation Modes of Pacemakers[NCT00161551] | Phase 4 | 402 participants (Anticipated) | Interventional | 2004-11-30 | Recruiting | ||
| IntAct, Study on Promotion of Intrinsic Activity.[NCT00156741] | Phase 4 | 150 participants | Interventional | 2004-04-30 | Active, not recruiting | ||
| A Single Center Prospective, Pilot Study Examining the Non-invasive Evaluation of Ventricular Synchrony in Pediatric Patients[NCT00165932] | 145 participants (Actual) | Observational | 2004-06-30 | Completed | |||
| Left Ventricular Septum Pacing in Patients by Transvenous Approach Through the Inter-ventricular Septum - Feasibility, Long-term Lead Stability and Safety[NCT01609738] | 12 participants (Actual) | Observational | 2012-11-30 | Completed | |||
| Impact of Atrio-ventricular Optimization With His Bundle Pacing on Treatment of Atrio-ventricular Dromotropathy[NCT04544345] | 17 participants (Actual) | Interventional | 2019-12-23 | Completed | |||
| PReventive Effect Of Left Bundle Branch Area Pacing Versus righT vEntricular paCing on All Cause deaTh, Heart Failure Progression, and Ventricular dysSYNChrony in Patients With Substantial Ventricular Pacing (PROTECT-SYNC): Multicenter Prospective Randomi[NCT05585411] | 450 participants (Anticipated) | Interventional | 2023-12-31 | Not yet recruiting | |||
| Comparison of Right Ventricular Septal Pacing to Minimized Right Ventricular Septal Stimulation in Patients With Sick Sinus Syndrome[NCT01477138] | 126 participants (Anticipated) | Observational | 2011-07-31 | Recruiting | |||
| CRT-P or CRT-D in Patients With Dilated Cardiomyopathy and Heart Failure Without LGE-CMR High-risk Markers[NCT04139460] | 924 participants (Anticipated) | Interventional | 2020-06-30 | Not yet recruiting | |||
| Telemedicine Enabling Patients in Self-care Behaviors[NCT04297735] | 60 participants (Actual) | Interventional | 2020-02-26 | Completed | |||
| [NCT00000531] | Phase 3 | 0 participants | Interventional | 1992-09-30 | Completed | ||
| [NCT00000464] | Phase 3 | 0 participants | Interventional | 1987-04-30 | Completed | ||
| Catheter Ablation for Ventricular Tachycardia in Patients With an Implantable Cardioverter Defibrillator (CALYPSO) PILOT TRIAL[NCT01576042] | 27 participants (Actual) | Interventional | 2012-05-31 | Terminated (stopped due to Main objectives of the study were met; consensus among investigators that continuing the study would not add new information beyond that already learned.) | |||
| Effects of Surgical Monopolar Electrocautery and Optimal Electrosurgery Unit Return Pad Placement on Implantable Cardioverter Defibrillators Protocol[NCT01572246] | 167 participants (Actual) | Observational | 2012-05-31 | Completed | |||
| EvaLuation Using Cardiac Insertable Devices And TelephonE in Hypertrophic CardioMyopathy[NCT03259113] | 30 participants (Anticipated) | Interventional | 2017-08-16 | Recruiting | |||
| aMsa and amiOdarone Study in cArdiaC Arrest[NCT04997980] | 500 participants (Anticipated) | Observational | 2015-01-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Neurologic status at discharge will be assessed using the modified Rankin Score (MRS). A higher value indicates a worse outcome. 0-No symptoms at all; 1-No significant disability despite symptoms; able to carry out all usual duties and activities, 2-Slight disability; unable to carry out all previous activities, but able to look after own affairs without assistance, 3-Moderate disability; requiring some help, but able to walk without assistance; 4-Moderately severe disability; unable to walk without assistance and unable to attend to own bodily needs without assistance, 5-Severe disability; bedridden, incontinent and requiring constant nursing care and attention; 6-Dead (NCT01401647)
Timeframe: Patients will be followed from the time of the cardiac arrest until death, hospital discharge, or December 31, 2015, whichever occurs first.
| Intervention | Participants (Count of Participants) |
|---|---|
| Amiodarone | 182 |
| Lidocaine | 172 |
| Normal Saline | 175 |
Patients may die in the field (outside of the hospital at the time of the cardiac arrest), at the emergency room, in the hospital, or they are discharged alive from the hospital. (NCT01401647)
Timeframe: Patients will be followed from the time of the cardiac arrest until death, hospital discharge, or December 31, 2015, whichever occurs first.
| Intervention | participants (Number) |
|---|---|
| Amiodarone | 237 |
| Lidocaine | 233 |
| Normal Saline | 222 |
Records participants hospitalized for VT during the study (NCT01576042)
Timeframe: Baseline, 6 months
| Intervention | participants (Number) |
|---|---|
| Catheter Ablation | 5 |
| Antiarrhythmic Medication | 7 |
Records participants who completed Month 3 Follow-Up Visit (NCT01576042)
Timeframe: 3 months
| Intervention | participants (Number) |
|---|---|
| Catheter Ablation | 11 |
| Antiarrhythmic Medication | 12 |
Records participants who completed Month 6 Follow-Up Visit (NCT01576042)
Timeframe: 6 Months
| Intervention | participants (Number) |
|---|---|
| Catheter Ablation | 7 |
| Antiarrhythmic Medication | 10 |
Records participants who had at least one of the efficacy outcome measurement (including death, hospitalization due to VT) (NCT01576042)
Timeframe: 6 Months
| Intervention | participants (Number) |
|---|---|
| Catheter Ablation | 11 |
| Antiarrhythmic Medication | 14 |
Records participants who received study randomized treatment during the study (NCT01576042)
Timeframe: 6 months
| Intervention | participants (Number) |
|---|---|
| Catheter Ablation | 11 |
| Antiarrhythmic Medication | 14 |
Records participants who only received study treatment as randomized during the entire study (NCT01576042)
Timeframe: 6 month
| Intervention | participants (Number) |
|---|---|
| Catheter Ablation | 6 |
| Antiarrhythmic Medication | 13 |
Records participants who received study treatment as randomized and later switched to other treatment arm during the study (NCT01576042)
Timeframe: 6 months
| Intervention | participants (Number) |
|---|---|
| Catheter Ablation | 5 |
| Antiarrhythmic Medication | 1 |
Days from the date of the first study treatment to the date of first ICD recurrent therapy for VT. (NCT01576042)
Timeframe: Baseline, 6 months
| Intervention | Days (Mean) |
|---|---|
| Catheter Ablation | 70.1 |
| Antiarrhythmic Medication | 78.7 |
102 reviews available for amiodarone and Atrioventricular Nodal Re-Entrant Tachycardia
| Article | Year |
|---|---|
Mexiletine for recurrent ventricular tachycardia in adult patients with structural heart disease and implantable cardioverter defibrillator: an EHRA systematic review.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Catheter Ablation; Defibrillators, Implantable; Humans; M | 2022 |
Systematic Review and Meta-Analysis of Clinical Outcome After Implantable Cardioverter-Defibrillator Therapy in Patients With Chagas Heart Disease.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Chagas Cardiomyopathy; Death, Sudde | 2019 |
Management of arrhythmias in pulmonary hypertension.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Dogs; Humans; Hypertension, Pulmon | 2021 |
[Clinical aspects of treatment with amiodarone].
Topics: Amiodarone; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Electrocardiograph | 2017 |
Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.
Topics: Amiodarone; Anti-Arrhythmia Agents; Catheter Ablation; Defibrillators, Implantable; Electric Counter | 2017 |
Meta-analysis of the efficacies of amiodarone and nifekalant in shock-resistant ventricular fibrillation and pulseless ventricular tachycardia.
Topics: Amiodarone; Humans; Publication Bias; Pulse; Pyrimidinones; Randomized Controlled Trials as Topic; S | 2017 |
Antiarrhythmic drug therapy during cardiopulmonary resuscitation: should we use it?
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiopulm | 2018 |
Amiodarone for sustained stable ventricular tachycardia in the prehospital setting.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Electrocardiography; Emergency Medical Services; Fe | 2018 |
[Electrical storm: definition, prevalence, causes and prognostic implications].
Topics: Adrenergic beta-Antagonists; Amiodarone; Combined Modality Therapy; Defibrillators, Implantable; Hum | 2014 |
Ventricular tachycardia associated with radiation-induced cardiac sarcoma.
Topics: Amiodarone; Anti-Arrhythmia Agents; Breast Neoplasms; Echocardiography; Electrocardiography; Female; | 2014 |
[Amiodarone and the thyroid].
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Hyperthyroidism; Hypothyroidism; Ta | 2014 |
Best Clinical Practice: Emergency Medicine Management of Stable Monomorphic Ventricular Tachycardia.
Topics: Amiodarone; Anti-Arrhythmia Agents; Electric Countershock; Electrocardiography; Emergency Service, H | 2017 |
[Amiodarone-induced pulmonary toxicity].
Topics: Amiodarone; Anti-Arrhythmia Agents; Bronchial Spasm; Controlled Clinical Trials as Topic; Cryptogeni | 1997 |
Appropriate evaluation and treatment of heart failure patients after implantable cardioverter-defibrillator discharge: time to go beyond the initial shock.
Topics: Adrenergic beta-Antagonists; Algorithms; Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; | 2009 |
[Amiodarone-induced thyroid gland dysfunctions].
Topics: Amiodarone; Anti-Arrhythmia Agents; Drug Interactions; Follow-Up Studies; Half-Life; Humans; Hyperth | 2010 |
Amiodarone for the treatment and prevention of ventricular fibrillation and ventricular tachycardia.
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Humans; Infusions, Intravenous; Tachycardi | 2010 |
Amiodarone supplants lidocaine in ACLS and CPR protocols.
Topics: Action Potentials; Advanced Cardiac Life Support; Amiodarone; Anti-Arrhythmia Agents; Bretylium Comp | 2011 |
Postoperative wide complex tachycardia: an alternative hypothesis.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Aortic Valve Stenosis; Atrial Fibrillation; Electrocardiog | 2013 |
[Incessant or recurrent ventricular tachycardia. Indications for emergency ablation].
Topics: Amiodarone; Anti-Arrhythmia Agents; Catheter Ablation; Combined Modality Therapy; Contraindications; | 2012 |
[Heart failure].
Topics: Adrenergic beta-Antagonists; Amiodarone; Angiotensin Receptor Antagonists; Angiotensin-Converting En | 2002 |
[Management of lethal ventricular arrhythmias after cardiac surgery].
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Cardiac Surgical Procedures; Cardiop | 2002 |
Significance and control of cardiac arrhythmias in patients with congestive cardiac failure.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Death, Sudden, | 2002 |
Amiodarone: an emergency medicine perspective.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Drug Interactions; Humans; Tachycardia, Ven | 2002 |
Antiarrhythmic therapy in heart failure.
Topics: Algorithms; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Arrhythmia | 2002 |
Identification and management of ventricular tachycardia.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Catheter Ablation; Defibrillators, | 2003 |
Arrhythmias in the intensive care patient.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; | 2003 |
[Amiodarone-induced thyrotoxicosis: case report and review of the literature].
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Antithyroid Agents; Cardiomyopathy, Hypertrophic, Familia | 2003 |
Oral class III antiarrhythmics: what is new?
Topics: Amiodarone; Anti-Arrhythmia Agents; Dronedarone; Humans; Hydantoins; Imidazoles; Imidazolidines; Phe | 2004 |
Etiology and management of sustained ventricular tachycardia.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Catheter Ablation; Defibrillators, | 2001 |
Can amiodarone prevent sudden cardiac death in patients with hemodynamically tolerated sustained ventricular tachycardia and coronary artery disease?
Topics: Amiodarone; Clinical Trials as Topic; Coronary Disease; Death, Sudden, Cardiac; Defibrillators, Impl | 2005 |
Optical imaging of spiral waves: pharmacological modification of spiral-type excitations in a 2-dimensional layer of ventricular myocardium.
Topics: Amiodarone; Animals; Anisotropy; Anti-Arrhythmia Agents; Heart Conduction System; Humans; Myocardium | 2005 |
[Strategy for cardiac arrhythmias in acute coronary syndrome].
Topics: Amiodarone; Angina, Unstable; Anti-Asthmatic Agents; Aprindine; Atrial Fibrillation; Bepridil; Elect | 2006 |
Ventricular tachyarrhythmias (out of hospital cardiac arrests).
Topics: Amiodarone; Anti-Arrhythmia Agents; Bretylium Compounds; Electric Countershock; Humans; Lidocaine; T | 2006 |
Adjunctive therapy for recurrent ventricular tachycardia in patients with implantable cardioverter defibrillators.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Combined Modality Therapy; Defibril | 2007 |
[Ventricular arrhythmias after myocardial infarction: risk classification and treatment concepts].
Topics: Adrenergic beta-Antagonists; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia A | 1995 |
Use of amiodarone in the postmyocardial infarction patient.
Topics: Amiodarone; Cause of Death; Clinical Trials as Topic; Electrocardiography; Humans; Myocardial Infarc | 1995 |
Invasive and noninvasive methods to predict the long-term efficacy of amiodarone: a compilation of clinical observations using meta-analysis.
Topics: Aged; Amiodarone; Cardiac Pacing, Artificial; Electrocardiography, Ambulatory; Electrophysiology; Fe | 1994 |
[Anti-arrhythmia agents in the therapy of ventricular arrhythmias in the post-CAST era].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Humans; Multicenter Studies as Topi | 1994 |
Amiodarone-associated proarrhythmic effects. A review with special reference to torsade de pointes tachycardia.
Topics: Amiodarone; Atrial Fibrillation; Humans; Tachycardia, Ventricular; Torsades de Pointes | 1994 |
[Congestive heart failure and arrhythmia].
Topics: Adrenergic beta-Antagonists; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia A | 1993 |
[Treatment of ventricular tachycardia by endocardial fulguration. Apropos of 86 cases].
Topics: Actuarial Analysis; Amiodarone; Catheter Ablation; Female; Follow-Up Studies; Humans; Male; Tachycar | 1993 |
Antiarrhythmic drugs versus implantable defibrillators: the need for a randomized controlled study.
Topics: Amiodarone; Anti-Arrhythmia Agents; Clinical Trials as Topic; Defibrillators, Implantable; Humans; P | 1994 |
[Tachycardias: considerations in childhood in the 90s].
Topics: Adenosine; Adolescent; Adult; Amiodarone; Atrial Flutter; Child; Child, Preschool; Electrocardiograp | 1993 |
Class III antiarrhythmic drugs.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Electrocardiogra | 1994 |
Pharmacological therapy in coronary heart disease: prevention of life-threatening ventricular tachyarrhythmias and sudden cardiac death.
Topics: Action Potentials; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Cal | 1993 |
Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Bepridil; Cardiovascular Agents; Disopyramid | 1993 |
Empiric use of amiodarone and sotalol.
Topics: Amiodarone; Cardiomyopathy, Hypertrophic; Coronary Disease; Death, Sudden, Cardiac; Heart Diseases; | 1993 |
Amiodarone-induced thyroid dysfunction.
Topics: Adult; Aged; Amiodarone; Humans; Hyperthyroidism; Hypothyroidism; Male; Tachycardia, Ventricular; Th | 1993 |
Amiodarone-induced epididymitis: report of a new case and literature review of 12 cases.
Topics: Amiodarone; Anti-Bacterial Agents; Cohort Studies; Epididymitis; Humans; Male; Mass Screening; Middl | 1993 |
Treatment of ventricular arrhythmias in patients with hypertrophic cardiomyopathy.
Topics: Amiodarone; Cardiomyopathy, Hypertrophic; Defibrillators, Implantable; Humans; Tachycardia, Ventricu | 1993 |
Concomitant amiodarone and the implantable cardioverter-defibrillator: is there a place?
Topics: Amiodarone; Animals; Combined Modality Therapy; Death, Sudden, Cardiac; Defibrillators, Implantable; | 1993 |
Antiarrhythmic therapy in patients with congestive heart failure.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Humans; Multicenter Studies as Topic; M | 1993 |
Parenteral antiarrhythmic drug therapy in ventricular tachycardia/ventricular fibrillation: evolving role of class III agents--focus on amiodarone.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Electrophysiology; Heart; Hemodynamics; Humans; Injecti | 1995 |
An overview of antiarrhythmic drug management of electrical storm.
Topics: Amiodarone; Anti-Arrhythmia Agents; Clinical Trials as Topic; Humans; Infusions, Intravenous; Lidoca | 1996 |
Evaluation and treatment of nonsustained ventricular tachycardia.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiomegaly; Cardiomyopathy, Dilated; Electrocardiography; Hear | 1996 |
[Prognostic factors after sustained ventricular fibrillation or tachycardia. A multivariate study apropos of 160 cases].
Topics: Actuarial Analysis; Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Amiodarone; Cardiac Pacin | 1996 |
Antiarrhythmic actions of amiodarone: a profile of a paradoxical agent.
Topics: Amiodarone; Anti-Arrhythmia Agents; Heart Rate; Hemodynamics; Humans; Tachycardia, Ventricular; Vent | 1996 |
Major clinical trials assessing the prophylactic use of amiodarone in patients with ventricular tachyarrhythmias.
Topics: Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Defibrillators, Implantable; Humans; Myo | 1996 |
Beta-blockers for ventricular arrhythmias: have we underestimated their value?
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Clinical Trials as Topic; Humans; R | 1996 |
[Anti-arrhythmia therapy after myocardial infarct: preliminary results of EMIAT and CAMIAT studies].
Topics: Adult; Aged; Amiodarone; Death, Sudden, Cardiac; Electrocardiography, Ambulatory; Female; Heart Cond | 1996 |
[Ventricular cardiac arrhythmias. New anti-arrhythmia agents].
Topics: Amiodarone; Anti-Arrhythmia Agents; Clinical Trials as Topic; Electrocardiography; Heart Conduction | 1996 |
[Pharmacologic therapy of ventricular tachyarrhythmias: value of class III anti-arrhythmia drugs].
Topics: Amiodarone; Anti-Arrhythmia Agents; Clinical Trials as Topic; Combined Modality Therapy; Death, Sudd | 1996 |
Clinical trials of antiarrhythmic drugs in patients with sustained ventricular tachyarrhythmias.
Topics: Adrenergic beta-Antagonists; Amiodarone; Catheter Ablation; Clinical Trials as Topic; Defibrillators | 1997 |
Intravenous amiodarone.
Topics: Amiodarone; Anti-Arrhythmia Agents; Dose-Response Relationship, Drug; Heart Conduction System; Hemod | 1997 |
Nonsustained polymorphous ventricular tachycardia during amiodarone therapy for atrial fibrillation complicating cardiomyopathy. Management with intravenous magnesium sulfate.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiomyopathies; Humans; Infusions, | 1997 |
Pharmacologic and nonpharmacologic treatment of ventricular arrhythmias in heart failure.
Topics: Amiodarone; Anti-Arrhythmia Agents; Bradycardia; Catheter Ablation; Defibrillators, Implantable; Ele | 1997 |
What can we expect from prophylactic implantable defibrillators?
Topics: Amiodarone; Anti-Arrhythmia Agents; Cause of Death; Death, Sudden, Cardiac; Defibrillators, Implanta | 1997 |
Drug-induced cardiac arrhythmias: incidence, prevention and management.
Topics: Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Anti-Infective Agents; | 1997 |
Drugs versus devices in controlling ventricular tachycardia, ventricular fibrillation, and recurrent cardiac arrest.
Topics: Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Heart Arrest; Humans; Randomized Co | 1997 |
Ventricular arrhythmias in the elderly.
Topics: Aged; Aged, 80 and over; Amiodarone; Angioplasty, Balloon, Coronary; Anti-Arrhythmia Agents; Coronar | 1998 |
Amiodarone in congestive heart failure.
Topics: Amiodarone; Anti-Arrhythmia Agents; Clinical Trials as Topic; Death, Sudden, Cardiac; Heart Failure; | 1998 |
Amiodarone and "primary" prevention of sudden death: critical review of a decade of clinical trials.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Clinical Trials as Topic; Death, Sudden, Cardiac; Female; | 1999 |
Antiarrhythmic drugs or implantable cardioverter defibrillators in heart failure: the "poor heart".
Topics: Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Defibrillators, Implantable; Heart Failu | 1999 |
New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Defibrillators, Implantable | 1999 |
[The use of oral amiodarone as a chronic treatment in a patient with prior fulminant hepatitis due to intravenous amiodarone].
Topics: Acute Disease; Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Chemical and Drug Induced L | 1999 |
Drugs for ventricular arrhythmias in the era of the implantable cardioverter defibrillator.
Topics: Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Follow-Up Studies; Humans; Sotalol; | 1999 |
Sudden cardiac death: who needs an implantable cardioverter-defibrillator and who needs antiarrhythmic drugs?
Topics: Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Defibrillators, Implantable; Humans; Sec | 1999 |
Management of the older person with ventricular arrhythmias.
Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors | 1999 |
Evidence-based analysis of amiodarone efficacy and safety.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Death, Sudden; Humans; Tachycardia, Ventric | 1999 |
Overview of trends in the control of cardiac arrhythmia: past and future.
Topics: Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Electrocardiography, Ambulatory; Hu | 1999 |
Amiodarone: ionic and cellular mechanisms of action of the most promising class III agent.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Dose-Response Relationship, Drug; Electrocardiography; | 1999 |
Intravenous antiarrhythmic therapy in the acute control of in-hospital destabilizing ventricular tachycardia and fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; | 1999 |
Intravenous antiarrhythmic drug therapy in the resuscitation from refractory ventricular arrhythmias.
Topics: Amiodarone; Anti-Arrhythmia Agents; Clinical Trials as Topic; Electric Countershock; Humans; Infusio | 1999 |
Implantable devices versus antiarrhythmic drug therapy in recurrent ventricular tachycardia and ventricular fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Humans; Multicenter Studies as Topi | 1999 |
Implantable defibrillators and antiarrhythmic drugs in patients at risk for lethal arrhythmias.
Topics: Amiodarone; Anti-Arrhythmia Agents; Clinical Trials as Topic; Death, Sudden, Cardiac; Defibrillators | 1999 |
Concomitant device and drug therapy: current trends, potential benefits, and adverse interactions.
Topics: Amiodarone; Anti-Arrhythmia Agents; Combined Modality Therapy; Defibrillators, Implantable; Electroc | 1999 |
Mortality reduction by antiadrenergic modulation of arrhythmogenic substrate: significance of combining beta blockers and amiodarone.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Drug Therapy, Combination; Electroc | 1999 |
Lessons from antiarrhythmic trials involving class III antiarrhythmic drugs.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Clinical Trials as Topic; Humans; M | 1999 |
Class III drugs and congestive heart failure: focus on the congestive heart failure-survival trial of antiarrhythmic therapy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Clinical Trials as Topic; Death, Sudden, Cardiac; Heart Failure; | 1999 |
Class III antiarrhythmic agents in cardiac failure: lessons from clinical trials with a focus on the Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA).
Topics: Amiodarone; Anti-Arrhythmia Agents; Clinical Trials as Topic; Heart Failure; Humans; Survival Rate; | 1999 |
Amiodarone: maximising survival benefit with empiric or guided therapy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Clinical Trials as Topic; Drug Administration Schedule; Empirici | 2000 |
Amiodarone: clinical trials.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Death, Sudden; D | 2000 |
Amiodarone: what have we learned from clinical trials?
Topics: Amiodarone; Anti-Arrhythmia Agents; Clinical Trials as Topic; Death, Sudden, Cardiac; Defibrillators | 2000 |
[Long-term outcome of pharmacological and nonpharmacological treatment for ventricular arrhythmias].
Topics: Adrenergic beta-Antagonists; Amiodarone; Catheter Ablation; Electric Countershock; Humans; Tachycard | 2000 |
Evidence-based medicine and the implantable defibrillator.
Topics: Amiodarone; Anti-Arrhythmia Agents; Coronary Artery Bypass; Death, Sudden, Cardiac; Defibrillators, | 1999 |
Is primary antiarrhythmic drug therapy for ventricular arrhythmias obsolete?
Topics: Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Defibrillators, Implantable; Humans; Ran | 1999 |
The role of antiarrhythmic therapy in the management of nonsustained ventricular tachycardia.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Electr | 1999 |
Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
Topics: Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Defibrillators, Implantable; Humans; Ran | 2000 |
Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
Topics: Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Defibrillators, Implantable; Humans; Ran | 2000 |
Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
Topics: Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Defibrillators, Implantable; Humans; Ran | 2000 |
Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
Topics: Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Defibrillators, Implantable; Humans; Ran | 2000 |
Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
Topics: Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Defibrillators, Implantable; Humans; Ran | 2000 |
Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
Topics: Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Defibrillators, Implantable; Humans; Ran | 2000 |
Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
Topics: Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Defibrillators, Implantable; Humans; Ran | 2000 |
Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
Topics: Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Defibrillators, Implantable; Humans; Ran | 2000 |
Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
Topics: Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Defibrillators, Implantable; Humans; Ran | 2000 |
Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
Topics: Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Defibrillators, Implantable; Humans; Ran | 2000 |
Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
Topics: Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Defibrillators, Implantable; Humans; Ran | 2000 |
Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
Topics: Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Defibrillators, Implantable; Humans; Ran | 2000 |
Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
Topics: Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Defibrillators, Implantable; Humans; Ran | 2000 |
Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
Topics: Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Defibrillators, Implantable; Humans; Ran | 2000 |
Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
Topics: Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Defibrillators, Implantable; Humans; Ran | 2000 |
Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
Topics: Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Defibrillators, Implantable; Humans; Ran | 2000 |
Intravenous antiarrhythmic agents.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Infusions, Intravenous; Procainamid | 2001 |
Perspectives: does amiodarone increase non-sudden deaths? If so, why?
Topics: Amiodarone; Anti-Arrhythmia Agents; Death, Sudden; Death, Sudden, Cardiac; Female; Heart Failure; Hu | 2000 |
Amiodarone in the new AHA guidelines for ventricular tachyarrhythmias.
Topics: Administration, Oral; American Heart Association; Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonar | 2001 |
[Ventricular tachycardia in anterior wall aneurysm after myocardial infarct].
Topics: Aged; Amiodarone; Drug Therapy, Combination; Electrocardiography, Ambulatory; Heart Aneurysm; Heart | 1992 |
78 trials available for amiodarone and Atrioventricular Nodal Re-Entrant Tachycardia
| Article | Year |
|---|---|
Ventricular tachycardia characteristics and outcomes with catheter ablation vs. antiarrhythmic therapy: insights from the VANISH trial.
Topics: Amiodarone; Anti-Arrhythmia Agents; Catheter Ablation; Humans; Myocardial Infarction; Tachycardia, V | 2022 |
Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2022 |
Ventricular Tachycardia and ICD Therapy Burden With Catheter Ablation Versus Escalated Antiarrhythmic Drug Therapy.
Topics: Adenosine Triphosphate; Aged; Amiodarone; Anti-Arrhythmia Agents; Catheter Ablation; Defibrillators, | 2023 |
Quality of life with ablation or medical therapy for ventricular arrhythmias: A substudy of VANISH.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Anxiety; Australia; Catheter Ablation; Emotions; Europe; F | 2018 |
Mexiletine or catheter ablation after amiodarone failure in the VANISH trial.
Topics: Action Potentials; Aged; Amiodarone; Anti-Arrhythmia Agents; Catheter Ablation; Drug Substitution; F | 2018 |
Clinical and Electrocardiographic Characteristics of Electrical Storms Due to Monomorphic Ventricular Tachycardia Refractory to Intravenous Amiodarone.
Topics: Aged; Aged, 80 and over; Amiodarone; Drug Resistance; Electrocardiography; Female; Humans; Male; Mid | 2015 |
Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Central Nervous Syst | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Randomized comparison of intravenous procainamide vs. intravenous amiodarone for the acute treatment of tolerated wide QRS tachycardia: the PROCAMIO study.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Drug Administration Schedule; Female; Hu | 2017 |
Relationship between amiodarone-induced subclinical lung toxicity and Th1/Th2 balance.
Topics: Administration, Oral; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Female; Flow Cytometry; Human | 2009 |
The effects of nifekalant hydrochloride on the QT dispersion after direct-current defibrillation.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; | 2008 |
Intravenous diltiazem is superior to intravenous amiodarone or digoxin for achieving ventricular rate control in patients with acute uncomplicated atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cohort Studies; Digoxin; Diltiazem; F | 2009 |
Effects of intravenous nifekalant as a lifesaving drug for severe ventricular tachyarrhythmias complicating acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Amiodarone; Anti-Arrhythmia Agents; Blood Pressure; Electrocardiograp | 2009 |
[Therapeutic effects of amiodarone and metoprolol on chronic heart failure complicated by ventricular arrhythmia].
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anti-Arrhythmia Agents; Chronic Disease; Drug Therap | 2009 |
Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Benzofurans; Death, Sudden, Cardiac; Defibrillators, Impla | 2011 |
Intravenous lidocaine versus intravenous amiodarone (in a new aqueous formulation) for incessant ventricular tachycardia.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Blood Pressure; Double-Blind Method; El | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2002 |
Amiodarone versus implantable cardioverter-defibrillator:randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia--AMIOVIRT.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Costs and Cost Analysis; Defibrillators | 2003 |
Amiodarone prevents symptomatic atrial fibrillation and reduces the risk of cerebrovascular accidents and ventricular tachycardia after open heart surgery: results of the Atrial Fibrillation Suppression Trial (AFIST).
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial | 2003 |
Amiodarone decreases plasma brain natriuretic peptide level in patients with heart failure and ventricular tachyarrhythmia.
Topics: Amiodarone; Anti-Arrhythmia Agents; Biomarkers; Electrocardiography; Female; Heart Failure; Humans; | 2003 |
Lower observed versus expected (based on U.S. age and gender specific rates) survival in patients treated for near-fatal ventricular arrhythmias.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiac Output; Case-Control Studies; Cohort Studies; Conf | 2004 |
Effect of biventricular pacing therapy in patients with dilated cardiomyopathy with severe congestive heart failure.
Topics: Administration, Oral; Aged; Amiodarone; Atrial Fibrillation; Cardiac Pacing, Artificial; Cardiomyopa | 2004 |
The Midlands Trial of Empirical Amiodarone versus Electrophysiology-guided Interventions and Implantable Cardioverter-defibrillators (MAVERIC): a multi-centre prospective randomised clinical trial on the secondary prevention of sudden cardiac death.
Topics: Amiodarone; Anti-Arrhythmia Agents; Clinical Protocols; Death, Sudden, Cardiac; Defibrillators, Impl | 2004 |
Iohexol contrast medium induces QT prolongation in amiodarone patients.
Topics: Amiodarone; Anti-Arrhythmia Agents; Contrast Media; Humans; Iohexol; Long QT Syndrome; Retrospective | 2004 |
Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS).
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Canada; Comorbidity; Coronary Artery Bypass; Death, Sudden | 2004 |
Japanese randomized trial for investigation of a combined therapy of amiodarone and implantable cardioverter defibrillator in patients with ventricular tachycardia and fibrillation: the Nippon ICD Plus Pharmachologic Option Necessity study design.
Topics: Amiodarone; Anti-Arrhythmia Agents; Combined Modality Therapy; Defibrillators, Implantable; Follow-U | 2006 |
Skeletal myoblast transplantation in ischemic heart failure: long-term follow-up of the first phase I cohort of patients.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Cicatrix; Cohort Studies; Combined Modality Th | 2006 |
Observations on the safety and effectiveness of dofetilide in patients with paroxysmal atrial fibrillation and normal left ventricular function.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flut | 2007 |
Electrophysiologic study-guided amiodarone for sustained ventricular tachyarrhythmias associated with structural heart diseases.
Topics: Aged; Amiodarone; Death; Electrocardiography, Ambulatory; Electrophysiologic Techniques, Cardiac; Fe | 2008 |
Exploring the minimal dose of amiodarone with antiarrhythmic and hemodynamic activity.
Topics: Adult; Aged; Amiodarone; Cardiac Complexes, Premature; Chi-Square Distribution; Double-Blind Method; | 1994 |
Effects of amiodarone, sematilide, and sotalol on QT dispersion.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Electrocardiography; Follow- | 1994 |
Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. The Intravenous Amiodarone Multicenter Investigators Group.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Bretylium Tosylate; Dose-Response Relationship, Drug; Doub | 1995 |
Dose-ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias. The Intravenous Amiodarone Multicenter Investigators Group.
Topics: Amiodarone; Anti-Arrhythmia Agents; Dose-Response Relationship, Drug; Double-Blind Method; Female; H | 1995 |
Predictors of mortality in patients with sustained ventricular tachycardias or ventricular fibrillation and depressed left ventricular function: importance of beta-blockade.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Death, Sudden, Cardiac; Demography; Female; Follow-Up | 1995 |
Effect of amiodarone therapy on mortality in patients with left ventricular dysfunction and asymptomatic complex ventricular arrhythmias: Argentine Pilot Study of Sudden Death and Amiodarone (EPAMSA).
Topics: Aged; Amiodarone; Argentina; Death, Sudden, Cardiac; Female; Follow-Up Studies; Humans; Incidence; M | 1995 |
ICD versus drugs in cardiac arrest survivors: preliminary results of the Cardiac Arrest Study Hamburg.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Defibrillators, Implantable | 1993 |
[Long-term results of amiodarone therapy in patients with sustained ventricular tachycardia or ventricular fibrillation for prevention of cardiac sudden death].
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Death, Sudden, Cardiac; Female; Humans; Long-Term Care; | 1994 |
Antiarrhythmics Versus Implantable Defibrillators (AVID)--rationale, design, and methods.
Topics: Amiodarone; Cross-Over Studies; Defibrillators, Implantable; Humans; Prospective Studies; Quality of | 1995 |
Prediction of electrophysiologic study results in patients treated with amiodarone.
Topics: Aged; Amiodarone; Cardiac Pacing, Artificial; Electrophysiology; Female; Humans; Male; Proportional | 1995 |
The effects of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of amiodarone and sematilide in humans.
Topics: Action Potentials; Adrenergic beta-Agonists; Amiodarone; Anti-Arrhythmia Agents; Blood Pressure; Ele | 1994 |
Effects of amiodarone on the circadian rhythm and power spectral changes of heart rate and QT interval: significance for the control of sudden cardiac death.
Topics: Aged; Amiodarone; Circadian Rhythm; Death, Sudden, Cardiac; Electrocardiography, Ambulatory; Heart R | 1994 |
Are patients receiving amiodarone at increased risk for cardiac operations?
Topics: Aged; Amiodarone; Combined Modality Therapy; Female; Follow-Up Studies; Hemodynamics; Hospital Morta | 1994 |
Electrophysiologic effects of sotalol and amiodarone in patients with sustained monomorphic ventricular tachycardia.
Topics: Aged; Amiodarone; Analysis of Variance; Chi-Square Distribution; Electrophysiology; Female; Humans; | 1994 |
Clinical efficacy and safety of intravenous Amiodarone in infants and children.
Topics: Adolescent; Amiodarone; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combina | 1994 |
Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg).
Topics: Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Defibrillators, Implantable; Female; Hea | 1994 |
Antiarrhythmic drugs versus implantable defibrillators: the need for a randomized controlled study.
Topics: Amiodarone; Anti-Arrhythmia Agents; Clinical Trials as Topic; Defibrillators, Implantable; Humans; P | 1994 |
Prospective, randomized comparison of conventional and high dose loading regimens of amiodarone in the treatment of ventricular tachycardia.
Topics: Aged; Amiodarone; Cardiac Pacing, Artificial; Drug Administration Schedule; Electrophysiology; Femal | 1993 |
Canadian Implantable Defibrillator Study (CIDS): study design and organization. CIDS Co-Investigators.
Topics: Amiodarone; Canada; Defibrillators, Implantable; Humans; Proportional Hazards Models; Tachycardia, V | 1993 |
Preliminary results of the Cardiac Arrest Study Hamburg (CASH). CASH Investigators.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Defibrillators, Implantable | 1993 |
Veterans Affairs congestive heart failure antiarrhythmic trial. CHF STAT Investigators.
Topics: Amiodarone; Double-Blind Method; Heart Failure; Hospitals, Veterans; Humans; Prospective Studies; Ta | 1993 |
Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE Study). The CASCADE Investigators.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Chi-Square Distribution; Electrocardiography, Ambulatory; | 1993 |
Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias. Intravenous Amiodarone Multicenter Trial Group.
Topics: Amiodarone; Analysis of Variance; Anti-Arrhythmia Agents; Bradycardia; Cause of Death; Chi-Square Di | 1996 |
[The influence of amiodarone on results of the signal-averaged electrocardiogram].
Topics: Adult; Aged; Amiodarone; Electrocardiography; Female; Humans; Male; Middle Aged; Myocardial Infarcti | 1996 |
Normalization of peripheral thyroid hormone metabolism induced by successful chronic amiodarone treatment in patients with ventricular arrhythmias.
Topics: Aged; Aged, 80 and over; Amiodarone; Analysis of Variance; Anti-Arrhythmia Agents; Cardiac Complexes | 1996 |
[Prediction of long-term efficacy of amiodarone for refractory ventricular tachycardia: clinical significance of electrophysiologic study and Holter monitoring].
Topics: Administration, Oral; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Deat | 1996 |
[Short-term and long-term outcome of left heart function after cardioverter defibrillator implantation].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Defibrillators, Implantable | 1996 |
Nonsustained ventricular tachycardia in severe heart failure. Independent marker of increased mortality due to sudden death. GESICA-GEMA Investigators.
Topics: Amiodarone; Analysis of Variance; Anti-Arrhythmia Agents; Cohort Studies; Confidence Intervals; Deat | 1996 |
Effects of amiodarone on the circadian pattern of sudden cardiac death (Department of Veterans Affairs Congestive Heart Failure-Survival Trial of Antiarrhythmic Therapy).
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Circadian Rhythm; Death, Sudden, Cardiac; Double-Blind Met | 1997 |
Influence of amiodarone on QT dispersion in patients with life-threatening ventricular arrhythmias and clinical outcome.
Topics: Amiodarone; Anti-Arrhythmia Agents; Coronary Angiography; Coronary Disease; Dose-Response Relationsh | 1997 |
Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Confounding Factors, Epidemiologic; Coronary Disease; Deat | 1997 |
A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Female; Humans; Male; Middle | 1997 |
A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Female; Humans; Male; Middle | 1997 |
A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Female; Humans; Male; Middle | 1997 |
A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Female; Humans; Male; Middle | 1997 |
A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Female; Humans; Male; Middle | 1997 |
A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Female; Humans; Male; Middle | 1997 |
A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Female; Humans; Male; Middle | 1997 |
A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Female; Humans; Male; Middle | 1997 |
A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Female; Humans; Male; Middle | 1997 |
Prevalence and significance of nonsustained ventricular tachycardia in patients with premature ventricular contractions and heart failure treated with vasodilator therapy. Department of Veterans Affairs CHF STAT Investigators.
Topics: Aged; Amiodarone; Death, Sudden, Cardiac; Electrocardiography, Ambulatory; Heart Failure; Humans; Mi | 1998 |
Comparison of sotalol with amiodarone for long-term treatment of spontaneous sustained ventricular tachyarrhythmia based on coronary artery disease.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Coronary Disease; Cross-Over Studies; Electrocardiography; | 1999 |
Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Chi-Square Dis | 1999 |
Beta-blocker use and survival in patients with ventricular fibrillation or symptomatic ventricular tachycardia: the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Combined Modality Therapy; De | 1999 |
Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias. AVID Investigators. Antiarrhythmics Versus
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Female; Hemodynamics; Humans; | 1999 |
Learning more about indications for implantable cardioverter-defibrillators.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Female; Hemodynamics; Humans; | 1999 |
In-hospital versus out-of-hospital presentation of life-threatening ventricular arrhythmias predicts survival: results from the AVID Registry. Antiarrhythmics Versus Implantable Defibrillators.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Defibrillators, Implantable | 1999 |
Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Female; Humans; Male; Middle | 2000 |
Determinants of outcome in patients with sustained ventricular tachyarrhythmias: the antiarrhythmics versus implantable defibrillators (AVID) study registry.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Female; Humans; Male; Middle | 2000 |
Diagnostic accuracy of KL-6 as a marker of amiodarone-induced pulmonary toxicity.
Topics: Adult; Aged; Amiodarone; Antigens; Antigens, Neoplasm; Atrial Fibrillation; Biomarkers; C-Reactive P | 2000 |
Electrophysiologically guided amiodarone therapy versus the implantable cardioverter-defibrillator for sustained ventricular tachyarrhythmias after myocardial infarction: results of long-term follow-up.
Topics: Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Defibrillators, Implantable; Disease-Fre | 2002 |
Congestive heart failure: survival trial of antiarrhythmic therapy (CHF STAT). The CHF STAT Investigators.
Topics: Amiodarone; Cardiac Complexes, Premature; Dose-Response Relationship, Drug; Double-Blind Method; Dru | 1992 |
A multicentre, randomized trial on the benefit/risk profile of amiodarone, flecainide and propafenone in patients with cardiac disease and complex ventricular arrhythmias. Antiarrhythmic Drug Evaluation Group (A.D.E.G.).
Topics: Amiodarone; Cardiomyopathy, Dilated; Cardiomyopathy, Hypertrophic; Dose-Response Relationship, Drug; | 1992 |
Effects of chronic amiodarone therapy on defibrillation threshold.
Topics: Amiodarone; Defibrillators, Implantable; Electrodes, Implanted; Female; Follow-Up Studies; Humans; M | 1992 |
A prospective study of the efficacy and safety of adjuvant metoprolol and xamoterol in combination with amiodarone for resistant ventricular tachycardia associated with impaired left ventricular function.
Topics: Adult; Aged; Amiodarone; Drug Therapy, Combination; Electrocardiography; Exercise Test; Female; Foll | 1992 |
[Prospective long-term ECG study of 100 patients surviving sudden cardiac death].
Topics: Adult; Aged; Amiodarone; Death, Sudden, Cardiac; Defibrillators, Implantable; Electrocardiography, A | 1992 |
[Risk stratification and long-term therapy with amiodarone in patients with idiopathic dilated cardiomyopathy].
Topics: Adult; Aged; Amiodarone; Cardiomyopathy, Dilated; Death, Sudden, Cardiac; Electrocardiography; Femal | 1992 |
372 other studies available for amiodarone and Atrioventricular Nodal Re-Entrant Tachycardia
| Article | Year |
|---|---|
A Young Man With Wide Complex Tachycardia-The Devil Is in the Details.
Topics: Amiodarone; Anti-Arrhythmia Agents; Bundle-Branch Block; Cardiomyopathy, Dilated; Defibrillators, Im | 2021 |
Propafenone use in coronary artery disease patients undergoing atrial fibrillation ablation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Artery Disease; Death, Sudden, Car | 2022 |
Primary hypothyroidism with an episode of ventricular tachycardia in a patient with COVID-19: A case report.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; COVID-19; Electrocardiography; Human | 2022 |
Slow Ventricular Tachycardia on Amiodarone: An Adverse Complication or an Efficacy Outcome.
Topics: Accelerated Idioventricular Rhythm; Amiodarone; Anti-Arrhythmia Agents; Electrocardiography; Humans; | 2022 |
Clinical Outcomes in Patients With Dilated Cardiomyopathy and Ventricular Tachycardia.
Topics: Aged; Amiodarone; Cardiomyopathy, Dilated; Catheter Ablation; Female; Humans; Male; Middle Aged; Rec | 2022 |
Urgent desensitization for severe amiodarone intolerance with a 12-step protocol.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Humans; Male; Tachycardia, Ventricular | 2022 |
Comparison of the effects of lidocaine and amiodarone for out-of-hospital cardiac arrest patients with shockable rhythms: a retrospective observational study from a multicenter registry.
Topics: Adult; Amiodarone; Cardiopulmonary Resuscitation; Electric Countershock; Emergency Medical Services; | 2022 |
Single beta-blocker or combined amiodarone therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator patients: Insights from the German DEVICE registry.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Cardiac Resynchronization Therapy; | 2023 |
Single beta-blocker or combined amiodarone therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator patients: Insights from the German DEVICE registry.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Cardiac Resynchronization Therapy; | 2023 |
Single beta-blocker or combined amiodarone therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator patients: Insights from the German DEVICE registry.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Cardiac Resynchronization Therapy; | 2023 |
Single beta-blocker or combined amiodarone therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator patients: Insights from the German DEVICE registry.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Cardiac Resynchronization Therapy; | 2023 |
The short-long-short-short sequence and polymorphic ventricular tachycardias storm.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Humans; Tachycardia, V | 2023 |
The short-long-short-short sequence and polymorphic ventricular tachycardias storm.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Humans; Tachycardia, V | 2023 |
The short-long-short-short sequence and polymorphic ventricular tachycardias storm.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Humans; Tachycardia, V | 2023 |
The short-long-short-short sequence and polymorphic ventricular tachycardias storm.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Humans; Tachycardia, V | 2023 |
Association between amiodarone and ventricular tachycardia after left ventricular assist device implant: a single-center experience.
Topics: Amiodarone; Arrhythmias, Cardiac; Heart Failure; Heart-Assist Devices; Humans; Tachycardia, Ventricu | 2023 |
Association between amiodarone and ventricular tachycardia after left ventricular assist device implant: a single-center experience.
Topics: Amiodarone; Arrhythmias, Cardiac; Heart Failure; Heart-Assist Devices; Humans; Tachycardia, Ventricu | 2023 |
Association between amiodarone and ventricular tachycardia after left ventricular assist device implant: a single-center experience.
Topics: Amiodarone; Arrhythmias, Cardiac; Heart Failure; Heart-Assist Devices; Humans; Tachycardia, Ventricu | 2023 |
Association between amiodarone and ventricular tachycardia after left ventricular assist device implant: a single-center experience.
Topics: Amiodarone; Arrhythmias, Cardiac; Heart Failure; Heart-Assist Devices; Humans; Tachycardia, Ventricu | 2023 |
Mortality after catheter ablation of structural heart disease related ventricular tachycardia.
Topics: Aged; Amiodarone; Catheter Ablation; Humans; Recurrence; Stroke Volume; Tachycardia, Ventricular; Tr | 2023 |
Stable Ventricular Fibrillation: A Paradigm Rather Than Septal Shift?
Topics: Amiodarone; Arrhythmias, Cardiac; Humans; Lidocaine; Tachycardia, Ventricular; Ventricular Fibrillat | 2023 |
Wide-QRS Tachycardia in an 89-Year-Old Woman With an ICD.
Topics: Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Electrocardiogra | 2019 |
Wide QRS tachycardia with alternating QRS morphologies: What is the mechanism?
Topics: Amiodarone; Anti-Arrhythmia Agents; Catheter Ablation; Defibrillators, Implantable; Epicardial Mappi | 2020 |
Improved Survival With Extracorporeal Cardiopulmonary Resuscitation Despite Progressive Metabolic Derangement Associated With Prolonged Resuscitation.
Topics: Acidosis, Lactic; Advanced Cardiac Life Support; Amiodarone; Brain Damage, Chronic; Cardiopulmonary | 2020 |
Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Amiodarone; Andersen Syndrome; Anti-Arrhythmia Agent | 2020 |
Dramatic reduction of ventricular tachycardia burden after dronedarone plus mexiletine treatment in a patient refractory to hybrid ablation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Catheter Ablation; Defibrillators, Implantable; Dronedarone; Dru | 2020 |
Successful management of ventricular fibrillation and ventricular tachycardia using defibrillation and intravenous amiodarone therapy in a cat.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Cardiomyopathy, Hypertrophic; Cardiopulmonary Resuscita | 2020 |
Ventricular tachycardia: beginning and ending fate of a benign invasive cardiac lipoma.
Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Combined Modality Therapy; Defibrillators, Implantab | 2020 |
Different effects of amiodarone and dofetilide on the dispersion of repolarization between well-coupled ventricular and Purkinje fibers
Topics: Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Dogs; Electrocardiography; Female; H | 2021 |
Quinidine hypersensitivity: a side effect of a forgotten antiarrhythmic.
Topics: Acute Disease; Aged; Amiodarone; Anti-Arrhythmia Agents; Chemical and Drug Induced Liver Injury; Dru | 2020 |
Arrhythmogenic Right Ventricular Cardiomyopathy: An Exuberant Case Affecting Both Ventricles.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular Dysplasia; Bundle-Branch Block; | 2020 |
Comparable risk of recurrent ventricular tachyarrhythmias in implantable cardioverter-defibrillator recipients treated with single beta-blocker or combined amiodarone.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Amiodarone; Defibrillators, | 2021 |
[Amiodarone-induced Ventricular Tachycardia after Coronary Artery Bypass Grafting;Report of a Case].
Topics: Amiodarone; Anti-Arrhythmia Agents; Coronary Artery Bypass; Humans; Male; Middle Aged; Tachycardia, | 2020 |
Sustained Ventricular Tachycardia as a Harbinger of Cardiac Amyloidosis.
Topics: Aged; Amiodarone; Amyloid Neuropathies, Familial; Defibrillators, Implantable; Electric Countershock | 2020 |
Fast and furious: flecainide toxicity presenting as monomorphic ventricular tachycardia.
Topics: Amiodarone; Electrocardiography; Female; Flecainide; Humans; Middle Aged; Tachycardia, Ventricular; | 2020 |
Catheter ablation of ventricular tachycardia in ischemic cardiomyopathy: Impact of concomitant amiodarone therapy on short- and long-term clinical outcomes.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Female; Follow-Up Stu | 2021 |
Amiodarone and hypothyroidism.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Humans; Hypothyroidism; Male; Tachycardia, Ventricular | 2021 |
Amiodarone during ventricular tachycardia ablation: A total eclipse of the heart?
Topics: Amiodarone; Catheter Ablation; Humans; Tachycardia, Ventricular | 2021 |
Ventricular tachycardia converts to sinus rhythm after administration of propofol.
Topics: Amiodarone; Anesthetics, Intravenous; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Defibrillators | 2021 |
Mexiletine for ventricular arrhythmias in patients with chronic coronary syndrome: a cohort study.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Cohort Studies; Coronary Artery Disease | 2022 |
Use of Antiarrhythmic Medications in Medicare Part D Patients With an Implantable Cardioverter-Defibrillator and Ventricular Tachycardia.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Databases, | 2017 |
Sustained left ventricular outflow tract ventricular tachycardia following transcatheter aortic valve replacement.
Topics: Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Aortic Valve Stenosis; Electrocardiography; H | 2017 |
Fatal monomorphic ventricular tachycardia in a semi-urban setting in Cameroon: a case report.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cameroon; Electrocardiography; Fatal Outcome; Heart Rate; | 2017 |
Outcomes after repeat ablation of ventricular tachycardia in structural heart disease: An analysis from the International VT Ablation Center Collaborative Group.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Catheter Ablation; Electric Countershock; Electrocardiogra | 2017 |
A rare form of extremely wide QRS complex due to reversed homologous electrical ventricular separation of acute heart failure.
Topics: Acute Disease; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Benzaze | 2018 |
Neonatal complex arrhythmias possibly related to a TTN mutation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Bundle-Branch Block; Connectin; Electrocardiography; Fetal Monit | 2017 |
Desmosterol accumulation in users of amiodarone.
Topics: Amiodarone; Anti-Arrhythmia Agents; Biopsy; Cardiac Imaging Techniques; Cardiomyopathies; Cholestero | 2018 |
Delayed Onset of Atrial Fibrillation and Ventricular Tachycardia after an Automobile Lightning Strike.
Topics: Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Eme | 2017 |
Amiodarone-induced Thyrotoxicosis with Cardiopulmonary Arrest.
Topics: Amiodarone; Anti-Arrhythmia Agents; Female; Heart Arrest; Humans; Middle Aged; Tachycardia, Ventricu | 2018 |
Learning from errors: unnecessary intensive care unit admissions.
Topics: Administration, Intravenous; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Chronic Disease; | 2017 |
[Update Ventricular Tachycardia].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Catheter Ablation; Defibrillators; Humans; | 2018 |
March 26th Question.
Topics: Ablation Techniques; Action Potentials; Adult; Amiodarone; Anti-Arrhythmia Agents; Cardiac Pacing, A | 2018 |
Amiodarone-induced reversible and irreversible hepatotoxicity: two case reports.
Topics: Aged; Alanine Transaminase; Amiodarone; Anti-Arrhythmia Agents; Aspartate Aminotransferases; Chemica | 2018 |
A delayed diagnosis of catecholaminergic polymorphic ventricular tachycardia with a mutant of RYR2 at c.7580T>G for 6 years in a 9-year-old child.
Topics: Amiodarone; Anti-Arrhythmia Agents; Child; Death, Sudden, Cardiac; Delayed Diagnosis; Electrocardiog | 2018 |
Amiodarone Discontinuation or Dose Reduction Following Catheter Ablation for Ventricular Tachycardia in Structural Heart Disease.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Case-Control Studies; Catheter Ablation; Drug | 2017 |
Amiodarone for Suppression of Ventricular Tachycardia: When Less Is More.
Topics: Amiodarone; Anti-Arrhythmia Agents; Catheter Ablation; Humans; Tachycardia, Ventricular | 2017 |
Re: Amiodarone for sustained stable ventricular tachycardia in the prehospital setting.
Topics: Amiodarone; Anti-Arrhythmia Agents; Electrocardiography; Humans; Tachycardia, Ventricular | 2018 |
Ventricular Tachycardia (VT) Storm After Cryoballoon-Based Pulmonary Vein Isolation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cryosurgery; Defibrillators, Implantable; H | 2018 |
Brugada pattern exposed with administration of amiodarone during emergent treatment of ventricular tachycardia.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Brugada Syndrome; Defibrillators, Implantable; Electrocar | 2019 |
Topics: Amiodarone; Brain Neoplasms; Defibrillators, Implantable; Diagnosis, Differential; Glioblastoma; Hum | 2019 |
Prognostic impact of beta-blocker compared to combined amiodarone therapy secondary to ventricular tachyarrhythmias.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia | 2019 |
Cardiac manifestations in Emery-Dreifuss muscular dystrophy.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Defibrillators, Implantable; Ele | 2018 |
2018 American Heart Association Focused Update on Advanced Cardiovascular Life Support Use of Antiarrhythmic Drugs During and Immediately After Cardiac Arrest: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Em
Topics: American Heart Association; Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Emerg | 2018 |
2018 American Heart Association Focused Update on Pediatric Advanced Life Support: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
Topics: American Heart Association; Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Child | 2018 |
Quinidine-Responsive Polymorphic Ventricular Tachycardia in Patients With Coronary Heart Disease.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Coronary Artery Disease; Drug Evaluation; Drug Resistance; | 2019 |
Cardiovascular Collapse with Intravenous Amiodarone in Children: A Multi-Center Retrospective Cohort Study.
Topics: Administration, Intravenous; Adolescent; Age Distribution; Amiodarone; Anti-Arrhythmia Agents; Blood | 2019 |
Pseudo-Ventricular Tachycardia, Pseudo-Atrial Fibrillation, and Pseudo-Atrial Flutter in a Patient With Parkinson Disease: Two's Company, Three's a Crowd.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Diagnosis, Differential; El | 2019 |
Outcomes associated with amiodarone and lidocaine for the treatment of adult in-hospital cardiac arrest with shock-refractory pulseless ventricular tachyarrhythmia.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Electric Countershock; Female; Heart Ar | 2020 |
Safety of therapeutic hypothermia in post VF/VT cardiac arrest patients.
Topics: Amiodarone; Anti-Arrhythmia Agents; Electrocardiography; Female; Heart Arrest; Humans; Hypothermia, | 2013 |
Mexiletine as an adjunctive therapy to amiodarone reduces the frequency of ventricular tachyarrhythmia events in patients with an implantable defibrillator.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Cohort Studies | 2013 |
Protective effects of saffron (Crocus sativus) against lethal ventricular arrhythmias induced by heart reperfusion in rat: a potential anti-arrhythmic agent.
Topics: Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Crocus; Disease Models, Animal; Dose | 2013 |
[Amiodarone administered orally or intravenously - the same or different drug?].
Topics: Action Potentials; Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Atrioventricular Node; | 2013 |
Prophylactic amiodarone and lidocaine improve survival in an ovine model of large size myocardial infarction.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Disease Mode | 2013 |
[A case of idiopathic ventricular tachycardia in a 14-year-old obese patient due to golden berry fruit extract pills for weight loss].
Topics: Administration, Oral; Adolescent; Amiodarone; Anti-Arrhythmia Agents; Diagnosis, Differential; Elect | 2013 |
External defibrillation on an implantable defibrillator.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Electric Countershock; Emerge | 2014 |
[Monomorphic ventricular tachycardia during the ajmaline test].
Topics: Adult; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Electrocardiography; Humans; Male; Tachycardia, | 2013 |
Ventricular tachycardia in hypertrophic cardiomyopathy with apical aneurysm successfully treated with left ventricular aneurysmectomy and cryoablation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Hypertrophic; Cryosurgery; Diabetes Mellitus, Ty | 2013 |
Anaphylactic shock after amiodarone infusion resulting in haemodynamic collapse requiring a temporary ventricular assist device.
Topics: Adolescent; Amiodarone; Anaphylaxis; Anti-Arrhythmia Agents; Heart Failure; Heart-Assist Devices; He | 2015 |
Outcomes associated with amiodarone and lidocaine in the treatment of in-hospital pediatric cardiac arrest with pulseless ventricular tachycardia or ventricular fibrillation.
Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Child; Child, Preschool; Cohort Studies; Heart Arres | 2014 |
Rapid diagnostics and treatment of early complications after CABG surgery: a life saver.
Topics: Aged; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Coronary Artery Bypass; Coronary Artery Disease; | 2013 |
Implantable cardioverter-defibrillators for treatment of sustained ventricular arrhythmias in patients with Chagas' heart disease: comparison with a control group treated with amiodarone alone.
Topics: Accelerated Idioventricular Rhythm; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Chagas Cardiomy | 2014 |
Endocardial or epicardial ventricular tachycardia in nonischemic cardiomyopathy? The role of 12-lead ECG criteria in clinical practice.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Cerebral Palsy; Electrocardiography; Ele | 2014 |
Dronedarone: an option in the treatment of ventricular arrhythmias.
Topics: Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Dronedarone; Humans; Hypertension; | 2013 |
Renewed impact of lidocaine on refractory ventricular arrhythmias in the amiodarone era.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Drug Therapy, Combination; Female; Huma | 2014 |
Comparative study of the protective effects of terfenadine and amiodarone on barium chloride/aconitine-induced ventricular arrhythmias in rats: a potential role of terfenadine.
Topics: Aconitine; Amiodarone; Animals; Anti-Arrhythmia Agents; Barium Compounds; Chlorides; Electrocardiogr | 2014 |
Drug-induced post-repolarization refractoriness as an antiarrhythmic principle and its underlying mechanism.
Topics: Action Potentials; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Cardiac Pacing, Arti | 2014 |
Intravenous amiodarone homogeneously prolongs ventricular repolarization in patients with life-threatening ventricular tachyarrhythmia.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Electrocardiography; Female; Heart Cond | 2015 |
Proarrhythmic effect of 'Reverse Mode Switch' in a patient with dilated cardiomyopathy and drug-induced long QTc interval.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiac Resynchronization Therapy; Cardiac Resynchronizati | 2015 |
Cat's whiskers & corneal verticillata secondary to amiodarone intake.
Topics: Aged; Amiodarone; Cardiomyopathy, Dilated; Cataract; Dose-Response Relationship, Drug; Humans; Male; | 2015 |
Acute Diaphragm Paralysis Caused by Intravenous Administration of Amiodarone.
Topics: Administration, Intravenous; Adult; Amiodarone; Anti-Arrhythmia Agents; Child; Humans; Male; Respira | 2015 |
Ventricular tachycardia associated with mid-ventricular obstructive hypertrophic cardiomyopathy and apical aneurysm.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Aneurysm; Anti-Arrhythmia Agents; Cardiomyopathy, Hyp | 2015 |
Acute Thrombotic Occlusion of the Left Brachial Artery After Intra-Arterial Administration of Amiodarone.
Topics: Amiodarone; Anti-Arrhythmia Agents; Brachial Artery; Compartment Syndromes; Female; Humans; Infusion | 2016 |
Blue man syndrome.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Humans; Male; Pigmentation Disorders; Syndrome; Tachycardi | 2016 |
ECMO Used in a Refractory Ventricular Tachycardia and Ventricular Fibrillation Patient: A National Case-Control Study.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Case-Control Studies; Comorbidity; Electric Counter | 2016 |
Pathological autopsy of a patient that underwent a successful ablation of an electrical storm from the left ventricular summit.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Autopsy; Catheter Ablation; Electrocardiography; Electroph | 2016 |
Long-term outcome and its predictors in giant cell myocarditis.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhy | 2016 |
The use of dronedarone for recurrent ventricular tachycardia: a case report and review of the literature.
Topics: Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Catheter Ablation; Dronedarone; Fatal Outcome | 2016 |
Atrioventricular Conduction Disorder as a First Manifestation of Arrhythmogenic Right Ventricular Dysplasia.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Arrhythmogenic Righ | 2016 |
Triple Oral Antithrombotic Therapy: A Teachable Moment.
Topics: Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Chest Pain; Coronary Artery Disease; Drug-Elu | 2016 |
Amiodarone administration for refractory ventricular fibrillation or pulseless ventricular tachycardia.
Topics: Administration, Intravenous; Adult; Amiodarone; Anti-Arrhythmia Agents; Emergency Nursing; Heart Arr | 2016 |
Aconite poisoning with arrhythmia and shock.
Topics: Aconitum; Amiodarone; Anti-Arrhythmia Agents; Electrocardiography; Fluid Therapy; Humans; Male; Midd | 2016 |
Do not consider amiodarone, give it! Comment on antiarrhythmic drugs for shock‑refractory ventricular fibrillation or pulseless ventricular tachycardia.
Topics: Amiodarone; Anti-Arrhythmia Agents; Humans; Tachycardia, Ventricular; Ventricular Fibrillation | 2016 |
Comparison of Patient Characteristics and Course of Hypertensive Hypokinetic Cardiomyopathy Versus Idiopathic Dilated Cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Angiotensin Receptor Antagonists; Angiotensin- | 2017 |
Abiotrophia defectiva Endocarditis Complicated by Ventricular Tachycardia.
Topics: Abiotrophia; Aged; Amiodarone; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Drug Therapy, Combinat | 2016 |
A Perfect Storm: Tyrosine Kinase Inhibitor-Associated Polymorphic Ventricular Tachycardia.
Topics: Adenine; Amiodarone; Anti-Arrhythmia Agents; Antineoplastic Agents; Cardiotonic Agents; Electric Cou | 2017 |
Acute hemodynamic effects of intravenous amiodarone treatment in paediatric cardiac surgical patients.
Topics: Adolescent; Algorithms; Amiodarone; Anti-Arrhythmia Agents; Cardiac Surgical Procedures; Catecholami | 2008 |
Atrial fibrillation due to late amiodarone-induced thyrotoxicosis.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiomyopathy, Hypertrophic; Humans; Male; | 2008 |
Irregular ventricular tachycardia underdetected by implantable cardioverter defibrillator device.
Topics: Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Equipment Failure; Humans; Male; Ta | 2008 |
Thyrotoxicosis-induced ventricular arrhythmias.
Topics: Adult; Aged; Amiodarone; Fatal Outcome; Female; Humans; Male; Middle Aged; Tachycardia, Ventricular; | 2008 |
Case files of the medical toxicology fellowship at the toxikon consortium in Chicago: cocaine-associated wide-complex dysrhythmias and cardiac arrest - treatment nuances and controversies.
Topics: Amiodarone; Anti-Arrhythmia Agents; Anticonvulsants; Antidotes; Arrhythmias, Cardiac; Charcoal; Coca | 2008 |
Short-term amiodarone treatment attenuates the production of monocyte cytokines and chemokines by C-reactive protein and improves cardiac function in patients with idiopathic dilated cardiomyopathy and ventricular tachycardia.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; C-Reactive Protein; Cardiomyopathy, Dilated; Cells, Cultur | 2009 |
Implantable cardioverter defibrillator therapy for patients with chronic Chagas' disease: a randomized trial may not be necessary in high-risk patients.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Chagas Cardiomyopathy; Chagas Disease; Chronic Disease; | 2009 |
Does anti-inflammatory action of amiodarone explain the high efficacy in patients with heart failure?
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; C-Reactive Protein; Cardiomyopathy, Dilated; Cells, Cultur | 2009 |
Management of isolated yew berry toxicity with sodium bicarbonate: a case report in treatment efficacy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Antidotes; Drug Therapy, Combination; Electrocardiography; Human | 2009 |
Amiodarone for pediatric resuscitation: a word of caution.
Topics: Amiodarone; Anti-Arrhythmia Agents; Child; Contraindications; Diagnostic Errors; Electrocardiography | 2009 |
Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: a report from the North American ARVC Registry.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventric | 2009 |
Empiric antiarrhythmic drug therapy in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia: pragmatism or anachronism?
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular Dy | 2009 |
Termination of recurrent ventricular tachycardia by continuous positive airway pressure ventilation.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Carbazoles; Cardiomyopathy, H | 2009 |
Severe ventricular arrhythmias in a patient with cardiac sarcoidosis: insights from MRI and PET imaging and importance of early corticosteroid therapy.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Defibrillators, Implantable; Humans; Hy | 2010 |
A case of myotonic dystrophy presenting with ventricular tachycardia and atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Defibrillators, Implantable | 2009 |
Longitudinal analysis of the depressive effects of intravenous amiodarone on depolarization and repolarization: a case report.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Depression, Chemical; Electrocard | 2009 |
Ventricular tachycardia revealing a left ventricular aneurysm.
Topics: Administration, Oral; Adult; Amiodarone; Anti-Arrhythmia Agents; Calcinosis; Electric Countershock; | 2009 |
Septal ventricular tachycardia with alternating LBBB-RBBB morphology in isolated ventricular noncompaction.
Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Bundle-Branch Block; Catheter Ablation; Echocardiogr | 2010 |
Ventricular tachycardia after ingestion of ayurveda herbal antidiarrheal medication containing aconitum.
Topics: Aconitum; Amiodarone; Anti-Arrhythmia Agents; Diarrhea; Electrocardiography; Follow-Up Studies; Huma | 2010 |
Mortality and safety of catheter ablation for antiarrhythmic drug-refractory ventricular tachycardia in elderly patients with coronary artery disease.
Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Amiodarone; Anti-Arrhythmia Agents; Body Surface Pot | 2010 |
Amiodarone or procainamide for the termination of sustained stable ventricular tachycardia: an historical multicenter comparison.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cohort Studies; Drug Administration Schedule; Electrocardi | 2010 |
Interactive medical case. The beat goes on.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Biopsy; Bundle-Branch Block; Cardiomyopathy, Dilated; Def | 2010 |
Clinical problem-solving. The beat goes on.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrioventricular Block; Biopsy; Cardiomyopathies; Diagnosis, Dif | 2010 |
Suppression of ventricular tachycardia with dronedarone: a case report.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Dronedarone; Humans; Male; Secondary Pr | 2011 |
Acute amiodarone promotes drift and early termination of spiral wave re-entry.
Topics: Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Disease | 2010 |
Homozygous mutation in SCN5A associated with atrial quiescence, recalcitrant arrhythmias, and poor capture thresholds.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Cardiopulmonar | 2011 |
Antiarrhythmic drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarction.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cohort Studies; Confidence Intervals; Dose-Response Relati | 2011 |
A patient with recurrent atrial fibrillation and monomorphic ventricular tachycardia treated successfully with dronedarone.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Defibrillators, Implantable; Dronedar | 2011 |
PMS: premenstrual storm? An unusual cause of electrical storm in a young woman with vasospastic angina.
Topics: Adult; Amiodarone; Angina Pectoris, Variant; Biomarkers; Defibrillators, Implantable; Diltiazem; Dru | 2011 |
A comparison of long-standing implantable cardioverter-defibrillator patients with and without appropriate therapy for ventricular arrhythmias: impact of a widening QRS.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Combined Modality Ther | 2011 |
Drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarction: What does the crystal ball tell you?
Topics: Amiodarone; Anti-Arrhythmia Agents; Critical Care; Critical Illness; Electrocardiography; Female; Hu | 2011 |
Efficacy and safety of dofetilide in the treatment of frequent ventricular tachyarrhythmias after amiodarone intolerance or failure.
Topics: Amiodarone; Cohort Studies; Female; Humans; Male; Phenethylamines; Sulfonamides; Tachycardia, Ventri | 2011 |
Letter by Ayalloore and LeLorier regarding article, "Relationship between nonsustained ventricular tachycardia after non-ST-elevation acute coronary syndrome and sudden cardiac death: observations from the Metabolic Efficiency with Ranolazine for Less Isc
Topics: Acetanilides; Acute Coronary Syndrome; Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; E | 2011 |
Ventricular tachycardia ablation remains treatment of last resort in structural heart disease: argument for earlier intervention.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Catheter Ablation; Chi-Square Distribution; Defibrillators | 2011 |
Safety of nerve conduction studies in patients with implantable cardioverter-defibrillators.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Electromagnetic Phenomena; Fe | 2012 |
Electrocardiography Series. What is the cause of the regular wide QRS complex tachycardia?
Topics: Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Bundle-Branch Block; Cardiology; Diagnosis, D | 2011 |
Proarrhythmic potential of amiodarone: an underestimated risk?
Topics: Action Potentials; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathy, Dilated | 2012 |
Incessant ventricular tachycardia and cardiogenic shock: a common presentation of an uncommon diagnosis.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Biopsy; Blood Chemical Analysis; Cardiac Catheterization; | 2011 |
Guidelines for the diagnosis and management of arrhythmogenic right ventricular cardiomyopathy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular Dysplasia; Defibrillators, Impl | 2011 |
Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocks.
Topics: Acetanilides; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Cohort Studies; Def | 2011 |
[79-year-old patient with dyspnoea and blue skin colour].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Coronary Disease; Cyanosis; Dermatitis, Photoallergic; Dia | 2011 |
Incessant monomorphic ventricular tachycardia induced by the proarrhythmic effect of amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Electrocardiography; Female; Humans; Injections, Intravenous; Midd | 2011 |
Acute inhibition of the Na(+)/Ca(2+) exchanger reduces proarrhythmia in an experimental model of chronic heart failure.
Topics: Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Disease Models, Animal; Heart; Heart | 2012 |
Amiodarone-induced thyrotoxicosis with thyroid papillary cancer in multinodular goiter: case report.
Topics: Amiodarone; Anti-Arrhythmia Agents; Carcinoma; Carcinoma, Papillary; Goiter, Nodular; Humans; Male; | 2012 |
Retrospective evaluation of the use of amiodarone in dogs with arrhythmias (from 2003 to 2010).
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dog Diseases; Dogs; Female; Follo | 2012 |
A neonate with long QT syndrome, refractory ventricular arrhythmias, and lidocaine toxicity.
Topics: Amiodarone; Anesthetics, Local; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; DNA Mutational A | 2012 |
Therapy-resistant ventricular tachycardia caused by amiodarone-induced thyrotoxicosis: a case report of electrical storm.
Topics: Amiodarone; Anti-Arrhythmia Agents; Electrocardiography; Emergency Service, Hospital; Heart; Humans; | 2012 |
Recurrent ventricular tachycardia in a child with juvenile dermatomyositis - an unusual association.
Topics: Amiodarone; Anti-Arrhythmia Agents; Child; Dermatomyositis; Fatal Outcome; Humans; Immunosuppressive | 2012 |
Amiodarone-induced pulmonary toxicity.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Humans; Lung Diseases; Male; Tachycardia, Ventricular; Tom | 2012 |
Challenges in cardiac resynchronization therapy-defibrillator upgrade in a patient with right pneumonectomy.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiac Resynchronization Therapy; Defibrillators, Implant | 2012 |
Large right ventricular fibroma in a 6-month-old infant.
Topics: Amiodarone; Anti-Arrhythmia Agents; Echocardiography; Female; Fibroma; Heart Neoplasms; Heart Ventri | 2012 |
Possible proarrhythmia with dronedarone.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Dronedarone; Electrocardiography; Humans; M | 2013 |
The presence of giant epsilon waves in a patient with arrhythmogenic right ventricular cardiomyopathy.
Topics: Amiodarone; Arrhythmogenic Right Ventricular Dysplasia; Defibrillators, Implantable; Echocardiograph | 2012 |
Low doses of ranolazine and dronedarone in combination exert potent protection against atrial fibrillation and vulnerability to ventricular arrhythmias during acute myocardial ischemia.
Topics: Acetanilides; Amiodarone; Animals; Atrial Fibrillation; Chromatography, High Pressure Liquid; Diseas | 2013 |
[Recurrent failed ICD therapy of ventricular tachycardia].
Topics: Aged; Amiodarone; Anterior Wall Myocardial Infarction; Anti-Arrhythmia Agents; Atrioventricular Node | 2012 |
Bidirectional ventricular tachycardia due to coronary allograft vasculopathy a unique presentation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Coronary Artery Disease; Defibrillators, Implantable; Drug-Eluti | 2012 |
Ventricular tachycardia in "end stage" hypertrophic cardiomyopathy: a role of dronedarone.
Topics: Adult; Amiodarone; Cardiomyopathy, Hypertrophic; Dronedarone; Humans; Male; Tachycardia, Ventricular | 2012 |
Implantable cardiac defibrillators.
Topics: Amiodarone; Anti-Arrhythmia Agents; Combined Modality Therapy; Defibrillators, Implantable; Humans; | 2002 |
Acute hepatitis induced by parenteral amiodarone.
Topics: Acute Disease; Aged; Amiodarone; Anti-Arrhythmia Agents; Chemical and Drug Induced Liver Injury; Dos | 2002 |
Life after a ventricular arrhythmia.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Female; Follow-Up Studies; He | 2002 |
Effect of risk stratification on cost-effectiveness of the implantable cardioverter defibrillator.
Topics: Amiodarone; Anti-Arrhythmia Agents; Clinical Trials as Topic; Cost-Benefit Analysis; Death, Sudden, | 2002 |
Ischemia versus amiodarone induced polymorphic ventricular tachycardia.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Diagnosis, Differe | 2002 |
Is KL-6 a serum indicator of early pulmonary fibrosis in childhood cancer patients?
Topics: Amiodarone; Anti-Arrhythmia Agents; Antigens; Antigens, Neoplasm; Biomarkers; Biopsy; Bone Marrow Tr | 2003 |
Life support treatment.
Topics: Adenosine; Amiodarone; Anti-Arrhythmia Agents; Electric Countershock; Humans; Life Support Care; Myo | 2002 |
Incremental net benefit in randomized clinical trials with quality-adjusted survival.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cost-Benefit Analysis; Health Care Costs; Heart Arrest; Humans; | 2003 |
Monitoring of hepatic function during amiodarone therapy.
Topics: Administration, Oral; Aged; Amiodarone; Analysis of Variance; Chemical and Drug Induced Liver Injury | 2003 |
Hemodynamics during chronic amiodarone administration in Japanese patients with idiopathic dilated cardiomyopathy and ventricular arrhythmia: a retrospective study.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Drug Administration Schedu | 2003 |
Successful resuscitation of a patient with electrical storm.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Combined Modality Therapy; Electric Countershock; Female; | 2003 |
Retinal evaluation of patients on chronic amiodarone therapy.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electroretinography; Female; Fluoresc | 2003 |
Clinical usefulness of electrophysiologic testing in patients with ventricular tachycardia and chronic chagasic cardiomyopathy treated with amiodarone or sotalol.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Brazil; Chagas Cardiomyopathy; Death, Sudden, Cardiac; Dr | 2003 |
Do we need a randomized trial of defibrillator therapy in every subset of patients with increased risk of sudden death?
Topics: Amiodarone; Anti-Arrhythmia Agents; Chagas Cardiomyopathy; Death, Sudden, Cardiac; Defibrillators, I | 2003 |
The role of amiodarone in the management of patients with cardiac arrest.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Heart Arrest; Humans; Practice Gu | 2000 |
Study of precursors of ventricular tachycardia from data stored in the memory of a dual chamber implantable cardioverter defibrillator.
Topics: Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Female; Humans; Male; Middle Aged; | 2003 |
Differential diagnosis and clinical course of amiodarone-induced thyroid dysfunction.
Topics: Adult; Aged; Amiodarone; Antithyroid Agents; Atrial Fibrillation; Diagnosis, Differential; Female; H | 2003 |
Electrical storm: case series and review of management.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Anti-Obesity Agents; B | 2003 |
Verapamil sensitive idiopathic ventricular tachycardia in an infant.
Topics: Amiodarone; Anti-Arrhythmia Agents; Drug Resistance; Drug Therapy, Combination; Electrocardiography; | 2003 |
Shocks from pacemaker cardioverter defibrillators increase with amiodarone in patients at high risk for sudden cardiac death.
Topics: Aged; Amiodarone; Case-Control Studies; Death, Sudden, Cardiac; Defibrillators, Implantable; Dose-Re | 2003 |
Percutaneous cardiopulmonary support aids resuscitation from sustained ventricular tachycardia.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Assisted Circulation; Humans; Imidazoles; Male; Resuscitat | 2003 |
Increase in ventricular tachycardia frequency after biventricular implantable cardioverter defibrillator upgrade.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Defibrillators, Implantable; Humans; | 2003 |
[Clinical study of ventricular tachycardia in children].
Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Child; Child, Preschool; Emergency Medical Services; | 2003 |
Images in cardiovascular medicine. Fatal bidirectional and polymorphic ventricular tachycardia with terminal depolarization abnormality in a child.
Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Combined Modality Therap | 2004 |
Radioiodine ablation of the thyroid to prevent recurrence of amiodarone-induced thyrotoxicosis in patients with resistant tachyarrhythmias.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Humans; Iodine Radioisotopes; Male; | 2004 |
Can amiodarone be restarted after amiodarone-induced thyrotoxicosis?
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Humans; Male; Medical Records; Recurrence; Tachycardia, Ve | 2004 |
[Prevention of recurrent amiodarone-induced hyperthyroidism by iodine-131].
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Hea | 2004 |
Amiodarone versus implantable cardioverter defibrillator for asymptomatic nonsustained ventricular tachycardia in nonischemic dilated cardiomyopathy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Defibrillators, Implantable; Evidence-B | 2004 |
Bidirectional ventricular tachycardia resulting from digoxin and amiodarone treatment of rapid atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Digoxin; Drug Synergism; Drug Therapy | 2004 |
Syndrome of inappropriate antidiuretic hormone secretion induced by amiodarone therapy.
Topics: Administration, Oral; Aged; Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Diagnos | 2004 |
Randomized clinical trials: how long should they last?
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cost-Benefit Analysis; Death, Sudden, Card | 2004 |
Excessive increase in QT interval and dispersion of repolarization predict recurrent ventricular tachyarrhythmia after amiodarone.
Topics: Amiodarone; Anti-Arrhythmia Agents; Electrocardiography; Female; Humans; Male; Middle Aged; Prognosi | 2004 |
Inappropriate single chamber ICD discharges due to supraventricular tachycardia with high degree atrioventricular block.
Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Electrocardiography; Eq | 2004 |
A patient with sustained ventricular tachycardia: identification of a responder to amiodarone using signal-averaged electrocardiogram.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Electrocardiography; Humans; Male; Signal Processing, Comp | 2004 |
Advantages and pitfalls of combining device-based and pharmacologic therapies for the treatment of ventricular arrhythmias: observations from a tertiary referral center.
Topics: Amiodarone; Anti-Arrhythmia Agents; Bradycardia; Combined Modality Therapy; Defibrillators, Implanta | 2004 |
An unusual case of ventricular tachycardia.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Cardiac Catheterization; Electrocardiography; Humans; Mal | 2005 |
Wide complex tachycardia: what is the mechanism?
Topics: Amiodarone; Defibrillators, Implantable; Electrocardiography; Humans; Male; Middle Aged; Tachycardia | 2005 |
Suppression by propranolol and amiodarone of an electrical storm refractory to metoprolol and amiodarone.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Defibrillator | 2005 |
[Positive troponin T in a chagasic patient with sustained ventricular tachycardia and no obstructive lesions on cine coronary angiography].
Topics: Amiodarone; Anti-Arrhythmia Agents; Biomarkers; Chagas Cardiomyopathy; Cineangiography; Coronary Ang | 2005 |
A comparison of the AVID and DAVID trials of implantable defibrillators.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; D | 2005 |
Ventricular tachycardia following naloxone administration in an illicit drug misuse.
Topics: Adult; Amiodarone; Analgesics, Opioid; Anti-Arrhythmia Agents; Cocaine; Dopamine Uptake Inhibitors; | 2005 |
[Radiofrequency ablation of ventricular tachycardia in a patient after surgery for Tetralogy of Fallot: case report].
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Catheter Ablation; Electrocardiography; Female; Humans; P | 2005 |
Bilateral upper extremity thrombophlebitis related to intravenous amiodarone: a case report.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arm; Humans; Infusions, Intravenous; Male; Middle Aged; Tachycar | 2005 |
Proarrhythmias and antiarrhythmias: two sides of the same coin.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing | 2005 |
Potential proarrhythmic effect of biventricular pacing: fact or myth?
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac | 2005 |
Effect of lidocaine and amiodarone on transmural heterogeneity of ventricular repolarization in isolated rabbit hearts model of sustained global ischemia.
Topics: Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Electrocardiography; Female; Heart V | 2005 |
Amiodarone toxicity presenting as pulmonary mass and peripheral neuropathy: the continuing diagnostic challenge.
Topics: Amiodarone; Anti-Arrhythmia Agents; Humans; Male; Middle Aged; Peripheral Nervous System Diseases; S | 2006 |
Amiodarone is poorly effective for the acute termination of ventricular tachycardia.
Topics: Aged; Aged, 80 and over; Amiodarone; Combined Modality Therapy; Dose-Response Relationship, Drug; El | 2006 |
The quest for a terminator.
Topics: Amiodarone; Clinical Protocols; Drug Evaluation; Emergency Medicine; Humans; Research Design; Tachyc | 2006 |
Clinical significance of the electrophysiologic study (EPS)-guided therapy for the secondary prevention of ventricular tachycardia.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Catheter Ablation; Defibrilla | 2006 |
Comparing intravenous amiodarone or lidocaine, or both, outcomes for inpatients with pulseless ventricular arrhythmias.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Hear | 2006 |
[Bradycardia in an elderly woman caused by amiodarone assessed by ECG].
Topics: Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Bradycardia; Electrocardiography; Female; Hum | 2006 |
Amiodarone-induced pulmonary hemorrhage.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Biomarkers; Hemorrhage; Humans; Lung Diseas | 2006 |
Amiodarone-induced alveolar hemorrhage.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Hemorrhage; Humans; Lung Diseases; Ma | 2006 |
Fatal case of amiodarone-induced acute respiratory distress syndrome in a patient with severe left ventricular dysfunction due to extensive anterior acute myocardial infarction.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Fatal Outcome; Humans; Male; Myocardial Infarction; Respir | 2006 |
Tachycardia-induced elevations in cardiac troponin in the absence of coronary artery disease.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Catheter Abla | 2006 |
Follow-up defibrillator testing for antiarrhythmic drugs: probability and uncertainty.
Topics: Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Follow-Up Studies; Humans; Probabil | 2006 |
Amiodarone induced thrombophlebitis.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Catheterization; Hand; Humans; Infusions, Intravenous; Mal | 2006 |
[Eleven-years long follow-up in a patient after myocardial infarction, with low ejection fraction and recurrent ventricular tachycardia. The role of implantable cardioverter defibrillator and selective ablation].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Catheter Ablation; Defibrillators, Implantable; Electrophy | 2006 |
Anesthetic management of an AAI pacemaker patient with paroxysmal atrial fibrillation during colorectal surgery.
Topics: Aged; Amiodarone; Anesthesia, General; Anti-Arrhythmia Agents; Atrial Fibrillation; Atropine; Bradyc | 2006 |
Ventricular tachycardia induced by abuse of ephedrine in a young healthy woman.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Electrocardiography; Electrophysiology; Ephedrine; Female | 2006 |
Extensive scar myocardium in hypertrophic cardiomyopathy with severe myocardial bridge.
Topics: Adult; Amiodarone; Cardiomyopathy, Hypertrophic; Cicatrix, Hypertrophic; Combined Modality Therapy; | 2007 |
[Polymorphic ventricular tachycardia in acute myocardial infarction without ST elevation in a patient with thrombocytopenia].
Topics: Acute Disease; Aged; Amiodarone; Anti-Arrhythmia Agents; Coronary Angiography; Electrocardiography; | 2006 |
[Myocarditis and arrhythmogenic dysplasia of right ventricle].
Topics: Aged; Amiodarone; Arrhythmogenic Right Ventricular Dysplasia; Bundle-Branch Block; Cardiac Pacing, A | 2006 |
Appropriate ICD therapy in patients with idiopathic dilated cardiomyopathy: long term follow-up.
Topics: Adrenergic beta-Antagonists; Amiodarone; Cardiomyopathy, Dilated; Defibrillators, Implantable; Femal | 2006 |
Amiodarone and polymorphic ventricular tachycardia: to slow down or to accelerate the underlying rhythm?
Topics: Aged; Aged, 80 and over; Amiodarone; Angioplasty, Balloon, Coronary; Anti-Arrhythmia Agents; Atrial | 2006 |
[Arrhythmic storm induced by AICD discharge in a patient with catecholaminergic polymorphic ventricular tachycardia].
Topics: Administration, Oral; Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Catecholamines | 2006 |
Low dose amiodarone associated cirrhosis.
Topics: Amiodarone; Anti-Arrhythmia Agents; Diagnosis, Differential; Humans; Liver Cirrhosis; Liver Function | 2007 |
[Cardioversion of amiodarone-insensitive atrial fibrillation by bepridil in heart failure: two case reports].
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bepridil; Cardiomy | 2006 |
QT dispersion significantly increases after implantable cardioverter-defibrillator shocks.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Electric Countershock; | 2007 |
Comparative antiarrhythmic efficacy of amiodarone and dronedarone during acute myocardial infarction in rats.
Topics: Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Disease Models, Animal; Dronedarone; | 2007 |
Case report: Cardiac sarcoidosis presenting with ventricular arrhythmias: case report and review of the literature.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Defibrillators, Implantable; Diagnosis, Differ | 2007 |
Antiarrhythmic induced electrical storm in Brugada syndrome: a case report.
Topics: Adrenergic beta-Agonists; Amiodarone; Anti-Arrhythmia Agents; Brugada Syndrome; Defibrillators, Impl | 2007 |
Amiodarone--avoid the danger of torsade de pointes.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Flutter; Female; Humans; Tachyca | 2008 |
A practical guide for clinicians who treat patients with amiodarone: 2007.
Topics: Amiodarone; Anti-Arrhythmia Agents; Drug Interactions; Female; Humans; Lung Diseases; Male; Tachycar | 2007 |
Circadian pattern of spontaneous ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators.
Topics: Amiodarone; Circadian Rhythm; Defibrillators, Implantable; Female; Humans; Male; Middle Aged; Tachyc | 2007 |
Ventricular tachycardia in acute fulminant myocarditis: medical management and follow-up.
Topics: Acute Disease; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Drug Th | 2008 |
Cardiac transplantation in a patient with emotionally triggered implantable cardioverter defibrillator storms.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anxiety; Bradycardia; Defibrillators, Implantable; Electric | 2007 |
Comparative effects of acute vs. chronic oral amiodarone treatment during acute myocardial infarction in rats.
Topics: Administration, Oral; Adrenergic alpha-Agonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Catech | 2007 |
Dual tachycardia in the setting of amiodarone-induced hyperthyroidism.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Electrocardiography; | 2007 |
[Practical problems of ECG in the elderly: ventricular tachycardia. Case No. 8].
Topics: Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Electrocardiography; Female; Humans; Tachycar | 2007 |
Idiopathic cardiac electrical storm.
Topics: Adrenergic beta-Antagonists; Amiodarone; Drug Therapy, Combination; Electrocardiography; Humans; Mal | 2009 |
Ventricular tachycardia and aggravation of Brugada ECG pattern in a patient with coronary artery disease and combined amiodarone and betablocker therapy.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Brugada Syndrome; Coronary Ar | 2008 |
Intravenous amiodarone for the pharmacological termination of haemodynamically-tolerated sustained ventricular tachycardia: is bolus dose amiodarone an appropriate first-line treatment?
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Female; Humans; Infusions, Intravenous; Male; Retrospectiv | 2008 |
AVID revisited: quality of life is important too.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Female; Heart Arrest; Humans; | 2008 |
Amiodarone-induced keratopathy: full-thickness corneal involvement.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Corneal Diseases; Endothelium, Corneal; Humans; Male; Micr | 2008 |
ICD patients with elevated defibrillation threshold: clinical behavior and therapeutic alternatives.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Defibrillators, Im | 2008 |
Catheter ablation in patients with ICDs.
Topics: Amiodarone; Anti-Arrhythmia Agents; Catheter Ablation; Defibrillators, Implantable; Humans; Tachycar | 2008 |
Intravenous amiodarone.
Topics: Amiodarone; Anti-Arrhythmia Agents; Clinical Trials as Topic; Drug Costs; Humans; Infusions, Intrave | 1995 |
Response to sotalol predicts the response to amiodarone during serial drug testing in patients with sustained ventricular tachycardia and coronary artery disease.
Topics: Amiodarone; Cardiac Complexes, Premature; Cardiac Pacing, Artificial; Cohort Studies; Coronary Disea | 1994 |
Usefulness of Holter monitoring in predicting efficacy of amiodarone therapy for sustained ventricular tachycardia associated with coronary artery disease.
Topics: Actuarial Analysis; Amiodarone; Cardiac Complexes, Premature; Coronary Disease; Death, Sudden, Cardi | 1994 |
AVID necessity.
Topics: Amiodarone; Arrhythmias, Cardiac; Bias; Clinical Trials as Topic; Defibrillators, Implantable; Ethic | 1994 |
Significance of supraventricular tachyarrhythmias in patients with implanted pacing cardioverter defibrillators.
Topics: Amiodarone; Atrial Fibrillation; Chemotherapy, Adjuvant; Defibrillators, Implantable; Electrocardiog | 1994 |
[Computerized tomography aspects of amiodarone poisoning].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Coronary Disease; Dose-Response Relationship, Drug; Female | 1995 |
A young man with broad-complex tachycardia.
Topics: Adult; Amiodarone; Coronary Angiography; Echocardiography; Electrocardiography; Humans; Male; Tachyc | 1995 |
Amiodarone for ventricular tachycardia after coronary artery bypass grafting.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Coronary Artery Bypass; Humans; Infusio | 1995 |
Intravenous amiodarone. Another option in the acute management of sustained ventricular tachyarrhythmias.
Topics: Amiodarone; Anti-Arrhythmia Agents; Bretylium Tosylate; Dose-Response Relationship, Drug; Female; Hu | 1995 |
Bradycardia-facilitated polymorphic ventricular tachycardia caused by amiodarone after radiofrequency modification of atrioventricular conduction.
Topics: Aged; Amiodarone; Atrial Fibrillation; Atrioventricular Node; Bradycardia; Catheter Ablation; Electr | 1995 |
Fatal hepatotoxicity following oral administration of amiodarone.
Topics: Administration, Oral; Alanine Transaminase; Alkaline Phosphatase; Amiodarone; Aspartate Aminotransfe | 1995 |
Amiodarone and lipid disorder.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Humans; Hyperlipidemias; Lipids; Male; Tachycardia, Ventr | 1995 |
Efficacy and safety of combination therapy with amiodarone and type I agents for treatment of inducible ventricular tachycardia.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Drug Therapy, Combinati | 1993 |
Predictors of defibrillation energy requirements with nonepicardial lead systems.
Topics: Amiodarone; Defibrillators, Implantable; Electric Countershock; Electrodes, Implanted; Equipment Des | 1995 |
[Complex and asymptomatic hyperkinetic ventricular arrhythmias: a daily difficult decision problem].
Topics: Adrenergic beta-Antagonists; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Arrhythmias, Card | 1994 |
Amiodarone and risk of cardiac operations.
Topics: Amiodarone; Cardiopulmonary Bypass; Contraindications; Humans; Risk Factors; Tachycardia, Ventricula | 1995 |
Flecainide and amiodarone: combined therapy for refractory tachyarrhythmias in infancy.
Topics: Amiodarone; Drug Therapy, Combination; Electrocardiography, Ambulatory; Female; Flecainide; Follow-U | 1995 |
[Clinical, neurophysiologic and biopsy findings in neurotoxic amiodarone syndrome].
Topics: Amiodarone; Dose-Response Relationship, Drug; Evoked Potentials, Somatosensory; Follow-Up Studies; H | 1994 |
Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death.
Topics: Adolescent; Adult; Amiodarone; Cardiomyopathy, Hypertrophic; Child; Death, Sudden, Cardiac; Electroc | 1993 |
Risk stratification and prognosis of patients treated with amiodarone for malignant ventricular tachyarrhythmias after myocardial infarction.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Analysis of Variance; Angiocardiography; Electrophysiolo | 1993 |
[Lethal arrhythmias in a patient with coarctation of the aorta and severe heart failure: their control by combination of low dose amiodarone with procainamide for 3 years].
Topics: Administration, Oral; Adult; Amiodarone; Aortic Coarctation; Drug Therapy, Combination; Heart Failur | 1993 |
Comparison of electrophysiologic effects of quinidine and amiodarone in sustained ventricular tachyarrhythmias associated with coronary artery disease.
Topics: Adult; Aged; Amiodarone; Coronary Disease; Electrocardiography; Female; Heart Conduction System; Hum | 1993 |
Oral amiodarone loading for the rapid treatment of frequent, refractory, sustained ventricular arrhythmias associated with coronary artery disease.
Topics: Administration, Oral; Aged; Aged, 80 and over; Amiodarone; Coronary Disease; Drug Resistance; Female | 1993 |
The implantable defibrillator and antiarrhythmic drugs--competitive and complementary treatment for severe ventricular arrhythmia.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Combined Modality Therapy; Defibrillators, | 1993 |
Amiodarone-clonazepam interaction.
Topics: Aged; Amiodarone; Clonazepam; Drug Interactions; Heart Failure; Humans; Male; Tachycardia, Ventricul | 1993 |
Is there an effect of amiodarone on the defibrillation threshold?
Topics: Adult; Amiodarone; Cardiomyopathy, Dilated; Defibrillators, Implantable; Electrocardiography; Humans | 1993 |
Amiodarone pulmonary toxicity: its radiological features.
Topics: Aged; Amiodarone; Female; Humans; Lung; Lung Diseases; Male; Middle Aged; Tachycardia, Ventricular; | 1993 |
Cyclosporine-amiodarone interaction.
Topics: Aged; Amiodarone; Cyclosporine; Drug Interactions; Drug Monitoring; Female; Humans; Kidney Transplan | 1993 |
Frequency-dependent electrophysiologic effects of amiodarone in humans.
Topics: Amiodarone; Cardiac Catheterization; Cardiac Pacing, Artificial; Cohort Studies; Follow-Up Studies; | 1993 |
A three-site programmed electrical stimulation protocol in patients with and without ventricular tachyarrhythmias.
Topics: Amiodarone; Cardiac Pacing, Artificial; Electrocardiography; Female; Humans; Male; Middle Aged; Tach | 1993 |
Risks of developing supraventricular and ventricular tachyarrhythmias after implantation of a cardioverter-defibrillator, and timing the activation of arrhythmia termination therapies.
Topics: Age Factors; Aged; Amiodarone; Arrhythmias, Cardiac; Defibrillators, Implantable; Female; Humans; In | 1993 |
Stratification of sudden death risk in patients receiving long-term amiodarone treatment for sustained ventricular tachycardia or ventricular fibrillation.
Topics: Actuarial Analysis; Amiodarone; Death, Sudden, Cardiac; Defibrillators, Implantable; Female; Follow- | 1993 |
Electrophysiologic testing in patients who respond acutely to intravenous amiodarone for incessant ventricular tachyarrhythmias.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Amiodarone; Cardiac Pacing, Artificial; Combin | 1993 |
Intravenous amiodarone for life-threatening tachyarrhythmias in children and young adults.
Topics: Adolescent; Adult; Amiodarone; Child, Preschool; Female; Follow-Up Studies; Humans; Infant; Infant, | 1993 |
Recurrent amiodarone pulmonary toxicity.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Humans; Lung; Male; Recurrence; Respiratory Distress Syndr | 1996 |
Contemporary clinical trials in ventricular tachycardia and fibrillation: implications of ESVEM, CASCADE, and CASH for clinical management.
Topics: Amiodarone; Anti-Arrhythmia Agents; Electrocardiography, Ambulatory; Electrophysiology; Heart Arrest | 1995 |
A simulation study used to design the sequential monitoring plan for a clinical trial.
Topics: Amiodarone; Anti-Arrhythmia Agents; Computer Simulation; Decision Making; Defibrillators, Implantabl | 1995 |
Effects of a new amiodarone-like agent, SR 33589, in comparison to amiodarone, D,L-sotalol, and lignocaine, on ischemia-induced ventricular arrhythmias in anesthetized pigs.
Topics: Amiodarone; Analysis of Variance; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans | 1995 |
[Symptomatic bradycardia with amiodarone in patients with pre-existing conduction disorders].
Topics: Aged; Amiodarone; Bradycardia; Bundle-Branch Block; Dose-Response Relationship, Drug; Drug Administr | 1995 |
Amiodarone for ventricular tachycardia after coronary artery bypass grafting.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Bypass; Coronary Artery Bypass; Female; He | 1996 |
QT prolongation and polymorphous ventricular tachycardia associated with trasodone-amiodarone combination.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Antidepressive Agents, Second-Generation; Drug Interaction | 1995 |
[Value of thyroidectomy in amiodarone-induced hyperthyroidism. Apropos of 3 cases].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Antithyroid Agents; Female; Humans; Hyperthyroidism | 1996 |
From first class to third class: recent upheaval in antiarrhythmic therapy--lessons from clinical trials.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Heart Conduct | 1996 |
[Combination of celiprolol and amiodarone in the treatment of recurrent ventricular tachycardia].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Celiprolol; Chronic Di | 1996 |
[Predictive factors of induction of ventricular arrhythmia under amiodarone].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Death, Sudden, Cardiac; | 1996 |
[Treatment of amiodarone-induced hyperthyroidism by carbimazole with maintenance of amiodarone].
Topics: Amiodarone; Anti-Arrhythmia Agents; Antithyroid Agents; Carbimazole; Drug Administration Schedule; F | 1996 |
Effect of amiodarone on QT dispersion in the 12-lead standard electrocardiogram and its significance for subsequent arrhythmic events.
Topics: Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Dose-Response Relationship, Drug; Drug A | 1997 |
Long-term low-dose amiodarone therapy in the management of ventricular and supraventricular tachyarrhythmias: efficacy and safety.
Topics: Amiodarone; Anti-Arrhythmia Agents; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; | 1997 |
[Implantation of a transvenous defibrillation system in isolated persistent left superior vena cava].
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Coronary Angiography; Defibrillators, I | 1997 |
Circadian modulation of ventricular tachycardia cycle length variability in ICD patients with dilated cardiomyopathy.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Circadian Rhythm; Defibrillators, | 1997 |
Implantable cardioverter defibrillators in patients with Chagas' disease: are they different from patients with coronary disease?
Topics: Age Factors; Amiodarone; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Chagas Cardiomyopathy; | 1997 |
Sustained ventricular tachycardia in cardiac hemochromatosis treated with amiodarone.
Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Biopsy; Cardiomyopathies; Electrocardiography; Hemoc | 1997 |
A case of amiodarone-induced thyrotoxicosis successfully treated with prednisolone.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Humans; Male; Prednisolone; Tac | 1997 |
[Influence of anti-arrhythmia agents on heart rate variability].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Ele | 1997 |
Clinical predictors of defibrillation energy requirements.
Topics: Age Factors; Amiodarone; Anti-Arrhythmia Agents; Cardiac Surgical Procedures; Coronary Disease; Defi | 1997 |
[Etiologies of electric storm].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Bretylium Tosylate; Electric Countershock; Female; Hemodyn | 1997 |
Enlargement of extraocular muscles during treatment with amiodarone.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Diagnosis, Differential; Exophthalmos; Follow-Up Studies; | 1997 |
Introduction: primary prevention against sudden cardiac death.
Topics: Amiodarone; Anti-Arrhythmia Agents; Controlled Clinical Trials as Topic; Death, Sudden, Cardiac; Def | 1997 |
Amiodarone induced torsades de pointes with excessive QT dispersion following quinidine induced polymorphic ventricular tachycardia.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Electrocardiography; Electrocardiography, Ambulatory; Fem | 1997 |
Why the antiarrhythmics versus implantable defibrillator (AVID) trial sets the wrong precedent.
Topics: Amiodarone; Anti-Arrhythmia Agents; Bias; Death, Sudden, Cardiac; Defibrillators, Implantable; Ethic | 1997 |
[Ventricular tachycardia in a patient with mid-ventricular hypertrophic myocardiopathy and apical aneurysm].
Topics: Aged; Amiodarone; Atrial Fibrillation; Cardiomegaly; Echocardiography, Transesophageal; Electrocardi | 1997 |
Circadian variation of sustained ventricular tachycardia in patients subject to standard adrenergic blockade.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Circadian Rhythm; Female; Hum | 1997 |
Management of incessant ventricular tachycardia in a 39-year-old woman with cardiomyopathy.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Critical Illness; Defibrillators | 1997 |
Management of patients with life-threatening ventricular tachyarrhythmias in the defibrillator era: the need to differentiate.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Defibrillators, Implantable; Electro | 1997 |
Clinical trials of implantable defibrillators.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Artery Bypass; Coronary Disease; | 1997 |
Ventricular tachycardia in valvular heart disease: facilitation of sustained bundle-branch reentry by valve surgery.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Bundle of His; Defibrillators, Implantable; Electro | 1997 |
Right bundle-branch block and ST-segment elevation in leads V1 through V3: a marker for sudden death in patients without demonstrable structural heart disease.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Amiodarone; Anti-Arrhythmia Agents; Bundle-Branch Bl | 1998 |
[Effective low-dose amiodarone therapy for ventricular tachycardia complicated with ischemic heart disease and poor left ventricular function in an elderly patient].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Humans; Male; Myocardial Ischemia; Tachycardia, Ventricula | 1997 |
Effects of class I and III antiarrhythmic drugs on ventricular tachycardia-interrupting critical paced cycle length with rapid pacing.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Child; Electrophysiology; Female; Heart | 1998 |
A case report of myolysis during high-dose amiodarone therapy for uncontrolled ventricular tachycardia.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Humans; Male; Muscle, Skeletal; Pain; S | 1998 |
Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Hypertrophic; Death, Sudden, Cardia | 1998 |
Amiodarone induced epididymitis in children.
Topics: Adolescent; Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Child; Death, Sudden, Ca | 1998 |
[Amiodarone and thyroid function: clinical implications].
Topics: Amiodarone; Anti-Arrhythmia Agents; Female; Humans; Hyperthyroidism; Male; Myocardial Infarction; Ta | 1998 |
Implantable cardioverter defibrillators--for whom?
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiac Output, Low; Cause of Death; Coronary Artery Bypass; Dec | 1998 |
[Neonatal ventricular tachycardia].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Electrocardiography; Female; Fetal | 1998 |
Effect of relatively low dose amiodarone therapy on left ventricular function in patients with ventricular tachyarrhythmias.
Topics: Administration, Oral; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Disease Pro | 1998 |
Amiodarone for control of recurrent ventricular tachycardia secondary to cardiac metastasis.
Topics: Administration, Oral; Aged; Amiodarone; Anti-Arrhythmia Agents; Carcinoma, Squamous Cell; Heart Neop | 1998 |
[Misplacement of a transvenous lead from an implantable cardioverter-defibrillator into the left ventricle via a patent foramen ovale].
Topics: Amiodarone; Cardiac Catheterization; Coronary Artery Bypass; Defibrillators, Implantable; Echocardio | 1998 |
Ventricular tachycardia during repair of gastroschisis.
Topics: Amiodarone; Anti-Arrhythmia Agents; Electric Countershock; Gastroschisis; Humans; Infant, Newborn; I | 1998 |
Spontaneous termination of ventricular tachycardia with variable patterns and variable mechanisms?
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Electrocardiography; Electrop | 1999 |
Drug-induced torsade de pointes.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Electrocardiography; Heart Arrest; Humans; Male; Procainam | 1999 |
Intravenous amiodarone suppression of electrical storm refractory to chronic oral amiodarone.
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Follow-Up Stu | 1999 |
Amiodarone-induced pulmonary toxicity in an adolescent.
Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Cardiac Surgical Procedures; Drug Therapy, Combinati | 1999 |
Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy.
Topics: Adolescent; Adult; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Hypertrophic; Child; Death, S | 1999 |
Ventricular arrhythmias and the use of antiarrhythmic drugs after cardiovascular surgery.
Topics: Amiodarone; Anti-Arrhythmia Agents; Bretylium Compounds; Cardiovascular Surgical Procedures; Clinica | 1998 |
Acute alveolar hemorrhage and orthodeoxia induced by intravenous amiodarone.
Topics: Acute Disease; Amiodarone; Anti-Arrhythmia Agents; Biopsy; Hemorrhage; Humans; Hypoxia; Lung Disease | 1999 |
Ventricular tachycardia in a patient with cardiac lipoma.
Topics: Administration, Oral; Adult; Amiodarone; Anti-Arrhythmia Agents; Electrocardiography; Follow-Up Stud | 1999 |
Hyperkalemia probably reverses the antiarrhythmic effects of amiodarone: a case report.
Topics: Acute Kidney Injury; Amiodarone; Anti-Arrhythmia Agents; Humans; Hyperkalemia; Male; Middle Aged; My | 1999 |
Prospective clinical evaluation and follow-up of a cohort of consecutive VT/VF patients, using a staged-care protocol, including coronary arteriography, programmed electrical stimulation and cardiac surgery.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Cardiac Catheterization; Cardiac | 1999 |
Beneficial effect of amiodarone on pacing induced terminability of reentrant ventricular tachycardia.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Electrocardiography; Female; Heart Conduction System; Hum | 1999 |
[Diagnostic usefulness of KL-6 measurements in patients with pulmonary complications after administration of amiodarone].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Antigens; Antigens, Neoplasm; Atrial Fibrillation; Biomark | 2000 |
Long-term follow-up of patients requiring intravenous amiodarone to suppress hemodynamically destabilizing ventricular arrhythmias.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Clinical Trials as Topic; Combined Modality Therapy; Defib | 2000 |
Early prenatal management of a fetal ventricular tachycardia treated in utero by amiodarone with long term follow-up.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Female; Fetal Diseases; Gestational Age; Heart Rate, Feta | 2000 |
Temporal and geographical trends in indications for implantation of cardiac defibrillators in Europe 1993-1998. Medtronic ICD System Investigators.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Coronary Disease; Death, Sudden, Cardiac; Defi | 2000 |
Clusters of ventricular tachycardias signify impaired survival in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillators.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Defibrillators, Implantable; Hear | 2000 |
Are implantable cardioverter- defibrillators cost-effective?
Topics: Amiodarone; Anti-Arrhythmia Agents; Cost-Benefit Analysis; Death, Sudden, Cardiac; Defibrillators, I | 2000 |
[Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone].
Topics: Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Humans; Tachycardia, Ventricular; V | 2000 |
Successful treatment of aconitine induced life threatening ventricular tachyarrhythmia with amiodarone.
Topics: Aconitine; Adjuvants, Immunologic; Amiodarone; Anti-Arrhythmia Agents; Electrocardiography; Humans; | 2000 |
Hydatid cyst of heart presenting as ventricular tachycardia.
Topics: Adolescent; Albendazole; Amiodarone; Anthelmintics; Anti-Arrhythmia Agents; Diagnosis, Differential; | 1999 |
Action stat. Amiodarone overdose.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Drug Overdose; Emergency Nursing; Emergency Treatment; Hum | 2000 |
[Role of determination of QT dispersal intervals in anti-arrhythmia therapy].
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Electrocar | 1999 |
Amiodarone-induced pulmonary interstitial fibrosis.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Humans; Male; Pulmonary Fibrosis | 2000 |
Amiodarone: the AHA's new drug of choice for victims of ventricular arrhythmias.
Topics: American Heart Association; Amiodarone; Anti-Arrhythmia Agents; Emergency Treatment; Guidelines as T | 2000 |
"Stable" ventricular tachycardia is not a benign rhythm : insights from the antiarrhythmics versus implantable defibrillators (AVID) registry.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Controlled Clinical Trials as Topic; Defibrillators, Impla | 2001 |
[Diagnostic quiz. Increasing dyspnea after bypass operation. Interstitial lung disease].
Topics: Aged; Amiodarone; Coronary Artery Bypass; Humans; Lung Diseases, Interstitial; Male; Myocardial Infa | 2001 |
Effects of intravenous amiodarone on ventricular refractoriness, intraventricular conduction, and ventricular tachycardia induction.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Dose-Response Relationship, Drug; Electrophysiology; Heart | 2000 |
Amiodarone-induced long QT and polymorphic ventricular tachycardia.
Topics: Action Potentials; Age Factors; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cathe | 2001 |
Serious arrhythmias in patients with apical hypertrophic cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmi | 2001 |
Cost-effectiveness of the implantable cardioverter defibrillator?
Topics: Amiodarone; Cost-Benefit Analysis; Defibrillators, Implantable; Humans; Multicenter Studies as Topic | 2001 |
[52-year old patient with skin discoloration].
Topics: Amiodarone; Anti-Arrhythmia Agents; Humans; Male; Melanosis; Middle Aged; Photosensitivity Disorders | 2001 |
Beneficial effects of amiodarone and dronedarone (SR 33589b), when applied during low-flow ischemia, on arrhythmia and functional parameters asssessed during reperfusion in isolated rat hearts.
Topics: Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Circu | 2001 |
Amiodarone-Induced thyroid dysfunction and ventricular tachyarrhythmias during long-term therapy in Japan.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Drug Evaluation; Female; Follow-Up Studies; Humans; H | 2001 |
[Amiodarone induced pulmonary toxicity].
Topics: Adult; Aged; Amiodarone; Cardiomyopathy, Dilated; Humans; Long-Term Care; Male; Pneumonia; Pulmonary | 2002 |
Absence of a morning peak in ventricular tachycardia and fibrillation events in nonischemic heart disease: analysis of therapies by implantable cardioverter defibrillators.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Circadian Rhythm; Defibrillators, Implantable; Female | 2001 |
Electrical storm due to amiodarone induced thyrotoxicosis in a young adult with dilated cardiomyopathy: thyroidectomy as the treatment of choice.
Topics: Adult; Amiodarone; Cardiomyopathy, Dilated; Defibrillators, Implantable; Female; Humans; Tachycardia | 2001 |
Electrical storms in an ICD-recipient with 429 delivered appropriate shocks: therapeutic management with antiarrhythmic drug combination.
Topics: Aged; Amiodarone; Cardiomyopathy, Dilated; Defibrillators, Implantable; Electrocardiography; Follow- | 2002 |
Catheter ablation and antiarrhythmic drugs for haemodynamically tolerated post-infarction ventricular tachycardia; long-term outcome in relation to acute electrophysiological findings.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Catheter Ablation; Defibrillators, | 2002 |
Long-term efficacy of empirical chronic amiodarone therapy in patients with sustained ventricular tachyarrhythmia and structural heart disease.
Topics: Amiodarone; Anti-Arrhythmia Agents; Female; Follow-Up Studies; Heart Diseases; Humans; Male; Middle | 2002 |
Absence of change of signal-averaged electrocardiogram identifies patients with ventricular arrhythmias who are non-responders to amiodarone.
Topics: Administration, Oral; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Electrocardiography; Electrop | 2002 |
[The amiodarone-beta blockers combination could represent an alternative treatment in patients at risk for sudden death in which a benefit from implantable defibrillators has not been clearly demonstrated].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Defibrillat | 2002 |
Effect of low-dose amiodarone on atrial fibrillation or flutter in Japanese patients with heart failure.
Topics: Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Atrial Fibrillation; A | 2002 |
Suppression of incessant ventricular tachycardia in hypertrophic cardiomyopathy associated with improvement of severe left ventricular dysfunction.
Topics: Adult; Amiodarone; Cardiomyopathy, Hypertrophic; Electrocardiography; Humans; Male; Pacemaker, Artif | 1992 |
Frequency dependent effects of d-sotalol and amiodarone on the action potential duration of the human right ventricle.
Topics: Action Potentials; Administration, Oral; Aged; Amiodarone; Cardiac Pacing, Artificial; Female; Heart | 1992 |
[Evaluation of efficacy of amiodarone by electrophysiologic studies in patients with sustained ventricular tachycardia].
Topics: Amiodarone; Drug Evaluation; Electrocardiography; Electrophysiology; Female; Humans; Male; Middle Ag | 1992 |
Hepatotoxicity of amiodarone.
Topics: Aged; Amiodarone; Biopsy; Chemical and Drug Induced Liver Injury; Coronary Disease; Follow-Up Studie | 1992 |
[Ventricular tachycardia in a patient with rate-responsive cardiac pacemaker].
Topics: Aged; Amiodarone; Electrocardiography, Ambulatory; Heart Failure; Heart Rate; Humans; Male; Pacemake | 1992 |
Arrhythmia and hypertrophic cardiomyopathy.
Topics: Amiodarone; Atrial Fibrillation; Cardiomyopathy, Hypertrophic; Death, Sudden, Cardiac; Digoxin; Elec | 1992 |
[Cardiomyopathy induced by incessant ventricular tachycardia ("tachycardiomyopathy"): cure after control of arrhythmia].
Topics: Amiodarone; Cardiomyopathy, Dilated; Child; Electrocardiography; Heart Rate; Humans; Male; Tachycard | 1992 |
Cost effectiveness of the implantable cardioverter defibrillator: a preliminary analysis.
Topics: Amiodarone; Cost-Benefit Analysis; Death, Sudden, Cardiac; Defibrillators, Implantable; Electric Cou | 1992 |
Efficacy of beta-blocking agents in reducing the number of shocks in patients implanted with first-generation automatic defibrillators.
Topics: Acebutolol; Adolescent; Adult; Aged; Amiodarone; Combined Modality Therapy; Dose-Response Relationsh | 1992 |
Adverse effects of oral amiodarone therapy.
Topics: Administration, Oral; Adult; Aged; Amiodarone; Dose-Response Relationship, Drug; Female; Humans; Mal | 1992 |